Dokumentide edastamine

1 (1)

D(2025)0064

Helsinki, 27 January 2025 SMG/kg

P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu

For the attention of the Permanent Representations of the Member States to the European Union

Per email only

Subject: ECHA Single Programming Document 2025-2027 (final)

Your Excellency,

At its meeting from 12 to 13 December 2024, the Management Board of the European Chemicals Agency (ECHA) adopted the final ECHA Single Programming Document

2025-2027.

I am pleased to submit to you the above-mentioned document.

The final Single Programming Document 2025-2027 also be published on ECHA’s website (www.echa.europa.eu/plans-and-reports).

Should you, or your services, have any queries related to the documents, please do not hesitate to contact me.

Yours sincerely,

Dr Sharon McGuinness

Executive Director

Encl: Final ECHA Single Programming Document 2025-2027

Cc.: Sofia Zisi, Chair of the ECHA Management Board

1 (1)

D(2025)0064

Helsinki, 27 January 2025 SMG/kg

P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu

For the attention of the Permanent Representations of the Member States to the European Union

Per email only

Subject: ECHA Single Programming Document 2025-2027 (final)

Your Excellency,

At its meeting from 12 to 13 December 2024, the Management Board of the European Chemicals Agency (ECHA) adopted the final ECHA Single Programming Document

2025-2027.

I am pleased to submit to you the above-mentioned document.

The final Single Programming Document 2025-2027 also be published on ECHA’s website (www.echa.europa.eu/plans-and-reports).

Should you, or your services, have any queries related to the documents, please do not hesitate to contact me.

Yours sincerely,

Dr Sharon McGuinness

Executive Director

Encl: Final ECHA Single Programming Document 2025-2027

Cc.: Sofia Zisi, Chair of the ECHA Management Board

ECHA Single Programming Document 2025-2027 0

Single Programming Document

2025 – 2027

ECHA Single Programming Document 2025-2027 1

ECHA Single Programming Document 2025-2027

Helsinki, 13 December 2024

Doc: MB/32/2024 final

Reference: ECHA-25-R-01-EN

ISBN: 978-92-9468-467-7 ISSN: 2467-4532

Cat. Number: ED-01-25-001-EN-N

DOI: 10.2823/1867512 Publ. date: January 2025

Language: EN

© European Chemicals Agency, 2025

Cover page © European Chemicals Agency

If you have questions or comments in relation to this document, please send them (quote the reference and issue date) using the information request form. The information request form can be

accessed via the Contact ECHA page at:

http://echa.europa.eu/contact

European Chemicals Agency

Mailing address: P.O. Box 400, FI-00121 Helsinki, Finland

Visiting address: Telakkakatu 6, 00121 Helsinki, Finland

ECHA Single Programming Document 2025-2027 2

Table of Contents

Foreword .......................................................................................................................... 4 List of Acronyms .............................................................................................................. 5 Strategy Statement .......................................................................................................... 8 I General context ........................................................................................................... 10 II Multi-annual programming (2025–2028) ................................................................... 15 1. Multiannual Work Programme 2025–2028 ............................................................... 15 2. Human and financial resource outlook 2025-2028 ................................................... 25

2.1 Overview of the past and current situation ................................................................................. 25

2.2 Outlook for the years 2025-2028 .............................................................................................. 25

2.3 Resource programming for the years 2025-2028 ........................................................................ 26

2.4 Negative priorities/decrease of existing tasks ............................................................................. 29

2.5 Strategy for efficiency gains..................................................................................................... 29

III Work Programme ...................................................................................................... 31 Executive Summary ........................................................................................................ 31 1. REACH/CLP ................................................................................................................ 32

1.1 Dossier preparation ................................................................................................................... 32

1.2 Dossier submission and processing .............................................................................................. 33

1.3 Identification and prioritisation of (groups of) substances ................................................................ 35

1.4 Evaluation ................................................................................................................................ 37

1.5 Authorisation ............................................................................................................................ 39

1.6 Restrictions .............................................................................................................................. 42

1.7 Classification and Labelling ......................................................................................................... 44

1.8 Data management ..................................................................................................................... 46

1.9 Making data publicly available ..................................................................................................... 48

1.10 Promotion of alternatives to animal testing .................................................................................. 49

2. Biocides ...................................................................................................................... 51 3. Environmental Policy .................................................................................................. 55 4. Other tasks, including tasks under grant, cooperation and service-level agreement .. 61 5. Governance and enablers ........................................................................................... 65 Annexes ......................................................................................................................... 76

Annex I: Organisation ..................................................................................................................... 77

A. Organisation chart of the Agency (Staff in place as at 31/12/2024) .................................................... 77

B. Overview of regulatory tasks of the Agency .................................................................................... 78

Annex II: Resource allocation per activity ........................................................................................... 86

Annex III: Financial resources .......................................................................................................... 87

Annex IV: Human resources - quantitative ........................................................................................ 102

Annex V: Human resources - qualitative ............................................................................................ 110

Annex VI: Environment management ............................................................................................... 117

Annex VII: Building policy ............................................................................................................... 118

Annex VIII: Privileges and immunities .............................................................................................. 119

Annex IX: Evaluations and audits ..................................................................................................... 120

Annex X: ...................................................................................................................................... 121

ECHA Single Programming Document 2025-2027 3

A. ECHA Integrated Management System and Framework .................................................................... 121

B. Anti-Fraud Strategy .................................................................................................................... 123

Annex XI: Plan for grant, contribution or service-level agreements ........................................................ 125

Annex XII: Strategy for cooperation with third countries and/or international organisations ...................... 127

ECHA Single Programming Document 2025-2027 4

Foreword

We are pleased to present our Single Programming Document for the years 2025-2027, as well as the

detailed annual work programme for 2025.

This is the second year for implementation of our current strategy statement 2024-2028. Our vision, chemical safety through science, collaboration and knowledge, has informed the actions presented here

and will continue to guide us as we deliver our strategy over the next four years. At the core of implementing our strategic goals is our legal mandate and the protection of health and the environment

through our work on chemical safety. We will continue to implement our legal mandate by providing transparent, independent and high-quality scientific opinions and decisions, by collaborating with our EU

institutional partners and Member States as well as industry and NGO stakeholders and by sharing and

advancing knowledge and understanding on chemical safety.

In the coming period, we will implement in full the tasks that have been assigned to us in relation to

drinking water, batteries, serious cross-border threats to health, and industrial emissions. We also anticipate that the One Substance, One Assessment legislation package will be agreed, and planning for

implementation will commence once this is in place. Following the revision of the CLP regulation, we

expect to see proposals from the Member States, and the Commission, on the new hazard classifications.

Further to the review of the Integrated Regulatory Strategy (IRS), our focus will be on maintaining our knowledge about the chemicals in our databases and to deliver risk management for (groups of)

substances. In switching focus to delivering risk management outcomes, we will need to collaborate

closely with Member States and the Commission. We will also need to consider risk management options outside of REACH and CLP and look to measures that can be achieved under our new legislative

mandates.

In delivering scientific opinions and decisions, ECHA relies not just on the expertise of our staff but also

the expertise and experience of the members in our committees and working groups. Ensuring these bodies are sustainable and fully resourced continues to be an important focus of our collaborative efforts

with the Commission, Member States and other stakeholders. To support our committees, we will deliver

opportunities for learning to committee members and Member States.

As the EU’s chemicals agency, ECHA recognises that our role is delivered in collaboration with many

others. One of the many groups that we engage with are the other EU Agencies – EFSA, EMA, ECDC and EEA. We anticipate increased co-operation and engagement with these agencies in the coming years as

we implement the One Substance, One Assessment legislation proposal and the One Health Joint

Framework for Action.

Finally, we will take account of the findings of the organisational review completed in 2024 to ensure that ECHA is structured and working to deliver current and future tasks. We also anticipate proposals for

a revised REACH Regulation and an ECHA Basic Regulation from the Commission in the coming period. For ECHA, the Basic Regulation is necessary for several reasons – the consolidation of our current and

future mandate, the continuity of our scientific committees and the simplification of our resourcing

conditions (financial and people). ECHA will work closely with the Commission to provide our input and support the development and implementation of both the Basic Regulation and REACH Regulation

proposals.

Sofia Zisi Sharon McGuinness

Chair of the Management Board Executive Director

ECHA Single Programming Document 2025-2027 5

List of Acronyms

Acronym Description

AD Administrator

APCRA Accelerating the Pace of

Chemical Risk Assessment

ARN Assessment of regulatory needs

AST Assistant

BAT Best Available Technique

BEF BPR-EN-FORCE (Forum-

coordinated BPR enforcement project)

BPC Biocidal Products Committee

BPR Biocidal Products Regulation

BPRS BPR Subgroup of the Forum

BREF Best Available Techniques Reference documents

C&L Classification and labelling

CA Contract agent

CAD Chemical Agents Directive

98/24/EC

CCH Compliance check

CDPC Common Data Platform for Chemicals

CEOS

Conditions of Employment of Other Servants of the European Union

Chesar Chemical Safety Assessment and Reporting tool

CLH Harmonised classification and

labelling

CLP

Classification, labelling and packaging (and the respective Regulation)

CMR Carcinogens, Mutagens and Reprotoxic substances

CMRD

Carcinogens, Mutagens and

Reprotoxic substances Directive 2004/37/EC, CMD until 9 March 2022)

CMS Chemical Management System

COM European Commission

CoRAP Community rolling action plan

CSS

Chemicals Strategy for

Sustainability of the Commission

Acronym Description

DG EMPL

Directorate General for Employment, Social Affairs and

Inclusion

DG GROW

Directorate General for Internal Market, Industry,

Entrepreneurship and SMEs

DG NEAR

Directorate General for Neighbourhood and

Enlargement Negotiations

DNA Designated national authorities

DWD Drinking Water Directive

EAP Environmental Action

Programme

ECHA European Chemicals Agency

ECDC European Centre for Disease

Prevention and Control

ED Endocrine disruptors

EEA European Environment Agency

EFSA European Food Safety Authority

EFTA European Free Trade Association

EIPPCB European Integrated Pollution Prevention and Control Bureau

ELV Directive on end-of-life

vehicles

EMA European Medicines Agency

EMAS Eco-Management and Audit

Scheme

ENVI

European Parliament's Committee on Environment, Public Health and Food Safety

EPAA

European Partnership for Alternative Approaches to Animal Testing

EQS Environmental Quality Standards Directives

ESPR Ecodesign for Sustainable

Products Regulation

EU European Union

EUAN EU Agencies Network

EUCLEF European Union Chemicals

Legislation Finder

ECHA Single Programming Document 2025-2027 6

Acronym Description

EUON European Union Observatory

for Nanomaterials

EUSES European Union System for the Evaluation of Substances

Forum Forum for Exchange of Information on Enforcement

FRA Final regulatory action

GFC Global Framework on Chemicals

GHG Greenhouse gases

GHS

Globally Harmonized System of Classification and Labelling of Chemicals

HelpNet Network of national BPR, CLP

and REACH helpdesks

HR Human resources

IARC International Agency for

Research on Cancer

ICT Information communications technology

IED Industrial Emissions Directive 2010/75/EU

IMS Integrated Management System

IPA Instrument for Pre-Accession Assistance

IRS Integrated Regulatory Strategy

ISO International Organisation for Standardisation

IUCLID International Uniform Chemical

Information Database

JEAP Joint Evaluation Action Plan

MB Management Board

MFF Multiannual financial

framework

MSC Member State Committee

MSCA Member State competent

authority

NAMs New Approach Methodologies

NEA National Enforcement Authority

NGO Non-governmental organization

NPS Net Promoter Score

OECD Organisation for Economic Co- operation and Development

OEL Occupational exposure limit

Acronym Description

OSOA One Substance, One

Assessment

PACT/ ACT Public activities coordination tool

PARC Partnership for the Assessment of Risks of Chemicals

PCN Poison Centre Notifications

PFAS Per- and polyfluoroalkyl substances

PIC

Rotterdam Convention on the

prior informed consent procedure (and the respective Regulation)

PMT Persistent, mobile and toxic

POPs EU Persistent Organic Pollutants Regulation

PPP Plant protection products

QSAR Quantitative Structure-Activity Relationship

RAC Committee for Risk

Assessment

REACH

Registration, evaluation, authorisation and restriction of chemicals (and the respective

Regulation)

REACH-IT Dossier submission tool

REF

REACH-EN-FORCE (Forum-

coordinated REACH enforcement project)

R4BP 3 Register for Biocidal Products

(version 3)

RoHS Restriction of Hazardous Substances Directive

SCBTH Serious Cross-Border Threats

to Health Regulation

SCIP

Database for information on Substances of Concern In

articles

SEAC Committee for Socio-economic Analysis

SLA Service Level Agreement

SME Small and medium-sized enterprises

SNE Seconded National Expert

SPD Single Programming Document

SSbD Safe and sustainable by design framework

ECHA Single Programming Document 2025-2027 7

Acronym Description

SVHC Substances of very high

concern

TA Temporary agent

UN GHS United Nations Globally

Harmonised System of

Acronym Description

Classification and Labelling of

Chemicals

UNEP United Nations Environment Programme

WHO World Health Organization

ECHA Single Programming Document 2025-2027 8

Strategy Statement

Our Legal Basis

Legislation

Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

Classification, Labelling and Packaging Regulation (CLP)

Biocidal Products Regulation (BPR)

EU Prior Informed Consent (PIC) Regulation

EU Persistent Organic Pollutants (POPs) Regulation

Waste Framework Directive (SCIP database)

Drinking Water Directive (DWD)

8th Environmental Action Programme (EAP)

Regulation on Serious Cross-Border Threats to Health (SCBTH)

Batteries Regulation

Industrial Emissions Directive (IED) Packaging and Packaging Waste Regulation (Council adoption on 16 December 2024, entry

into force pending publication in the Official Journal)

Tasks under grant, cooperation, service level and other agreements

EU Observatory for Nanomaterials (EUON)

EU Chemicals Legislation Finder (EUCLEF)

Occupational Exposure Limits (OELs)

Instrument for Pre-accession Assistance (IPA) – support to accession countries

IUCLID for EFSA

Partnership for the Assessment of Risks from Chemicals (PARC)

Our Mandate

• Carry out technical, scientific, and administrative tasks related to the implementation of the EU’s chemicals legislation and policy

• Provide transparent, independent and high-quality scientific opinions and decisions, which shall serve as the basis for the drafting and adoption of Union measures

• Collaborate and partner with EU bodies and Institutions, Member State authorities, as well as third countries and international organisations

• Provide tools, advice, and support to industry, with a particular focus on small and medium- sized enterprises (SMEs), in fulfilling their duties under chemical legislation

• Ensure that relevant, reliable, and objective information is available for the public and

interested parties

Our purpose

• We protect health and the environment through our work for chemical safety

Our Vision

• Chemical safety through science, collaboration and knowledge

ECHA Single Programming Document 2025-2027 9

Our Values

• Integrity - We earn trust by being accountable and delivering our mandate in a fair,

consistent, and independent manner. We uphold the highest professional, financial,

governance, and ethical standards.

• Transparency – We make our opinions and decisions in an open, understandable and accessible way. We communicate clearly, courteously, and respectfully. We are open to

engaging and embracing diverse perspectives and are inclusive in how we work. We welcome

feedback.

• Collaboration – We work closely with our EU and Member State partners and institutions to

deliver our shared goals and priorities. We consult and cooperate with stakeholders. We listen,

engage, and consult with each other.

• Innovation - We continuously review and respond to changing circumstances. We analyse and use data and best available evidence to inform and deliver our mandate. We exploit

synergies and are open to adapting operations using new technologies and ways of working.

Our Goals

ECHA Single Programming Document 2025-2027 10

I General context

As the agency responsible for implementing EU chemical legislation, we remain committed to advancing chemical safety across Europe and protecting health and the environment. Our work is focussed on

implementation of our legal mandate and delivery of our strategic goals. Nonetheless, we recognise that EU policies will continue to evolve, for example, the European Commission’s focus on reducing

administrative burden and fostering competitiveness, while maintaining a high standard of protection of health and the environment. As we navigate this period, we also recognise the need for effective

collaboration with the Commission, Member States and other stakeholders to meet the increasing demands of our expanded legal mandate. We are focused on ensuring that our preparations for new

tasks and ongoing efforts align with the EU’s vision for a safe and sustainable future for generations to

come.

We anticipate proposals for a revised REACH Regulation and an ECHA Basic Regulation from the

Commission in the coming period. ECHA will work closely with the Commission to provide input and support the development and implementation of both the Basic Regulation and REACH Regulation

proposals. In addition, the Commission’s Clean Industrial Deal and the Chemicals Industry Package may

also have an impact on our work in the coming years.

It is within this context, and the below facts that ECHA has prepared the 2025-2028 multiannual plan as

well as specific plans for 2025 and 2026.

One aspect that is clear is that the implementation of existing legislation will be a major focus. In addition,

there will also be a focus on the simplification and reduction of administrative burden and increasing competitiveness. More directly in relation to ECHA’s legal mandate, we know that simplifying REACH and

clarifying Per- and polyfluoroalkyl substances (PFAS) will be on the future agenda. However, at this

stage, we do not know the extent to which these will impact how ECHA delivers its legal mandate.

From discussions with the Heads of Chemicals Authorities, we have got an outline of the plans and challenges in the Member States. It seems that there are no short-to-medium plans by Member States

to substantially increase the development of dossiers (Harmonised classification and labelling (CLH), restrictions, Biocidal Products Regulation (BPR)). Those Member States who have been active will likely

remain active, but others do not appear to be in a position to start or significantly increase their

involvement. Member States are also facing resource gaps as well as competence gaps, particularly in relation to new areas (e.g., endocrine disruptors). Nominations of experts to the Committees are also

unlikely to increase in the short to medium term.

Internally, we need to balance the implementation of our new Strategy Statement for the period 2024-

2028 while also delivering on our legal mandate and tasks. We have completed reviews of two of the key programmes under our previous strategy (2018-2023), namely, the Integrated Regulatory Strategy

(IRS) and the Joint Evaluation Action Plan (JEAP) and now need to implement the recommendations

arising.

New tasks have been assigned to the agency to bring coherence and synergies between EU chemicals

regulations and to support our central role in chemical safety. We must prepare for these new tasks, which may come with or without resources. Even when resources are provided, these are not available

until the starting date of implementation, so we still need to use existing resources to initiate preparations for implementation. As we receive more and more single tasks, either through new legislation or

cooperation and/or service-level-agreements (SLAs), the workload involved is substantial across the organisation when these are taken as a whole. In addition, delivering on our extended mandate requires

a focus on collaboration with Member States, other Agencies and key stakeholders. The One Substance, One Assessment (OSOA) ambition and the One Health framework provide new opportunities to increase

such collaboration and build an organisation considering the optimisation of resources.

ECHA Single Programming Document 2025-2027 11

As mentioned above, Member States do not appear to be in a position to substantially increase submission of dossiers on CLH/Restrictions/BPR. The Commission’s plans for requests to ECHA to prepare

dossiers on restrictions, in line with the restriction roadmap, are not yet known. Therefore, anticipating

workload remains a challenge. Similarly, predicting fee income from registrations and applications for

authorisation also remains a challenge.

Within ECHA, we need to increase competence and capacity across the secretariat as well as the committees. Relevant areas of competence development include new hazard classes in CLP as well as

sustainability, life cycle analysis, and waste aspects particularly relevant for new tasks under Restriction of Hazardous Substances Directive (RoHS), batteries etc. As competence development is a key topic for

Member States too, we need to consider how we can enhance synergies and opportunities for shared

learning and shared burden.

Finally, as a chemicals agency, ECHA has over the years developed significant levels of competence and

invested heavily in digital technologies in delivering our mandate. All new tasks, and particularly the Common Data Platform for Chemicals (CDPC), come with increasing demands on our digital capabilities

and offerings. We also need to ensure the digital tools used for existing tasks are kept up to date with technology and the demands of ever-increasing amounts of data. We need, therefore, to invest for the

future now if we are to keep up with new technologies such as AI and the demands of stakeholders and

duty holders.

With these in mind, ECHA has developed its multiannual plan for 2025-2028 and its draft outcomes for 2026. We have also reviewed and revised the outputs, indicators and targets for the 2025 work

programme. In setting out the programme, several areas are particularly worth noting in more detail.

Committees

The work and capacity of our committees, especially our scientific Committees (Committee for Risk

Assessment (RAC) and Committee for Socio-economic Analysis (SEAC)), will continue to drive specific actions and objectives over the coming period. Delivering transparent, independent, and high-quality

opinions remains a key output. We know that capacity in our Committees is decreasing as some Member States are unable to nominate two members. We also know their workload is increasing as new tasks

arise (new hazards under CLH, Drinking Water Directive, etc.); and dossiers become more complex, particularly when they involve groups of substances and multiple uses. The opinions and decisions

coming from our committees also need to be scientifically and legally robust so that the Commission can

use them as basis for its decision making. While we await the Basic Regulation to provide more long- term solutions, we will continue to engage with Member States about increasing the numbers of members

and experts; investigate ways to encourage all members to contribute (e.g. through rapporteur payments for new tasks); build capacity of Committee members so they have the competence and

knowledge to deliver on new areas (e.g., Endocrine disruptors (ED) and Persistent, mobile and toxic

(PMT) hazard classification, life cycle analysis, etc.).

Integrated Regulatory Strategy (IRS)

Following the review completed earlier in 2024, several new objectives have been developed, in

conjunction with the Commission and Member States, to ensure that IRS meets current and future

challenges. Key drivers for the IRS in the future include the need to maintain good knowledge about the chemicals in our databases and switch the focus to deliver risk management outcomes for (groups of)

substances. These outcomes can be REACH and CLP based (CLH, substances of very high concern (SVHC) identification, or restrictions), but with our increasing mandate, we can also now start to explore how

risk management can be delivered under new legislation. We also recognise that in switching the focus toward risk management, we need collaboration with Member States and the Commission to meet this

ambition and that our committees are also ready.

ECHA Single Programming Document 2025-2027 12

Joint Evaluation Action Plan (JEAP)

The JEAP has also been reviewed in 2024 in conjunction with the Member States and the Commission.

The main action from the JEAP, namely, to complete 20% of all dossiers registered by 2027 has already

been achieved by 2023. While this is good news, the focus in the past years on completing compliance check (CCH) decisions has meant that other areas under evaluation, such as concluding follow-up

decisions and checking testing proposals now have backlogs. As data generated under earlier CCH decisions is now coming back in, there is a need to focus on Follow-up decisions. We will also need to

address the increasing numbers of testing proposals that await our review. This will mean the workload in evaluation will be rebalanced away from CCH only to address Follow-up and testing proposals. While

we will continue to get cases for evaluation from the IRS, we will also investigate how to address other types of cases, including dossiers with information that has been submitted separately by one of more

registrants (also known as ‘opt-outs’). This will support a level playing field among registrants.

Enforcement

The delivery of the workplan for the Forum on Enforcement is a key priority, and the delivery of specific

REACH and Biocide Enforcement Projects (REF and BEF), as well as training of inspectors remains important. In addition, we will explore with the Forum ways to increase enforcement activity, including

the use of pilot projects in all or some Member States. Commitment from Member States to the work of the Forum and to enforcement, in general, needs to remain high if we are to support a level playing field.

An area of focus worth noting is the need to enhance engagement with National Enforcement Authorities (NEAs) as we move to increase efforts on Follow-up to CCH. We will need NEAs to be ready to take

enforcement action on evaluation cases when requested. We also need NEAs and national authorities to

support communication efforts on the outcomes of enforcement projects and Forum work.

Data and IT

Over the years, the complexity of ECHA’s IT and data systems has increased resulting in multiple IT tools that are highly customised and not always integrated. Data has also become more numerous and

fragmented as we have increased our mandate. Most of the new tasks will require either modification of existing systems or building new ones. The EU requirements for information security and cybersecurity

are also increasing. In addition, new IT approaches as well as advanced technologies are now available. To continue our focus on digitalised operations, ECHA must invest in new technologies to meet the

increasing demands of stakeholders as well as staff. Work has already begun on transforming our

business and IT/data systems to meet existing and new tasks, for example, we are already working on developing the systems needed for the Drinking Water Directive (DWD) by 2026. The IT system and

business processes for DWD are being developed as capability modules that can be reused in other Agency processes down the line. In the coming years, this work will continue. An ongoing challenge in

the transformation of the data and IT capabilities is the need for upfront focussed investment to be available to deliver the ambition required. We have prepared a 5-year IT plan, outlining the longer-term

IT development priorities, as well as providing a more detailed explanation of the specific plan for 2025. The IT plan will be updated annually and will replace the IT master plan, which has primarily focused on

one year at the time.

Preparation for new legislation

In the past few years, ECHA has already included in its mandate new tasks deriving from new legislation

such as Drinking Water, Batteries, Serious Cross-Border Threats to Health (SCBTH), and most recently, Industrial Emissions. We also know that further tasks will come during 2025-2026 under the One

Substance, One Assessment package (Data Regulation, POPs in waste, Medical Devices, RoHS) as well as Packaging and Packaging Waste (adopted by the Council on 16 December 2024, entry into force

pending publication in the Official Journal), Water protection, Toys, and End of Life Vehicles (ELV). In addition, there are further new tasks linked to the revision of existing mandates, for example,

introduction of the ex-ante SME verification as well as potential requests from the Commission to prepare

CLH dossiers. Overall, this work covers about 12 new tasks, with an additional 47 people to be onboarded

over the next 2-3 years.

ECHA Single Programming Document 2025-2027 13

While ECHA welcomes the opportunity to deliver the EU goals in relation to these new tasks, there are still several dependencies and challenges anticipated. Firstly, not all tasks come with resources, and even

those that do bring resources, these are not available to ECHA until the legislation is to be implemented.

This presents a challenge if we are to be ready. The new tasks bring additional complexities and work. For example, existing systems and processes may not always be suitable for new task without

modification. The number of stakeholders that ECHA must engage with at the EU, Member State, Industry and NGO levels will increase. The workload and skills needed in RAC and SEAC will also increase, putting

pressure on members who are already fully engaged in meeting existing tasks. In the coming years, ECHA will develop and implement onboarding plans for new tasks and commence delivery of the first

outputs anticipated (e.g. DWD notifications, scoping studies under Batteries, etc.). We will also work with the Committees to establish Working Groups and training opportunities, so the members are ready

when tasks arrive. To enable ECHA to deliver on these new tasks, adequate resources, as well as

appropriate transitional periods, are needed. Furthermore, ECHA’s Basic Regulation is also urgently needed to facilitate the extension of ECHA’s mandate, including the necessary expansion of the capacity

of the committees to be able to keep pace with the increased output demands.

Communication and engagement

In all the work ECHA carries out, the need for constant communication and engagement is high. We have established a Communications Strategy as well as a stakeholder approach to support the delivery of our

strategic goal. In our communication and engagement, we target efforts to the needs and requirements for each group – EU Institutions, Member State Authorities, Industry, groups representing the

environment, the public and workers. In order to maximise efficiency and impact, we need to collaborate

with our stakeholders and increase public confidence. That is why we rely on multipliers such as the Member State Communicators’ Network and the accredited stakeholders to collaborate with us to

increase awareness on the work carried out in relation to chemical safety. We aim to continue our engagement with the Member State Heads of Chemicals Authorities and close out the remaining bilaterals

with Member States. We will work closely with other EU agencies, such as EFSA, EMA, EEA, and ECDC, as we deliver our mandate and also the objectives of OSOA and One Health Framework for Action. We

will engage with industry to ensure that the tools and services we provide are aligned with their needs and expectations. In this regard, we will continue developing and implementing mechanisms and actions

to better understand SME requirements and support them in meeting their regulatory requirements.

Through our accredited stakeholder group, we will continue working with groups representing the environment, the public and workers to understand their needs and provide support. To be able to

monitor progress in our work in this area, we will launch a stakeholder benchmark exercise.

Leading on chemical knowledge and expertise

Our new strategy puts science in the frame, both in its vision as well as the strategic goal to lead on chemical knowledge and expertise. As a chemicals agency, ECHA needs to be proactive in informing and

implementing new scientific and technical thinking. The overall aim of this goal is to increase transparency and articulation of scientific and technical work that is ongoing or needed to deliver our

core tasks as well as EU policy. We have already published a report on key areas of regulatory challenge

and will continue to build on this work to inform the academic community and PARC. We will also continue our efforts on the promotion of alternatives to animal testing. The focus for the next years is to continue

our work on NAMs, in close collaboration with EU agencies and the Commission, as well as with the Organisation for Economic Co-operation and Development (OECD). We will continue to support PARC.

We will also continue to support the Commission in a range of areas to enhance engagement and synergies at international level, for example, through the IPA agreements, the OECD, the United Nations

Globally Harmonised System of Classification and Labelling of Chemicals (UN GHS) and the Global Framework on Chemicals. We will also develop and implement a governance model on science within

ECHA to have a clear roadmap on priority areas (e.g., socioeconomics, chemistry, hazard assessment),

as well as build capacity together with Member States and Committees, and communicate with NGOs,

industry and academia.

ECHA Single Programming Document 2025-2027 14

Capacity and Competence Building

ECHA recognises that it needs to invest in capacity and competence building not only for its own staff

but also for those involved in its Committees and Working Groups. To implement the strategic goal to

invest in people and organisational excellence, ECHA has developed a People and Organisational strategy that aims to attract the best candidates and train and develop staff to meet new tasks and challenges.

While ECHA does not have external training within its mandate, it still needs to invest in external capacity building so that current and future needs are met. The Heads of Chemicals Authorities are open to

increase Member States/ECHA collaboration and for ECHA to provide more opportunities for learning. In setting out actions on capacity building in the coming period, ECHA has adopted a balanced approach

that aims to deliver opportunities for learning internally (staff and Committees) as well as externally to

Member States without significant increases in resource allocation.

Resources

The inherent uncertainty in estimating ECHA’s fee income, which depends on market behaviour and the strategies of individual companies, continues to pose challenges. While, for 2025, ECHA’s resources

reflect a limited increase stemming from adopted legal mandates, ECHA has included the potential increased resourcing in 2026 linked to pending legislations. As noted above, existing resources are still

needed to prepare for implementation in advance of new resources’ arrival. Existing resources are also needed to deliver on existing tasks and support efforts on business and IT transformation. We will

continue to monitor overall resource levels over the coming years. We will implement recommendations arising from the organisational review completed in 2024, with the aim to streamline our structures and

ways of working. We will continue to explore ways to enhance the capacity of our Committees, for

example, through use of Working Groups and experts.

ECHA Single Programming Document 2025-2027 15

II Multi-annual programming (2025–2028)

The multi-annual Work Programme outlines the main actions needed to put ECHA’s strategy into practice. The actions below are those identified by the Agency to deliver our vision, strategic goals and priorities

over the strategy period until 2028. Also included is a reference to the activities in the annual work

programme, where the actions are implemented.

1. Multiannual Work Programme 2025–2028

Goal: Be a trusted chemicals agency

Delivering our legal mandate using independent expertise and robust data

Priority Actions to achieve the priority

[1] Deliver

transparent, independent, and

high-quality scientific

advice, opinions, and decisions as required

under our legal

mandate.

• Engage with Member States to ensure they understand their

obligations as EU Member States to fully resource scientific

committees with the necessary expertise and experience (Activity

1.4; 1.5; 1.6; 1.7; 2; 3; 4)

• Ensure opinions and background documents are scientifically and

legally robust (Activity 1.2; 1.4; 1.5; 1.6; 1.7; 2; 3; 4)

• Implement and, where necessary, adapt processes and structures to ensure the consistency, quality and timeliness of the output and

workability of the scientific committees, and effective use of

members’ expertise (Activity 1.4; 1.5; 1.6; 1.7; 2; 3; 4)

• Engage actively with institutional partners (e.g., EFSA) to further

align on scientific assessments and opinion making (Activity 1.3;

1.7; 1.10; 2; 4; 5)

• Implement consistently policies related to independence and transparency and ensure that committee members understand

them and meet their obligations (Activity 5)

• Foster cross-committee collaboration and learning to enhance

scientific expertise and experience (Activity 1.3; 2)

• Develop methodologies for assessment (e.g., hazard and risk) and

analysis (e.g., socio-economic; alternatives) supporting the

implementation of chemicals legislation (Activity 3)

• Support capacity building/training for the Committee members in

relation to new legislation or new scientific topics (e.g., EDs, PMTs,

NAMs) (Activity 1.4; 1.5; 1.6; 1.7; 2; 3; 4)

• Support the implementation of the restrictions roadmap and develop investigation reports and restrictions dossiers as requested

by the Commission (Activity 1.6)

• Support Member States and the Commission to accelerate the

Biocides Review Programme (Activity 2)

[2] Enhance decision and policy making

through optimal use of data, knowledge,

and competence.

• Develop and implement a consistent and robust approach for scientific and regulatory data management which facilitates smooth

integration of new tasks within ECHA’s portfolio and supports data

interoperability (Activity 1.8)

• Implement the Data governance and elaborate a Data strategy in

view of readiness for the development of the Common Data Platform including the operability between existing and future

databases (Activity 1.8; 3)

ECHA Single Programming Document 2025-2027 16

• Improve and extend the accessibility of tools used to search,

extract, analyse, and report data (Activity 1.8)

• Develop and deploy ECHA’s new Data availability system, ECHA

CHEM, with a focus on stability, and reliability while simplifying the use of the data and serving as the basis for the future Common

Data Platform on chemicals (Activity 1.7; 1.8; 1.9)

• Maximise the potential of the data held in the Agency for use in

delivery of wider EU goals on chemicals and environmental

sustainability, for example, ESPR and SSbD (Activity 1.8; 1.9; 3)

• Improve the regulatory processes in terms of efficiency and impact

and enhance interlinkages, for example, Registration and

Evaluation (Activity 1.1; 1.2; 1.4)

• Co-operate with institutional partners including other EU Agencies, in particular EFSA, EMA, and EEA, identifying synergies in the areas

of data and scientific and technical competences (Activity 1.3; 2;

3; 5)

[3] Facilitate the

prioritisation and coordination of

regulatory actions on

substances and groups of substances

with the Commission, EU agencies and

Member State

Authorities.

• Implement the Integrated Regulatory Strategy in line with the

review undertaken with Commission, Member States, and

stakeholders in 2024 (Activity 1.3)

• Support the Commission and Member States to identify (groups of) substances that require risk management through shortlisting

(groups of) substances considered as good candidates for CLH,

restriction, or other risk management options (Activity 1.3)

• Maintain knowledge on ECHA's chemical database by systematically

screening all substances above 100 tonnes (new registrations or tonnage upgrades) and priority 10- 100 tonnes substances (e.g.,

with high aggregated tonnage), concluding and updating ARNs when information available and performing compliance check for

potentially non-compliant dossiers (Activity 1.3; 1.4)

• Co-operate with the Commission, Member States and ENVI

agencies to further enhance prioritisation and coordination of actions across regulations, in particular, in the framework of the

One Substance, One Assessment Expert Group (Activity 1.3; 3)

• Implement recommendations from the Joint Evaluation Action Plan

review and adapt evaluation actions accordingly (Activity 1.4)

• Focus on the conclusion of follow-up of dossiers after decisions on

compliance checks (Activity 1.4)

• Use and develop, where necessary, tools and processes to identify

and address non-compliance (Activity 1.4; 5)

• Work with the Forum on Enforcement to ensure that quicker action

can be taken by national enforcement authorities (Activity 5)

Goal: Respond to emerging challenges and changes in our legal landscape

Getting ready for new tasks; informing EU chemical and environmental policy

Priority Actions to achieve the priority

[4] Implement new

legal requirements using existing and

new synergies and experience as

necessary.

• Articulate ECHA's needs, in the context of the Multiannual Financial

Framework (MFF), for resources, expertise, systems, and

processes to meet the assigned legal requirements (Activity 5)

• Develop and roll-out implementation plans for new legislative mandates (e.g., Data Regulation, Packaging, Water) or future

Union acts which will be adopted in 2025-2028 (Activity 3)

ECHA Single Programming Document 2025-2027 17

• Engage and co-operate with other EU Agencies (EFSA, EMA, and

EEA) as necessary, and in particular on implementation of requirements related to One Substance, One Assessment (Activity

1.3; 3)

• Ensure tools, procedures and guidance are prepared and in place to

support receiving applications as of end of 2026 under article 11 of

the Drinking Water Directive (DWD) (Activity 3)

• Deliver scoping studies to the Commission under the Batteries and

Packaging and Packaging Waste legislation (Activity 3)

• Enhance and adapt IT tools to efficiently implement the wider legal

mandate. Focus on modularity, re-usability and ease of use

(Activity 5)

[5] Work with

relevant EU agencies

and bodies to deliver Chemical Strategy for

Sustainability (CSS) actions and

objectives.

• Enhance the collaboration with relevant EU Agencies and relevant actors involved in regulations implementation on cross-cutting

topics (e.g., endocrine disruptors, PMTs, NAMs) to ensure

consistent and transparent approaches for delivery of our legal

mandates (Activity 1.3; 1.4; 2)

• Co-operate with EFSA and EMA to further advance the implementation of the basis and mechanisms for alignment of

evaluation of common substances under the REACH, BPR, DWD,

food safety, and medicine legislation (Activity 1.3; 1.7; 2; 3)

• Co-operate with the relevant agencies and Commission services for preparation and implementation of the provisions under the

legislative package on One Substance, One Assessment, in

particular development and building of the Common Data Platform

and the related governance (Activity 3)

• Support assessment of progress under the 8th Environmental

Action Programme (EAP) (Activity 3)

[6] Provide scientific and technical advice

on chemicals to EU

policy makers.

• Provide data analysis services of high quality in support of EU

policy development and implementation (Activity 1.8)

• Support the Commission and Member States in contributing to the

safe handling of hazardous substances by non-EU importing

countries (Activity 3)

• Provide technical input and support the Commission’s evaluation of

the BPR (Activity 2)

• Provide support and advice to EU policy and decision makers on chemical legislation as it progresses through the decision-making

process (Activity 3)

Goal: Communicate and Engage

Collaborating with stakeholders and partners; strengthening public confidence

Priority Actions to achieve the priority

[7] Deepen our network of

engagement with EU institutions and

agencies and Member

States.

• Hold regular engagement with EU Commission, European

Parliament, and Council (Activity 5)

• Ensure adequate Brussels presence to enhance institutional

engagements (Activity 5)

• Organise regular Heads of Chemicals Authorities meetings and

bilateral engagement activities with Member States (Activity 5)

• Keep the regular contacts and exchanges with other EU agencies,

with a focus on the ENVI agencies (EFSA, ECDC, EEA, EMA), via bilaterals and in the context of the Agencies network and the One

ECHA Single Programming Document 2025-2027 18

Substance, One Assessment and One health initiatives (Activity 5)

• Keep agreements with other agencies under review to add new areas of cooperation as well as ensure consistency and effective

collaboration on existing and new mandates. (Activity 5)

• Engage and co-operate with ENVI Agencies to implement the

strategic objectives of the One Health Framework for Action

(Activity 1.3)

• Align on priorities, messages, and build synergies via the regular

Member States Communicators’ Network (Activity 5)

[8] Collaborate and

provide tools, advice, and support to

industry.

• Introduce and adopt user-centric design processes and methods to

digital tool development (Activity 5)

• Reduce administrative burden for industry by working towards a

single industry portal for companies having to submit data to ECHA, and simplify the tasks they need to comply with (Activity

1.2)

• Develop and implement a mechanism to better understand the needs of SMEs so that ECHA’s actions meet those needs (Activity

5)

• Continue to engage and consult with industry user groups for IT

tools (Activity 1.1; 1.2; 2)

• Continue/further improve the efficient and streamlined processing

of all regulatory submissions, for the benefit of all companies, and

SMEs in particular (Activity 1.2)

• Provide opportunities for engagement with companies and their

stakeholder representatives, and in particular with those who may be working with ECHA for the first time due to new legal mandates

(Activity 5)

[9] Promote

awareness and

understanding of ECHA's work to

stakeholders representing

workers, the public

and the environment.

• Publish the next five-year report on the operation of REACH/CLP (due 2026) and follow up as necessary on actions arising (Activity

5)

• Implement ECHA’s communications strategy and stakeholders’

engagement approach (Activity 5)

• Provide opportunities for enhanced engagement with stakeholder

representative groups (Activity 5)

Goal: Lead on chemical knowledge and expertise

Advancing knowledge and understanding on chemical safety

Priority Actions to achieve the priority

[10] Contribute

proactively to expanding scientific

and technical competence and

knowledge on

chemical safety.

• Develop and implement a governance model on science within

ECHA (Activity 5)

• Support PARC and other relevant research activities and in

conjunction with other EU regulatory agencies when relevant

(Activity 4)

• Update and promote ECHA’s report on key areas of regulatory

challenge, which identifies regulatory research needs (Activity 1.4)

• Contribute to relevant scientific meetings and symposia and

organise science-related events as necessary (Activity 5)

• Implement options for enhancing capacity building amongst

Member State stakeholders (Activity 5)

[11] Promote the • Organise and support meetings with relevant stakeholders and

ECHA Single Programming Document 2025-2027 19

development and use

of alternative methods for the

assessment of hazards and risks of

chemicals.

academia to increase the understanding and use of NAMs for

regulatory purposes (Activity 1.10)

• Engage actively at EU, OECD, and international level to support

NAMs development, in the context of EPAA, APCRA, and the development of the roadmap for phasing out animal testing

(Activity 1.10)

• Enhance collaboration with EFSA and EMA to support the

development of harmonised approaches for reducing the need for

animal testing (Activity 1.10)

• Publish the report on the use of alternative methods under REACH

(Activity 1.10)

• Develop further and integrate predictive models to support

prioritisation and scientific decision making (Activity 1.10)

[12] Support the

Commission to enhance engagement

and synergies at

international level.

• Implement the updated Instrument for Pre-accession Assistance

(IPA) agreement (Activity 4)

• Contribute to the OECD chemicals programme, with focus on priority areas for EU/ECHA, such as test guidelines and validation,

harmonised methods and formats, and IT tools (Activity 1.1)

• Co-operate and collaborate with international regulatory agencies

and Commission services to advance knowledge and expertise on chemical management in the context of the UN GHS and the Global

Framework on Chemicals (GFC) (Activity 1.7)

• Update the agreements with international partners to ensure

consistent and effective collaboration (Activity 5)

Goal: Invest in people and organisational excellence

Working together to achieve our vision

Priority Actions to achieve the priority

[13] Develop and

empower our people

for success.

• Implement the People and Organisational Strategy for the period

2024-2028 (Activity 5)

• Embed organisational values and behaviours in our ways of

working with each other and with our stakeholders (Activity 5)

• Ensure, through our competence mapping and opportunities for

learning and development of staff, that the Agency has sufficient skills and knowledge available for current and future tasks (Activity

5)

• Enhance leadership capability to manage the organisation as it

expands its legal mandate and delivers its new strategy (Activity 5)

• Implement the organisation’s Wellbeing Action Plan, in conjunction

with the Joint Committee for Health and Wellbeing (Activity 5)

[14] Create optimal

ways of working for

the Agency, its bodies, its people,

and the environment.

• Complete and implement actions arising from the organisational

review (Activity 5)

• Implement the organisation’s Environmental Work Programme to

sustain environmentally-friendly work practices (Activity 5)

• Implement the organisation’s Diversity and Inclusion Action Plan to

sustain a diverse and inclusive work environment (Activity 5)

• Implement and meet quality standards, goals, and targets (Activity

5)

[15] Adopt an IT

delivery model that is

• Develop, keep updated, and implement the rolling 5-year IT plan

(Activity 5)

ECHA Single Programming Document 2025-2027 20

cost-effective,

streamlined, modular,

interoperable, cloud based and

centralised.

• Introduce and leverage modern technologies such as Public Cloud

and Artificial intelligence (Activity 5)

• Follow and enhance the value-based agile IT governance (Activity

5)

• Implement the target IT architecture focusing on the capabilities

needed by the new tasks and aiming to high modularity,

reusability, and interoperability (Activity 5)

• Ensure the compliance with cybersecurity and information security

regulations (Activity 5)

ECHA Single Programming Document 2025-2027 21

The figure below shows the flow of actions from strategic priorities, through strategy outcomes to

overall impact contributing to the implementation of EU Policy.

ECHA Single Programming Document 2025-2027 22

This section presents the approach to assessing progress in the implementation of ECHA's Strategy

Statement 2024-2028.

A mid-term review is currently foreseen for 2026. The expected approach will be to consider quantitative

data (focusing on a subset of SPD indicators and additional ad-hoc indicators as needed), with an assessment of progress in implementing the strategic actions for each goal and priority, as well as a

further qualitative assessment to be conducted internally and with feedback from the Management

Board.

A list of indicators linked to specific outcomes is presented below. The list largely relies on existing indicators from the annual work programme. To provide better visibility to multi-annual progress,

additional indicators have been envisaged, that will require an ad-hoc analysis effort. The lists below will

continue to be reviewed on an annual basis and will be updated as the strategy evolves.

Overall Strategy Outcomes 2024-2028

Outcome Potential indicators for assessing progress

Co-ordinated and prioritised

regulatory actions on chemicals between the

Commission, Member States and ECHA.

In assessing the achievement of this outcome, the following work

programme indicators will be considered: • Number of new substances added to Registry of Intention

(SVHC, CLH, Restrictions) originating from ARNs

Furthermore, the following additional data will be considered:

• Satisfaction among Commission and Member State authorities on ECHA's support to coordination and prioritisation of

regulatory actions

Increased numbers of substances covered by

hazard identification or risk management outputs

delivered for the decision- making process under

relevant regulatory areas.

In assessing the achievement of this outcome, the following work programme indicators will be considered:

• Number of compliance check decisions concluded in the follow- up to dossier evaluation

• Number of new and updated entries published in the Candidate List

• Number of opinions on biocidal active substances [approval & renewal] finalised and submitted to the Commission

• Number of opinions on Union authorisation [approval &

renewal] of biocidal products finalised and submitted to the Commission

• Number of RAC opinions on OELs completed and provided to the Commission

Furthermore, the following additional data will be considered:

• Number of substances classified • Number of substances for which occupational exposure limits

are set

• Number of substances added to PACT/ACT

Transparent, independent

and high-quality opinions

and decisions developed that contribute to the

implementation of EU legislation and policy.

In assessing the achievement of this outcome, the following work

programme indicators will be considered:

• Number of RAC and SEAC opinions adopted on applications for authorisation (number of uses) and submitted to the

Commission • Number of RAC and SEAC opinions on restriction proposals

delivered to the Commission • Number of RAC opinions on proposals for harmonised

classification and labelling adopted

ECHA Single Programming Document 2025-2027 23

• Number of opinions on applications for authorisation submitted to the Commission requiring further consideration by

Committees

• Number of opinions on restrictions submitted to the

Commission requiring further consideration by committees (Art 77 (3)(c)

• Number of requests from the Commission for a BPC opinion [pursuant to Article 75(1)(g)] to revise earlier adopted opinions

• Percentage of Scientific Committee (RAC and SEAC) membership positions filled

Furthermore, the following additional data will be considered:

• Total number of opinions submitted to the Commission

accepted without further consideration • Positive feedback from institutions on ECHA opinions

• Number of appeals upheld against ECHA decisions

• Numbers of comments received in consultations on opinions

Data that is reliable,

findable, accessible, interoperable, shared,

secure and reusable.

In assessing the achievement of this outcome, the following work

programme indicators will be considered: • Percentage of satisfaction of ECHA CHEM users

• Number of data products identified • Number of data provision and analysis requests

• Number of personal data breaches reported, as per legal

requirements, to the European Data Protection Supervisor

Regulatory processes and IT

tools streamlined and interoperable with high

levels of user satisfaction

and use.

In assessing the achievement of this outcome, the following work

programme indicators will be considered: • Percentage of administrative tooling modernised

• Number of high impact security incidents

• Percentage of internal IT user satisfaction • Percentage of availability of key systems

Furthermore, the following additional data will be considered:

• Positive feedback in line with Net Promotor Score (NPS)

• Number of legacy IT systems decommissioned

Stakeholders proactively

engaged, involved, and satisfied with ECHA

supports, tools and services.

In assessing the achievement of this outcome, the following work

programme indicators will be considered: • Number of high-level meetings conducted with Member States

and European Union institutions • Number of industry user group meetings held

• Total number of Helpdesk queries received

• Total number of Helpdesk queries received on IT tools • Number of access to documents requests received and

concluded • Number of legal appeals on ECHA decisions (REACH+BPR)

• Positive feedback from User satisfaction score based on regular NPS data collection

Furthermore, the following additional data will be considered:

• Percentage of stakeholders’ satisfaction with ECHA, from

various stakeholder groups

SME supports being easily

accessible, used, and levels

of satisfaction increased.

In assessing the achievement of this outcome, the following work

programme indicators will be considered:

• Number of SME dedicated dialogues held

ECHA Single Programming Document 2025-2027 24

Furthermore, the following additional data will be considered: • Positive feedback from SMEs on our enhanced SME support

approach • Number of SME contacts received through dedicated support

service

ECHA’s contribution to broader EU chemical and

environmental policy goals

recognised.

In assessing the achievement of this outcome, the following data will be considered.

• Number of requests received in relation to legislation outside

ECHA’s mandate • Stakeholder feedback on ECHA’s contribution to broader EU

chemical and environmental policy goals • Number of OECD meetings attended and supported

• Number of courtesy or business visits organised with international organisations and third countries (excluding IPA

and OECD)

Use of alternative and non- animal methods increased.

In assessing the achievement of this outcome, the following work programme indicators will be considered:

• Number of NAM projects initiated/completed • Number of Member States NAMs cases supported

• Number of scientific publications related to the use and

promotion of NAMs

Furthermore, the following additional data will be considered:

• Positive feedback from ECHA stakeholders

An organisation that values

its people and puts in place the processes, systems and

tools to help them work, learn and succeed.

In assessing the achievement of this outcome, the following work

programme indicators will be considered: • Percentage of staff participating in biannual staff satisfaction

survey • Percentage turnover rate of Temporary Agents (TA)

• Percentage turnover rate of Contract Agents (CA)

Furthermore, the following additional data will be considered:

• Increased ratio of underrepresented genders at both support and management levels

• Number of successful career enhancement/ internal mobility opportunities, including management level posts

• No (serious) gaps in assessment in annual internal control

assessment

ECHA Single Programming Document 2025-2027 25

2. Human and financial resource outlook 2025-2028

2.1 Overview of the past and current situation

ECHA’s portfolio of regulatory tasks has continued to grow steadily, and this trend is expected to continue, with new tasks likely to be allocated within the timeframe of this Single Programming

Document. The work and resource programming for 2025 and beyond continues to focus on ECHA’s regulatory actions in core areas under REACH, CLP, as well as biocidal active substances approval and

Union authorisations. In parallel, the tasks that are proposed to be allocated to ECHA under the ‘Environmental policy’ title will significantly broaden ECHA’s areas of work in coming years. While

uncertainties remain as to the timing and impact of many legislative changes, the Single Programming Document provides an overview of the continued scientific-technical support related to anticipated

legislative processes as well as future re-attribution of tasks to EU Agencies, the Data Regulation, and

other non-legislative actions.

In terms of ECHA’s overall financing, the inherent uncertainty in estimating ECHA’s fee income, which

depends on market behaviour and the strategies of individual companies, continues to pose challenges. In addition, ECHA’s planning assumption related to fee indexation in 2025 is dependent on the adoption

of the amended Fee Regulations under REACH and BPR under consideration by the Commission. In terms of staff population, the Agency has a stable basis to implement its allocated tasks, while new tasks

delegated to ECHA need to be accompanied by sufficient resources to ensure effective implementation and delivery of the EU’s chemicals policy. In addition, ECHA’s RAC and SEAC Committees, on which ECHA

is dependent, are at maximum capacity; however, additional flexibility will be required to ensure their

sustainability.

Despite ECHA’s commitment to deliver on its widening legal mandate and tasks, the challenges of

unpredictable fee financing and segregated budgeting arrangements impact effective Work Programme implementation. The proposed ECHA Basic Regulation, which aims to consolidate the current and

expanding number of ECHA tasks, simplify its governance, and ensure the sustainability of its funding model - enabling ECHA to deliver its legal mandate and implement its Work Programme more efficiently

- is awaited.

2.2 Outlook for the years 2025-2028

The overall workload for ECHA is expected to increase as a result of tasks under our existing legal mandate and the implementation of further legislative changes or obligations. In line with our Strategy

Statement 2024-2028, ECHA will be seeking to work closely with the Commission and Member States to facilitate prioritisation of regulatory action on substances and groups of substances so that, together, we

can address these challenges in a concerted and coherent way.

In this Single Programming Document, ECHA includes the financial and staffing estimates only for those

new tasks for which the legislative process has progressed sufficiently to allow for coherent planning based on the legislative financial statements accompanying the Commission proposals. ECHA is not

currently seeking an increase in budget contributions or staff resources for 2025-2028, except when

linked to the widening mandate; however, this approach is contingent on the level of EU contributions

and fee income remaining at the projected level, as adjusted for inflation.

While, for 2025, ECHA’s resources reflect a limited increase stemming from adopted legal mandates (namely the Drinking Water Directive, the Serious Cross-Border Threats to Health, and one post related

to the Packaging and Packaging Waste Regulation revision), ECHA notes the potential increased

resourcing in 2026 linked to pending legislations, as follows:

• Packaging and Packaging Waste Regulation revision (adopted by the Council on 16 December 2024, pending publication in the Official Journal)

• End-of-Life-Vehicle (ELV) Directive revision

ECHA Single Programming Document 2025-2027 26

• Toys Safety Regulation • POP Regulation revision

• Medical Devices Regulation revision

• Restriction of Hazardous Substances in electrical and electronic equipment (RoHS) Directive revision

• Regulation establishing a common data platform on chemicals.

In estimating resources for new tasks, certain assumptions were made. For example, the initial proposal

discussed with ECHA would remain largely unchanged. However, the Commission on occasion made further changes before the proposal was published. Furthermore, as the proposal goes through the co-

decision process, tasks are revised, expanded, and new ones are added. To optimise ECHA’s chances to be operational in time, it needs to start investing resources in advance of the legislative effective date

to plan its preparations and implement the necessary preparatory steps. This pre-investment of

resources has implications for ECHA’s core tasks. ECHA generally sets a 30% overhead in its calculations. However, this overhead includes IT as well as general administrative and governance needs. Given the

fact that all new tasks have a high dependency on IT tools and systems, this approach needs to be reviewed, as it may underestimate overall resource requirements. At the same time, it is important that

all new tasks include realistic transitional periods that allow ECHA to onboard its tasks once the new

resources are allocated.

2.3 Resource programming for the years 2025-2028

The detailed data for the resource programming is provided in Annexes II-V.

Revenues

REACH/CLP

The total fees and charges are currently estimated at c. EUR 33-34 million per year during 2025-2028, taking account of the estimates developed internally, based on historical averages, and the planned

indexation on REACH Registration fees (19.5%) with an entry into force as of 1 April 2025. The REACH balancing subsidy for 2025 is based on the latest Commission’s Draft EU budget, totalling EUR 76.3

million. For 2026, the balancing EU contribution (EUR 77.2 million) is based on the current MFF (2021- 2027) levels. In addition, the total of the EFTA contribution and the bank interest is estimated to be c.

EUR 3.0 million annually.

BPR

ECHA’s BPR activities are funded by fee income and the balancing EU contribution. The inherent

uncertainty continues with respect to the budgeted revenue from fees and charges, which is based on estimated dossier application volumes. For 2025, the fee income is presently estimated at c. EUR 6.3

million. The indicated available EU contribution, based on the Commission’s Draft Budget, is c. EUR 8.0 million. For 2026, the required balancing EU contribution (EUR 8.1 million) is based on the current MFF

(2021-2027) levels. In addition, the total of the EFTA contribution (including Switzerland’s direct

contribution to Biocides activities) and the bank interest is estimated to be c. EUR 0.7 million annually.

Environmental Policy

This budget area covers PIC, POPs, Waste Framework Directive, Drinking Water Directive, 8th Environmental Action Programme, Batteries Regulation, and Industrial Emissions Directive, as adopted.

The possible resourcing stemming from the adoption of the Water Framework, Groundwater and Environmental Quality Standards (EQS) Directives, the Packaging and Packaging Waste Regulation

(adopted by the Council on 16 December 2024, entry into force pending publication in the Official Journal), the End-of-Life Vehicles (ELV) Directive, the Regulation establishing a common data platform

on chemicals, and revision of the POP and Medical Devices Regulation, and RoHS Directive have also been included. It is to be noted that the resourcing of the latter is subject to the formal adoption of the

respective tasks by the EU Parliament and the Council. Nevertheless, the Commission decided to

frontload one TA post (EUR 0.16 million) for accelerating the work on the Packaging and Packaging Waste

ECHA Single Programming Document 2025-2027 27

task (entry into force expected in early 2025) and this has been incorporated in 2025 figures and onwards. The planned subsidy is within the Commission’s Draft EU budget for 2025, totalling EUR 10.5

million. For 2026, the balancing EU contribution totalling c. EUR 19.0 million takes account of the current

MFF (2021-2027) as well as the new legislative proposals planned to be adopted. In addition, the total of the EFTA contribution and bank interest are estimated to be c. EUR 0.4 million for 2025, and increasing

to c. EUR 0.7 million in 2026.

Expenditure

REACH/CLP

The total expenditure in 2025 is foreseen to total EUR 112.0 million, that is 6% above the 2024 level.

The needs for staff-related expenditure (Title 1) in 2025 total EUR 76.8 million, representing a 7% increase compared to 2024 and is aligned with the latest information received. The estimated Title 1

need for 2026 totals EUR 77.4 million, that is, 1% above the 2025 levels. The proportionally allocated

amount of the common infrastructure (Title 2) expenditure totals EUR 15.8 million for 2025 and EUR 15.7 million for 2026. The operational expenditure (Title 3) for 2025 and 2026 amounts to c. EUR 19.3

and EUR 20.5 million, respectively.

BPR

The total expenditure in 2025 is foreseen to total EUR 15.1 million, that is 7% above the 2024 actuals level. The needs for staff-related expenditure (Title 1) total EUR 10.1 million, representing a 9% increase

compared to 2024. The estimated Title 1 need for 2026 totals EUR 10.2 million, that is, 1% above the 2025 levels. The proportionally allocated amount of the common infrastructure (Title 2) expenditure

totals EUR 2.2 million for 2025 and EUR 2.1 million for 2026. The operational expenditure (Title 4) for

2025 and 2026 amounts to c. EUR 2.8 and EUR 3.0 million, respectively.

Environmental Policy

This budget area covers PIC, POPs, Waste Framework Directive, Drinking Water Directive, 8th Environmental Action Programme, Batteries Regulation, and Industrial Emissions Directive, as adopted.

The possible resourcing stemming from the adoption of the Water Framework, Groundwater and Environmental Quality Standards (EQS) Directives, the Packaging and Packaging Waste Regulation

(adopted by the Council on 16 December 2024, entry into force pending publication in the Official Journal), the End-of-Life Vehicles (ELV) Directive, the Regulation establishing a common data platform

on chemicals and revision of the POP and Medical Devices Regulation, and RoHS Directive have also been

included. It is to be noted, that resourcing of the latter is subject to the formal adoption of the respective

tasks by the EU Parliament and the Council.

The total expenditure in 2025 is foreseen to total EUR 10.9 million, that is EUR 5.2 million (92%) above the 2024 level. This increase is principally comprised of EUR 1.2 million increase in staff-related

expenditure and an increase of c. EUR 4.0 million in Title 5 (Operational expenditure) related to the

expected financing for the tasks pending adoption, as explained above.

The needs for 2025 staff-related expenditure (Title 1) total EUR 3.9 million, representing a EUR 1.2 million (44%) increase compared to 2024. This is mainly due to an increase in staff on the payroll for

the Industrial Emissions Directive, Drinking Water Directive, and Packaging and Packaging Waste

regulation. The estimated Title 1 need for 2026 totals c. EUR 4.0 million. The proportionally allocated amount of the common infrastructure (Title 2) expenditure totals EUR 1.2 million for both 2025 and

2026. The operational expenditure (Title 5) for 2025 amounts to c. EUR 5.9 million and for 2026 it

amounts to c. EUR 14.6 million, out of which EUR 12.6 million is related to the tasks pending adoption.

ECHA Single Programming Document 2025-2027 28

Staffing / Human resources

It is anticipated that ECHA’s overall staff population remains relatively stable, apart from the staffing

under ‘Environmental policy’. While, for 2025, ECHA’s resources reflect a limited increase stemming from

adopted legal mandates, ECHA has included the potential increased resourcing in 2026 linked to pending

legislations in Annex IV (ref. Section 2.2 above).

Evolution of resources outlook 2025-2026 Posts for 2025 Posts for 2026

TA CA TA CA

DWD +3 +1 +1

POP* +2

Water Directives* +7 +4

Packaging and packaging waste legislation +1

RoHs Directive* +4 +3

ELV Directive* +1

Data regulation* +9 +10

Serious Cross-Border Threats to Health +1

TOTAL +4 +2 +24 +17

*pending adoption

This is primarily linked to the potential adoption of the legislative proposals under the "One Substance,

One Assessment" legislative package, which would potentially result in further new tasks to ECHA. In the period of this Programming Document, ECHA will continue to implement proactive human resource

(HR) management practices, in line with its People and Organisational Strategy 2024-2028. ECHA will also continue to cooperate closely with the Commission services and the EU Agencies Network (EUAN)

in areas of people management that are of common interest. To deliver its chemicals mandate, ECHA has developed significant levels of competence and invested heavily in digital technologies. All adopted

and potential new tasks, and particularly the potential European Common Data Platform for Chemicals,1

come with increasing demands on our digital capabilities and offerings. We need, therefore, to invest for the future now if we are to keep up with new technologies such as AI and the demands of stakeholders

and duty holders.

ECHA will continue its work on developing competences needed for existing and new tasks entrusted to

the Agency and applying a flexible deployment of its staff to ensure delivery under the different pieces of legislation. ECHA recognises that it needs to invest in capacity and competence building for its own

staff and, also, for those involved in its Committees and Working Groups. To implement the strategic goal to ‘invest in people and organisational excellence’, ECHA’s People and Organisational strategy aims

to attract the best candidates and develop and motivate its staff to meet new tasks and challenges. While

ECHA does not presently contain external training within its mandate, it also recognises the need to invest in external capacity building to meet current and future needs. There is evidence that there is an

openness for increased Member States/ECHA collaboration and a desire for ECHA to provide more opportunities for professional development. In setting out actions on capacity building in the coming

period, ECHA will adopt a balanced approach that aims to deliver opportunities for shared learning internally (staff and Committees) and externally to Member States, without significant increases in

resource allocation.

ECHA engages operational interims principally for the verification of company size and completeness of

registration dossiers under REACH. It is planned to continue to reduce the dependency on interim support

in these areas by 2027. A small number of interims are also budgeted to cater for potential absences and/or peak workload periods. This approach does not apply to interims engaged to provide services

under delegated tasks or grant agreements (for example, EUCLEF), for which specific Contribution

Agreements are in place.

1 Available at: https://ec.europa.eu/commission/presscorner/detail/en/ip_23_6413

ECHA Single Programming Document 2025-2027 29

2.4 Negative priorities/decrease of existing tasks

The purpose of this section, which is required by the Commission’s guidelines for the drafting of the

Single Programming Document, is to highlight those activities that have been deprioritised, or reduced, due to inadequate resources and ability to effectively deliver. However, despite ECHA’s best efforts to

deliver on its widening legal mandate and tasks, the challenges inherent in our resourcing structure

mean that we may not be in a position to deliver to the fullest extent possible several activities, namely:

• Provision of updated guidance, advice and support in response to changing and new regulatory and science information.

• Limited development of some existing applications (example: Case management, REACH-IT, R4BP 3, Interact portal) due to the need to prioritise the modernization and transformation of the

regulatory IT tools, prepare for new tasks and further development of the new dissemination

solution ECHA CHEM. • Longer development schedule for the industry portal due to identified IT priorities and the

resulting extended transformation period for existing tools. Existing submission tools will continue to be maintained.

• Minimal maintenance of certain tools (examples: SCIP and EUCLEF). The future development of these initiatives will depend on potential legislative changes, which may provide the necessary

support for further advancement. • Over the next few years, a reduction in workload and need for ECHA support to Expert Groups

may materialise, as the implementation of the new CLP hazard classes progresses via harmonised

classification and not via SVHC route. Initially the subgroups will support this transition by giving expert advice to Member States developing CLH proposals upon request.

• Reduced intensity in activities under identification and prioritisation of substances due to the milestones already achieved (in screening high volume substances) and new objectives set for

Integrated Regulatory Strategy. • Decreased number of opinions that can be delivered on authorisation applications due to limited

committee capacity and increased restrictions activity. • Limited support and guidance for registrants in relation to company risk management via

exposure scenarios in Safety Data Sheets.

2.5 Strategy for efficiency gains

ECHA is taking the following actions to ensure that it is maximising the use and efficiency of our available

resources:

Organisational review

ECHA’s organisational review, which commenced in 2024, will inform the Agency on how best to organise

structurally directorates and units to deliver on existing, new and future tasks, and leverage synergies. In addition, we aim to identify ways of working that can increase our capacity, streamline areas of

duplication and embrace adaptive resource allocation and flexibility measures based on needs and

evolving factors.

Capacity and competence of Committees

We will continue to explore ways to enhance the capacity and competency of our Committees, for example, examining the potential of creating pools of experts to support Committee members and the

increased use of Working Groups. We also hope to increase capacity-building for both Member States and SMEs, however, as noted above, extensive capacity-building will not be possible given other priorities

and resource constraints in the short to medium term.

ECHA Single Programming Document 2025-2027 30

IT and Business transformation

ECHA is an Agency focussed on chemical safety through the implementation of EU policy and legislation.

However, we are also an Agency with a high delivery of digital tools and supports. Digital and business

transformation needs to be resourced fully to ensure we can meet current and future demands. By re- shaping the portfolio of its IT enterprise architecture and solutions, ECHA aims at achieving efficiency

gains in the definition, implementation, and use of IT products. In addition, to improve usability of ECHA's IT tools and streamline the work of the different user groups, we remain committed to invest in user-

centricity and user experience as part of the IT development process.

Integrated Management System Strategy and Framework

ECHA’s Integrated Management System Strategy and Framework is designed to enable the achievement

of ECHA’s strategic goals and priorities by ensuring a flexible and performance-based governance,

adapted to the Agency’s operational structure. By implementing the framework, ECHA’s processes are intended to be effective and efficient by design through a critical consideration of the level of controls

needed.

ECHA Single Programming Document 2025-2027 31

III Work Programme

Executive Summary

Our annual work programme translates and implements our Strategy Statement, as outlined in the multi-

annual work programme above.

The Integrated Regulatory Strategy was reviewed with the stakeholders in 2024. Our focus will be on

maintaining robust knowledge of chemicals in our databases and supporting the delivery of risk management outcomes for (groups of) substances. We will also explore synergies with the new

legislation within ECHA’s remit and strengthen relationships with our sister agencies to support delivering consistent outcomes, in relation to the evaluation of substances which are also regulated under their

mandates.

The focus of the evaluation work will shift to assessing the information coming back from registrants in response to compliance check decisions (‘follow up’), while continuing to select dossiers for compliance

check. We will continue to promote alternatives to animal testing, assuming an active role in supporting

policy developments and research.

Our activities in relation to risk management, such as harmonised classification, authorisation and restriction, will continue to take account of the experience in dealing with groups of substances. Our

work on harmonised classifications will take account of the new hazard classes introduced in the CLP Regulation in 2024. The restriction dossier on Chromium VI substances is expected to be published in

2025 and may ultimately lead to reducing the burden on the authorisation of these substances.

Ensuring that ECHA's bodies function well remains a high priority for us in 2025, particularly considering the increasing workload of our scientific committees. Together with the Commission and the Member

States, we will continue to promote the need to have committees that are fully resourced and members

who are competent and active.

We remain committed to delivering our obligations under the Biocidal Products Regulation. In 2025, we will continue our efforts to progress the evaluation of active substances in the Review Programme,

including by providing support to the Member States for delivering their evaluation dossiers. On Union authorisations we anticipate a continued increase of the workload. In 2025 we intend to produce an

analysis on the functioning of the Biocidal Products Regulation, in support of the evaluation of the

regulation by the Commission.

Regarding environmental policy, the implementation of existing and new tasks, as well as preparations

for the ones where legislation is pending, will also continue, as will the implementation of ECHA's other

tasks, including those under grant, cooperation and service-level agreements.

Our IT systems are critical to managing the vast amounts of data we process, and we remain committed to enhancing our digital tools to support both existing and new tasks. The transformation and adaptation

of our data management, IT systems and business processes will continue. IT tools will be developed to support the transparent sharing of information between companies, Member States and the Agency. We

will continue to prepare tools and processes for handling regulatory dossiers under new tasks, with a

focus on the user experience of duty holders.

In addition to our processes and systems, in 2025, we will continue to maintain a strong focus on our

people by implementing year 2 of our People and Organisational Strategy and the recommendations arising from the organisational review completed in 2024. We will continue to promote wellbeing, health

and safety at work and take further actions to meet EU equality and diversity goals. We will also continue

to take the necessary steps to meet EU environmental and quality goals and targets.

ECHA Single Programming Document 2025-2027 32

1. REACH/CLP

1.1 Dossier preparation

Overview

ECHA supports companies to access and remain on the European Union (EU) single market. Through the

inquiry and data sharing process, we help companies share their data across the EU, thereby reducing registration costs and avoiding unnecessary testing. It develops and provides IT tools (e.g., IUCLID,

Chesar, EUSES) for preparing and submitting dossiers required under the EU’s chemicals legislation. The harmonised submission of information, both in structure and in content, provides efficiencies to ECHA’s

other activities which rely on the information.

In 2025, ECHA will continue to deliver the inquiry process and will take decisions on data sharing

requests. IT tools will be maintained and will support the transparent sharing of information between

companies, Member States and the Agency.

Objective 1: Companies supported on inquiries and data sharing

Expected results

• Companies registering the same substance can connect, via the inquiry process, and share data

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Inquiries and disputes on data sharing are handled in line with legal requirements and timelines.

Number of inquiries received 4835 4800 5000 estimate

Percentage of data sharing disputes handled within legal

deadline

n/a n/a 100 target

Objective 2: Harmonised IT tools available to support the transparent sharing of harmonised data between industry and regulatory authorities

Expected results

• The use of IUCLID and Chesar Platform supports companies in effectively complying with regulatory

requirements under EU chemicals regulation. • Harmonised data formats support transparency and enhance EU competitiveness.

• A growing number of regulatory systems in the OECD member countries use IUCLID.

• The information submitted to authorities is harmonised, both in structure and in content, which enables more efficient processing and analysis of the data and increases its impact on regulatory

activities and decisions.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

IUCLID and Chesar are updated to incorporate existing, new and changing

regulatory requirements.

Timeline for release of version 1.0 of Chesar Platform for

REACH and Biocides

n/a n/a Q2 target

Promotion of IUCLID as the international harmonised format for chemical data continued.

Number of regulatory processes maintained in IUCLID

n/a n/a 55 target

IUCLID progressively updated to

support the needs of OECD and international partners.

Number of OECD IUCLID

expert group meetings attended and supported

n/a n/a 2 estimate

ECHA Single Programming Document 2025-2027 33

Scientific contribution made to development of the OECD harmonised test guidelines relevant for the EU

information requirements.

Number of test guidelines supported

n/a n/a 2 estimate

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 7 595 644 6 435 918 5 879 712

Human resources (FTE) 29 24 24

1.2 Dossier submission and processing

Overview

This activity covers the timely processing of all dossiers submitted by industry to ECHA under REACH and CLP, except those submitted for poison centres. It also includes the development and maintenance

of the corresponding IT solutions providing a clear and simple way for companies to fulfil their legal

obligations in terms of submission of information to the Agency.

In 2025, the focus will be on ensuring that the access to market continues to be fast and predictable. At the same time, the data provided in the dossiers should serve as a robust starting point for regulatory

identification and prioritisation as well as for the publication of non-confidential information. ECHA will

continue to prepare its tools and processes for handling regulatory dossiers under new tasks, with a

focus on the user experience of duty holders.

Objective 1: Access to market for duty holders is streamlined and predictable

Expected results

• Dossiers are timely processed, and companies know the information to be provided to fulfil their

regulatory obligations regarding submissions. • Information submitted to authorities is structured in content and format to effectively support the

subsequent processes.

• Companies active in the innovation of new chemicals or processes get their PPORD exemptions granted where appropriate.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

PPORD notifications processed, and

data analysed to identify and monitor innovation and new chemicals trends.

Number of PPORD

notifications received and processed

235 240 240 estimate

The verification of the size of SME companies continues and the time lag

between submission and beginning of the verification is further reduced.

Time lag between submission and beginning of SME verification process

n/a n/a 2 years target

Number of verifications of SME Registrants’ size

decisions issued

416 400 400 target

Ongoing work on the implementation of the ex-ante SME verification process,

including updates of guidance and tools, before it is launched by mid- 2026.

Timeline for having

implementation plan for ex- ante SME verification process in place

n/a n/a Q1 target

ECHA Single Programming Document 2025-2027 34

Registrations invalidated as necessary. Corresponding tools and processes for invalidation of registrations developed

further for different circumstances,

such as to facilitate compliance of registrations with Article 50(3) and the implementation of EU sanctions, etc.

Number of

invalidation/revocation

decisions issued

n/a 150 150 estimate

Classification and labelling (C&L) notifications processed.

Number of C&L notifications received

43 933 35 000 35 000 estimate

Registration dossiers processed.

Number of REACH registration dossiers received (initial & updates)

13 749 15 000 15 000 estimate

Percentage of REACH registration dossiers handled within legal deadline

n/a n/a 100 target

Percentage of registration dossiers verified with manual

completeness check

n/a n/a 30 estimate

Number of update requests following completeness check

n/a n/a 900 estimate

Number of confidentiality

request decisions issued n/a n/a 100 target

Number of registration

invoices issued n/a n/a 5 500 estimate

Positive registration decisions issued. Number of positive

registration decisions issued n/a n/a 14 000 estimate

Negative registration decisions issued. Number of negative

registration decisions issued n/a n/a 120 estimate

New substances registered.

Number of new substances

registered - (i.e. first time on the EEA market above 1tpa)

n/a n/a 350 estimate

High tonnage substances registered. Number of substances registered for the first time

above 100tpa

n/a n/a 50 estimate

Objective 2: Submission activities are user-focussed, streamlined and adaptable

Expected results

• Submission systems are built for new submission types needed for new tasks, with a focus on interoperability, maximise the use of new technology and the efficient integration of any new

regulatory processes as well as to reduce the administrative and financial burdens on duty holders, in particular, small and medium-sized enterprises (SME).

• Users’ experience in performing submission related activities is further aligned.

• Onboarding of new users and new regulatory processes is rapid and cost-effective.

ECHA Single Programming Document 2025-2027 35

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

ECHA’s solution for new submission

types (with focus on DWD).

Timeline for finalising new

submission solution for DWD n/a n/a Q2 target

Engagement actions with users of the ECHA’s submission systems.

Number of Workshops/Meetings organised with users of the ECHA’s submission systems

n/a n/a 2 target

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 8 375 567 8 597 854 11 504 671

Human resources (FTE) 34 36 36

1.3 Identification and prioritisation of (groups of) substances

Overview

Identification and prioritisation of substances and groups of substances is a central part of ECHA's strategy. The Integrated Regulatory Strategy (IRS) has been reviewed with the stakeholders in 2024 in

light of the new ECHA strategic plan and emerging priorities. It aims, together with the Commission and Member States, to identify and facilitate prioritisation and co-ordination of regulatory actions for (groups

of) substances under different legislation.

In 2025, we will initiate implementation of the objectives agreed during 2024 with the Commission and

the Member States. Our focus will be on maintaining good knowledge on the chemicals in our databases and supporting the delivery of risk management outcomes for (groups of) substances. We will also

explore synergies with the new legislation within ECHA’s remit and will strengthen the relationship with

our sister agencies to support delivering consistent outcomes.

Objective 1: Prioritisation of regulatory actions on (groups of) substances is coordinated

with the Commission and Member States

Expected results

• The Commission and Member States are supported to identify (groups of) substances that require

risk management through shortlisting (groups of) substances considered as good candidates for CLH, SVHC identification, and restriction.

• ECHA, the Commission and Member State national authorities take coordinated risk management actions to protect human health and the environment.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Shortlists of (groups of) substances provided to support the Commission

and Member States bringing forward candidates for CLH, SVHC

identification, and restriction.

Number of groups of

substances provided as candidates for CLH and restriction

n/a n/a 5 target

Number of new substances added to the Registry of

Intention (SVHC, CLH,

Restrictions) originating from ARNs

n/a n/a 15 estimate

ECHA Single Programming Document 2025-2027 36

Objective 2: Good knowledge on ECHA's chemical database is maintained

Expected results

• Knowledge on ECHA's chemical database is maintained, by screening substances above 100 tonnes

(new registrations or tonnage upgrades) and prioritising for data generation or risk management as appropriate.

• Transparency and predictability of regulatory activities is ensured by disseminating the outcome of assessments and the progress made in addressing particular (groups of) substances. This will

enable industry to be proactive and make informed decisions on chemicals in their portfolio.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Project to systematically screen all

substances registered above 100 tonnes after 2018 (tonnage upgrades and new registrations) commenced.

Number of substances above 100 tonnes screened

n/a n/a 100 target

ARNs concluded when information from compliance checks becomes available, to inform on the need (or not) for the

anticipated risk management.

Percentage of relevant ARNs concluded and update published to the website

n/a n/a 100 target

Objective 3: Co-operation and transparency on authorities' activities is further enhanced

Expected results

• Support is provided for alignment of authorities’ views on risk management options through e.g.

pilot projects on restrictions, optimising the collaboration between authorities (e.g., through RiME+) as well as use of the respective tools (e.g., ACT).

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Plans and priorities for ongoing and

future work between Member States, ECHA and the Commission shared through RiME+ and other mechanisms

(Heads of Chemicals Authorities).

Number of RiME+ meetings organised

n/a n/a 4 estimate

Targeted support to Member States on

e.g. pilot projects on restrictions and related to RiME+ discussions (e.g. on technical questions related to grouping and read-across).

Number of requests for

support from Member States in the context of RiME+ discussions addressed

n/a n/a 5 estimate

ACT and its integrated tracking list further developed to facilitate sharing

of priorities and co-operation among authorities.

Timeline for the update of ACT n/a n/a Q4 target

ECHA Single Programming Document 2025-2027 37

Objective 4: Collaboration with ENVI agencies is further enhanced under the One Substance, One Assessment and One health initiatives

Expected results

• Engage actively with other EU Agencies, in particular EFSA, EMA and EEA, to further enhance

prioritisation and coordination of actions across regulations, in particular, in the framework of the

One Substance, One Assessment; identify synergies in the areas of data and scientific and technical competences; further align on scientific assessments and opinion making.

• Co-operate with EFSA and EMA to support alignment of evaluation of common substances under the REACH, BPR, DWD, food safety and medicine legislation.

• Engage and co-operate, with ENVI Agencies to implement the strategic objectives of the One Health Framework for Action.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Collaboration with EFSA and EMA in the framework of One Substance, One Assessment continued.

Number of bilateral

governance meetings on OSOA to review and align approaches for common

substances and cross cutting topics

n/a n/a 6 estimate

One Health framework of action supported.

Number of projects related to

One Health framework under the leadership of ECHA initiated

n/a n/a 2 target

Pilots on prioritising actions on common substances across different

legislations initiated, considering the synergies between the existing and new tasks within ECHA’s mandate.

Number of pilot projects on

prioritising actions on

common substances across different legislations initiated to improve consistency of regulatory outputs

n/a n/a 1 estimate

Support to EFSA mandate to assess exposure to plasticizers in food contact

materials provided.

Timeline for support to EFSA provided in line with the

relevant Commission mandate

n/a n/a Q1-Q4 target

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 12 739 439 10 351 761 10 046 669

Human resources (FTE) 55 44 40

1.4 Evaluation

Overview2

Evaluation is a joint activity of ECHA and the Member States (through their Competent Authorities and the Member States Committee), to ensure that industry complies with their obligations to be compliant

and provide the necessary data in their registration dossiers. It is also aimed at identifying substances that need further regulatory action to ensure safe use. The Evaluation activity, as a whole, is a key

building block for accelerating data generation, intensifying identification of substances and groups of

substances, accelerating regulatory action on them, and ensuring a level playing field.

2 Title VI of Regulation (EC) No 1907/2006

ECHA Single Programming Document 2025-2027 38

In 2025, dossier evaluation outputs and focus will be aligned with the overall prioritisation plan mentioned above under 1.3. The focus of the evaluation work will be shifted to assessing the information

coming back from registrants in response to compliance check decisions (‘follow up’). We will also start

selecting dossiers for compliance check from several sources, instead of relying only on the grouping and screening as the source for new compliance checks. Substance Evaluation is expected to continue as is.

Audit follow ups on testing proposals will be implemented.

Objective 1: Dossier evaluation is impactful, efficient and scientifically and legally robust

Expected results

• The protection and compliance levels in the EU increase as hazard data generated on chemicals and on the groups they belong to and companies are required to update their dossiers.

• Data generated can be used by companies to improve risk management, to decide to substitute,

or market a substance as a substitute for a more hazardous alternative and/or to support innovation programs looking for alternatives.

• Information generated can be used for the further prioritisation of regulatory actions to better protect human health and environment.

• Knowledge generated is used by Member States and the Commission to identify and propose the appropriate risk management measure.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Evaluation targets and indicators

delivered in line with legal

requirements and the recommendations from the Joint Evaluation Action Plan (JEAP).

Number of compliance checks concluded: draft decisions or no action

301 250 200 target

Number of final decisions on

compliance checks n/a 250 200 estimate

Number of compliance check

decisions concluded in the follow-up to dossier evaluation n/a 250

200 target

Number of testing proposals

draft decisions issued 50 target

National enforcement authorities informed in case of non-compliance with the decision and follow-up

decisions drafted where appropriate.

Percentage of Failure to Respond notifications communicated to NEAs

without delay

n/a n/a 100 target

Updated recommendations and regulatory advice provided to

registrants stemming from evaluation report published and communicated.

Timeline for publication of

Article 54 report n/a Q1 Q1 target

Targeted study audits requested in

case a concern about compliance with principles of Good Laboratory Practice is identified by ECHA or a Member

State.

Number of study audits requested

n/a n/a <5 estimate

ECHA Single Programming Document 2025-2027 39

Objective 2: Substance Evaluation by Member States becomes more efficient and effective

Expected results

• The annual list of substances requiring substance evaluation (the Community rolling action plan)

provides clarity to stakeholders for which substance(s) and specific concern(s) additional hazard information needs to be generated.

• Substance evaluations are concluded promptly by Member State competent authorities to enable the initiation of appropriate regulatory risk management measures ensuring the safe use of the

substance(s).

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Updates of the Community rolling

action plan (CoRAP) proposed to the Member State Committee (MSC) for substances where substance evaluation is the most appropriate tool to

generate further hazard information.

Timeline for publication of CoRAP

n/a n/a Q2 target

Member States advised and supported in achieving substance evaluation

conclusions as fast as possible.

Number of substance evaluation final decisions

issued

6 10 10 estimate

Support provided to Member States to adopt the appropriate regulatory risk

management measures and initiatives.

Timeline for providing status update to Member States related to substance

evaluation

n/a n/a Q4 target

Substance evaluation cases currently

opened reduced further.

Percentage of open substance

evaluation cases n/a n/a 5 target

Substance evaluation cases concluded.

Number of substances for

which a conclusion was reached in substance evaluation

26 25 25 estimate

Resources 2023

actual

2024

est.

2025

est.

Financial resources (costs, EUR) 16 617 743 16 909 217 18 515 992

Human resources (FTE) 91 92 92

1.5 Authorisation

Overview3

Based on proposals prepared by Member States or the secretariat on request of the Commission, ECHA identifies SVHCs and places them on the Candidate List. From that list ECHA, taking into account the

opinion of the Member State Committee, recommends priority substances for inclusion in the REACH

authorisation list.

ECHA's Risk Assessment and Socio-economic Analysis Committees (RAC and SEAC) provide scientific opinions on companies’ applications for authorisation, including the risks, the benefits and the availability

3 Title VII of Regulation (EC) No 1907/2006

ECHA Single Programming Document 2025-2027 40

of suitable alternatives and possibilities to substitute. The opinions are provided to the Commission which

decides whether to grant or refuse an authorisation for using the substance in the EU.

In 2025, ECHA will continue to meet the legal obligations to identify substances of concern and place

them onto the candidate list and to recommend priority substances for inclusion on the authorisation list. The secretariat will also support the work of ECHA’s two scientific and technical committees, RAC and

SEAC, and facilitate the timely adoption of opinions on applications for authorisation.

We will also support the Commission as necessary to address follow-up actions in relation to the court

decision on chromates.

Objective 1: Substances of very high concern identified, recommendations for inclusion in Annex XIV and applications for authorisation progressed

Expected results

• Inclusion of substances in the candidate list incentivises reduction of their use and replacement by

safer alternatives or technologies. • Increased research and development for safer alternatives or technologies by companies spurring

innovation.

• Improved understanding of what are considered as safer alternatives.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Substances of very high concern identified and included in the Candidate List.

Number of new and updated entries published in the Candidate List

11 15 15 estimate

Applications for authorisation processed and progressed in line with agreed approach.

Number of applications for

authorisation and review reports submitted to ECHA (number of uses)

102 <60 <60 estimate

Number of applications for authorisation and review

reports for which opinion- making is initiated and progressed (number of uses)

n/a n/a 40 target

12th recommendation for substances to be included in Annex XIV submitted to the Commission and published on ECHA website within the legal

timelines.

Timeline for submission of 12th Annex XIV recommendation to the Commission and publication

on the website

n/a n/a Q4 target

Objective 2: Opinions of the Committees for Risk Assessment (RAC) and Socio-Economic

Analysis (SEAC) are timely and fit-for purpose

Expected results

• The European Commission’s decision-making on granting or refusing an authorisation enabled by

providing scientifically and legally robust opinions and decisions. • Authorisation opinions and decisions lead to proper control of the risks to workers, consumers and

the environment and a gradual replacement of SVHCs. • Support provided to the European Commission and RAC/SEAC to further improve the

implementation of the authorisation process.

ECHA Single Programming Document 2025-2027 41

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Opinions on applications for

authorisation delivered to Commission.

Number of RAC and SEAC

opinions adopted on applications for authorisation

and review reports (number of uses) and submitted to the Commission

58 40 35 target

Percentage of opinions on applications for authorisation and review reports submitted

to the Commission within legal deadline

n/a n/a 100 target

Number of opinions on applications for authorisation and review reports submitted

to the Commission requiring further consideration by committees

n/a n/a 144 estimate

Participation in workshops and network meetings facilitated as necessary, to develop methodologies and enhance

the capacity of Member States and companies to carry out analysis of alternatives and socio-economic

analysis with view of finding viable alternatives.

Number of meetings on

analysis of alternatives and socio-economic analysis organised / attended

n/a n/a 1 target

Objective 3: Commission supported in their decision-making tasks

Expected results

• ECHA supports the Commission with the necessary scientific and technical inputs and advice, on request, in the decision-making phase of the authorisation process.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Generic and case-specific support provided to Commission in the decision-making phase of the

authorisation process.

Number of comitology

meetings on applications for authorisation and review reports where support is

provided to Commission decision making

n/a n/a 4 estimate

Resources 2023

actual

2024

est.

2025

est.

Financial resources (costs, EUR) 5 549 010 6 205 080 6 240 745

Human resources (FTE) 26 31 30

4 The Commission requested ECHA, in view of a related Court decision, to prioritise in 2024 producing addenda to 14 opinions previously

submitted. As a result, ECHA can process fewer new opinions on applications for authorisation in 2024 to be delivered in 2025 (target 35 instead of 40).

ECHA Single Programming Document 2025-2027 42

1.6 Restrictions

Overview5

Member States or the ECHA secretariat (at the request of the Commission) develop dossiers for restrictions proposals and ECHA’s Risk Assessment and Socio-economic Analysis Committees (RAC and

SEAC) provide scientific opinions on the restriction proposals, with scientific and administrative support from ECHA staff. The opinions address the effectiveness, practicality and monitorability of proposals

(Annex XV criteria) to address the identified risks as well as the availability of alternatives and socio- economic aspects, enabling the Commission to consider these when deciding whether, and how, to

restrict substances in the EU. The Commission can also ask the ECHA secretariat to develop investigation

reports, preceding any restriction proposal requests.

In 2025, ECHA will continue to investigate the need for restrictions and develop restriction dossiers upon

request of the European Commission and analyse the need to restrict the use in articles for substances subject to authorisation (based on REACH article 69(2)). The restriction dossier on Chromium VI

substances is to be published in 2025 and may ultimately lead to reducing the burden on the authorisation of these substances. We will also support the work of our two scientific and technical

committees, RAC and SEAC, and facilitate the timely adoption of opinions for restriction proposals.

Objective 1: Commission supported in the implementation of the Restrictions Roadmap

Expected results

• Scientific and legally robust restriction dossiers for individual substances or groups of substances

are developed by ECHA (based on Article 68(1)) upon request of the Commission. • Investigation reports on the need for restriction of individual substances, groups of substances or

particular uses prepared upon request of the Commission. • The need to restrict the use in articles for substances, subject to authorisation (based on Article

69(2)) are analysed and findings documented as necessary in screening reports. • Dossiers developed by the ECHA secretariat provide the Committees with a fit-for-purpose basis

for developing their opinions. • Stakeholders have the opportunity to provide targeted and relevant contributions to the

development of the restriction dossier during calls for evidence and/or consultation steps in the

restriction dossier preparation process. • Member States are supported by ECHA in the development of fit-for-purpose restriction dossiers.

• The consistent approach to dossier preparation by ECHA and Member States ensures consistent and targeted decision making and increased legal certainty for companies.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Based on request of the European

Commission, Annex XV dossiers proposing restrictions and investigation reports prepared.

Number of restriction dossiers and investigation reports developed

8 5

1 target

Screening reports for substances under Article 69(2) prepared.

Number of screening reports for substances under Article 69(2) prepared

3 target

Support provided to Member States during their preparation of restriction dossiers notified in Registry of

Intentions.

Number of dossiers on which

support is provided to Member States in their preparation of restriction

dossiers

n/a n/a 2 estimate

5 Title VIII of Regulation (EC) No 1907/2006

ECHA Single Programming Document 2025-2027 43

Objective 2: Opinions of the Committees for Risk Assessment (RAC) and Socio-Economic

Analysis (SEAC) are timely, robust and fit-for-purpose

Expected results

• Committee opinions delivered that allow the Commission, together with the Member States, to take well-informed decisions on the proposed restrictions, and thereby to implement the objectives of

EU chemicals policy.

• The Committee’s opinion making is facilitated by adequate stakeholder involvement, independence of committee members and adherence to consistent approaches and methodologies.

Main outputs Indicators 2023 actual

2024 est.

2025

target/

estimat e

Opinions on restrictions delivered to the Commission.

Number of RAC and SEAC opinions on restriction

proposals delivered to the Commission

5 1 0 target

Percentage of opinions on restrictions submitted to the Commission adopted within

legal deadline

n/a n/a 100 target

Number of opinions on

restrictions submitted to the Commission requiring further consideration by committees

(Art 77 (3)(c)

n/a n/a 0 estimate

Contribution provided to the

development of methodologies related to socio-economic analysis, including the valuation of various health and environmental endpoints in

collaboration with the OECD and in line with the Commission’s Better Regulation guidelines.

Number of contributions provided to the development of methodologies related to

socio-economic analysis and analysis of alternatives

n/a n/a 2 target

Objective 3: Commission supported in their decision-making tasks

Expected results

• ECHA supports the Commission with the necessary scientific and technical inputs and advice, on request, in the decision-making phase of the restriction process.

• ECHA develops reports requested by the Commission. • ECHA supports the Commission in the implementation of the Annex XVII restriction entries.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Case-specific support provided to Commission in the decision-making phase of the restriction process.

Number of restriction opinions on which support is provided to Commission in decision

making

n/a 4 4 estimate

General and specific guidance to aid the implementation of Annex XVII

restriction entries delivered to the Commission.

Number of reports related to Annex XVII entries (e.g.

guidelines) delivered to the Commission

n/a 1 1 target

ECHA Single Programming Document 2025-2027 44

General and specific technical support to aid the implementation of Annex XVII restriction entries delivered to the

Commission.

Number of Annex XVII entries where implementation support

is provided to the Commission

n/a 1 1 target

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 6 137 817 5 681 846 6 427 136

Human resources (FTE) 29 28 31

1.7 Classification and Labelling

Overview6

The CLP Regulation governs the classification, labelling and packaging of chemicals. Classification and labelling is an important instrument in chemicals regulation for ensuring safe use and the protection of

human health and the environment. The harmonisation sets one EU standard for the classification, labelling and packaging across all uses within the EU single market. It applies to substances registered

under REACH, but also active substances used in biocidal products and plant protection products. The CLP Regulation also requires suppliers of hazardous chemical products to provide national poison centres

information for emergency health response.

In 2025, the focus will be on the implementation of legislative changes to CLP including addition of new hazard classes. This determines the need to execute activities to ensure smooth implementation together

with the relevant actors. In addition, the Commission has requested ECHA’s support in bringing these new hazard classes to the United Nations Globally Harmonised System of Classification and Labelling of

Chemicals (UN GHS) level as well as to contribute to the United Nations Environment Programme (UNEP)

project to pilot the implementation of GHS in four African countries.

Objective 1: Opinions of the Committee for Risk Assessment (RAC) are timely and fit-for

purpose.

Expected results

• The Commission, together with the Member States, can take well-informed, and timely decisions on the harmonised classifications, and thereby implement the objectives of EU chemicals policy.

• The members of the Risk Assessment Committee have a complete and robust basis for developing opinions for the Commission’s decision-making process, with effective and efficient support during

the dossier preparation and committee process.

• Stakeholders are in a position to provide targeted and relevant contributions to the further development of the proposals during the public consultations and when specifically asked for by

ECHA or RAC in respect of additional information or clarification needs. • The harmonised approach ensures a level playing field and increased legal certainty for companies,

supporting innovation while increasing human health and environment protection.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

CLH dossiers, including individual and groups of industrial chemicals, PPP and

biocides from the outcome of identification and prioritisation processed in line with legal

Number of proposals for

harmonised classification and labelling received and progressed

45 50 50 estimate

6 Regulation (EC) 1272/2008

ECHA Single Programming Document 2025-2027 45

requirements. Number of RAC opinions on proposals for harmonised classification and labelling

adopted

42 50 50 estimate

Objective 2: Member States, Commission services and duty holders supported to fulfil their legal obligations

Expected results

• Guidance and tools for industry and authorities support an efficient and effective implementation

of the CLP Regulation, including on grouping for CLH purposes. • ECHA’s expertise effectively supports the EU’s work in implementing UN GHS in the EU and

promoting it globally.

• The protection of commercial interests and availability of information for professional users and consumers are ensured through consistent decision making by ECHA on the use of alternative

names.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Support provided to Member States

during their preparation of CLH dossiers.

Timeline for providing support

to Member States during their preparation of CLH dossiers

n/a n/a Q1-Q4 target

Guidance made available and updated as necessary.

Number of CLP guidance documents updated

n/a n/a 1 target

Decisions made on requests to use an

alternative chemical name in line with

legal requirements.

Percentage of decisions issued

(Art 24 CLP) and sent in line

with the legal deadlines

n/a n/a 100 target

Scientific and technical support provided to the Commission in the context of the further development of the UN GHS.

Timeline for providing support to the Commission in the context of UN GHS

n/a n/a Q1-Q4 target

Scientific and technical support provided to the Commission in the implementation of the revisions of the

CLP regulation and the UNEP-GHS project in African countries.

Timeline for providing support to the Commission in the

context of UNEP-GHS project

n/a n/a Q1-Q4 target

Objective 3: Up-to-date information on the classifications for chemicals, both harmonised and non-harmonised, publicly available

Expected results

• Harmonised classification and self-classification information made available in the C&L inventory,

which supports classification by companies and safe use throughout the supply chain.

• The list of both harmonised and self-made classifications by companies is a point of reference at global level to access information about hazards of substances in commerce.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

New C&L inventory is operational and delivers reliable and up-to-date information about classification and

labelling to its customers.

Percentage of satisfaction of users of C&L inventory

n/a n/a Bench mark

TBD

target

ECHA Single Programming Document 2025-2027 46

Number of workshops organised to inform stakeholders/users about new

C&L Inventory

n/a n/a 1-2 estimate

Objective 4: Structured, high quality and consistent information for the EU poison centre scheme available across Europe

Expected results

• Companies and Member States can efficiently fulfil their obligations related to EU Poison Centres

for the purposes of emergency health responses. • The use of a unique formula identifier (UFI) printed on the label further helps consumers and

Member States to rapidly find precise information to speed up emergency health responses in

poisoning cases.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Notification portal maintained.

Number of Poison Centre notifications received

4.4 million

2 to 3 million

3-4 million

target

Percentage of notifications processed and made available to Appointed Bodies and

Poison Centres

n/a n/a 100 target

Support provided to companies and

Member States.

Number of Helpdesk replies

provided to Appointed bodies and Poison centres

n/a n/a 50 estimate

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 6 399 609 5 995 311 6 077 028

Human resources (FTE) 33 32 32

1.8 Data management

Overview

ECHA develops, operates and supports data management activities and tools so that data can be made available, exchanged, processed and used efficiently in the execution of regulatory processes within

ECHA and when collaborating with others. Through its data services it also develops methods to analyse

and report chemical data to support policy decisions, impact assessments and development of indicators. ECHA provides data analysis services to support European Commission and Member State competent

authorities to further develop legislation.

In 2025, ECHA will continue strengthening data management by: continue implementing the data

governance; review the reporting needs across organisation to optimise the service; develop a new

chemical identifier data management system supporting both existing and new regulatory processes.

ECHA Single Programming Document 2025-2027 47

Objective 1: Regulatory processes performed by relevant actors based on robust data systems and processes.

Expected results

• Data management improves the execution of regulatory processes and the overall effectiveness of

ECHA, contributing to a faster and more predictable decision-making process.

• Improved confidence in ECHA tools in general and a more wide-spread shift to incorporating these tools into regulatory process work.

• Increased use of common data formats and platforms enhances data flows across actors and legislations, achieving better connected regulatory processes which is at the core of the one-

substance-one-assessment approach.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Data governance to support regulatory data consistency, coherence,

transparency and reporting across regulations progressively matured. Data products identified through the

data catalogue.

Number of data products identified

n/a n/a 50 estimate

Internal reporting service reviewed and optimized, considering the new

available technologies.

Timeline for completion of internal reporting service

review

n/a n/a Q4 target

New chemical identifiers data

management system developed, and

implementation commenced to increase efficiency and effectiveness across new

and existing regulatory processes.

Timeline for release of first component of the chemical

identifiers data management system

n/a n/a Q2 target

Case management capabilities further

developed to increase efficiency of existing regulatory processes.

Timeline for first release of

new case management system applicable to the DWD process

n/a n/a Q3 target

Interact Portal maintained with due consideration of process and users’ requirements.

Number of meetings held with stakeholders in relation to Interact

n/a n/a 2 estimate

Data analysis services completed upon request from EU institutions or Member

States.

Number of data provision and analysis requests

n/a n/a 50 estimate

Resources 2023 actual

2024 est. 7

2025 est.

Financial resources (costs, EUR) n/a

n/a 7 425 402

Human resources (FTE) n/a

n/a 21

7 Starting from 2025, the activities 1.8 Data management and 1.9 Making data publicly available, were separated, while previously they were

included in a single activity.

ECHA Single Programming Document 2025-2027 48

1.9 Making data publicly available

Overview

ECHA operates the world’s largest public databases of chemicals with a usage of almost 50 million views per year. This platform includes the published data on chemicals from the REACH, CLP, BPR, PIC, POPs,

WFD and Chemical Agents Directive / Carcinogens, Mutagens and Reprotoxic substances (CAD/CMR) legislations, as well as from more than 50 additional pieces of legislation via the European Union

chemicals legislation finder (EUCLEF).

In 2025, ECHA will continue to further integrate data in ECHA CHEM, following its launch in 2024, with a

focus on information on the regulatory status of substances and their classification and labelling information. ECHA will ensure public communication on the planned changes and the corresponding

timetable. The work on data availability will consider the progress on the foreseen Data Regulation

including the development of an EU common data platform with information on chemicals.

Objective 1: Transparent and public access to data submitted under different regulations as

well as progress on regulatory activities made available

Expected results

• Information on the hazards and uses of chemicals is made publicly available in ways that facilitate

its use for the benefit of chemical safety. • Visibility of ongoing and upcoming regulatory activities promotes regulatory predictability and a

well-functioning internal market.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

ECHA’s new public data availability

system ECHA CHEM is operational and further developed and kept up-to-date.

Percentage of satisfaction of ECHA CHEM users

n/a n/a

Bench

mark TBD

target

Timeline for integration of

information on classification and labelling in ECHA CHEM

n/a n/a Q2 target

Timeline for integration of information on regulatory

status of substances in ECHA CHEM

n/a n/a Q2 target

OECD Global Portal to Information on Chemical Substances (eChemPortal) maintained.

Number of ECHA data updates

on eChemPortal n/a n/a 1 target

Number of eChemPortal

releases n/a n/a 1 target

Resources 2023 actual

2024 est. 8

2025 est.

Financial resources (costs, EUR) n/a

n/a 2 985 136

Human resources (FTE) n/a

n/a 9

8 Starting from 2025, the activities 1.8 Data management and 1.9 Making data publicly available, were separated, while previously they were

included in a single activity.

ECHA Single Programming Document 2025-2027 49

1.10 Promotion of alternatives to animal testing

Overview9

ECHA supports efforts to further reduce animal testing in Europe, promotes alternative methods for hazard assessment and assists in implementing policies and administer processes where alternatives to

animal testing play an increasingly important role.

In 2025, ECHA will continue to promote alternatives, assuming an active role in supporting policy

developments, investing and supporting research (for example, via PARC10) with the overall aim to reduce the animal testing and proactively communicate its actions. The Agency will also support

consistently the efforts undertaken at EU level to develop and deliver the roadmap towards replacement

of animal testing.

Objective 1: Industry generates hazard data using non-animal testing methods and new

approaches

Expected results

• Increased implementation of the ‘Three Rs’ principle (to replace, reduce and refine testing on

vertebrate animals) by supporting industry to avoid unnecessary tests. • REACH registrants can use the QSAR Toolbox and ECHA guidance to provide robust scientific

justifications when using non-animal methods and grouping of chemicals, to avoid unnecessary testing, reduce costs and enhance competitiveness.

• ECHA uses alternative methods to the greatest extent possible in development of dossiers they have been asked to prepare.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Development of the QSAR toolbox to integrate new information (for example, metabolites, biocides or data from pharmaceuticals) and models

further developed.

Number of QSAR toolbox updates

n/a n/a 1 target

Data available for download (REACH studies results and pharmaceutical

industry data contribution) expanded to be used for NAMs development and/or avoiding unnecessary animal testing.

Number of dataset updates to support NAMs development

n/a n/a 2 target

Implementation of the OECD QSAR Assessment Framework (QAF)

supported.

Number of external events organised or attended to

present the QAF

n/a n/a 2 estimate

Objective 2: ECHA information and advice on alternatives to animal testing provided to

policy makers and stakeholders

Expected results

• Enhanced cooperation with the European Commission, other institutional partners, the scientific community and stakeholders to support the development and implementation of the roadmap

towards full replacement of animal testing.

• European Institutions refer and use the technical-scientific competences of the Agency and its networking capacity.

9 Title III of the Regulation (EC) No 1907/2006 10 See activity 4.

ECHA Single Programming Document 2025-2027 50

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Support provided to the Commission

roadmap on phasing out animal testing.

Number of meetings held with

stakeholders on NAMs n/a n/a 4 estimate

Workshop on the roadmap organised jointly with the Commission.

Timeline for workshop on NAMs roadmap organised and delivered timely and

effectively

n/a n/a Q2 target

Development of non-animal test

methods in cooperation with ECHA’s international partners progressed.

Number of NAMs projects

initiated n/a n/a 3 estimate

Collaboration with EFSA enhanced to

support development of harmonised approaches for reducing the need for animal testing within regulatory

context.

Number of bilateral meetings on NAMs organised

n/a n/a 4 estimate

OECD activities related to further development of alternatives and

integration of regulatory relevant alternatives in test guidelines supported.

Number of OECD projects

related to NAMs supported n/a n/a 2 estimate

International collaboration towards the identification and acceptance of alternatives in regulatory frameworks

e.g., with US and Canada within the APCRA initiative (Accelerating the Pace of Chemical Risk Assessment)

maintained.

Number of meetings related

to NAMs with international

partners organised and supported

n/a n/a 2 estimate

ECHA supports Member States with the

use of NAMs in pilot cases for CLH proposals as appropriate.

Number of Member States

NAMs cases supported n/a n/a 4 estimate

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 2 454 907 1 487 058 1 884 740

Human resources (FTE) 6 5 7

ECHA Single Programming Document 2025-2027 51

2. Biocides

Overview

The Biocidal Products Regulation (BPR) establishes the rules for the making available on the market and

use of biocidal active substances and products. The regulation aims at protecting people, animals and the environment by ensuring that the active substances and products allowed on the market only target

harmful organisms, like pests or bacteria.

In 2025, ECHA will continue the efforts to progress the evaluation of active substances in the Review

Programme, including by providing support to the Member States for delivering their evaluation dossiers with particular focus on the evaluation of Article 5(2). On Union authorisations we anticipate a continued

increase of the workload, also due to the complexity of product families applications and the increase of

the number of applications for changes and same biocidal products authorisations. Additionally, in 2025 ECHA intends to produce an analysis on the functioning of the Biocidal Products Regulation based on its

experience and provide it in support to the evaluation of the regulation by the Commission. Furthermore, ECHA will continue the long-term activity to better integrate the IT tools required for the purpose of the

BPR implementation with ECHA’s overall IT architecture.

ECHA will continue to closely collaborate with other agencies (e.g. the European Food Safety Authority

(EFSA) and the European Medicines Agency (EMA)) to implement the OSOA concept in relation to the evaluation of substances which are also regulated under legislation within their mandates. The OSOA

concept, under the Commission’s Chemicals Strategy for Sustainability, aims to improve effectiveness,

efficiency and coherence of the safety assessment of chemicals across chemicals legislation.

Objective 1: Active substance and Union authorisation opinions are timely and of high

quality

Expected results

• The opinions delivered on active substance approvals and Union authorisations follow the agreed

guidance and procedures and are clear, consistent and of high quality. • The Summaries of the Product Characteristics for Union authorisations are clear, consistent and

harmonised. • The Commission, together with the Member States, can take well-informed decisions on the

approval of active substances and Union authorisations of biocidal products. • The Biocidal Products Committee (BPC) and its working groups develop robust approaches to

scientific-regulatory questions, ensuring consistency across processes and over time. • The harmonised approach ensures a level playing field, increases legal certainty for companies in

a functioning internal market and increases human health and environment protection.

• The implementation of the One Substance, One Assessment concept under the current regulatory framework provides the basis for synergies, efficiencies and improved coherence between BPR and

other EU legislation thereby safeguarding the reputation of scientific advice at EU level.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Opinions on biocides active substances.

Number of opinions on biocidal active substances

[approval & renewal] finalised and submitted to the Commission

13 15 15 estimate

Opinions on Union authorisation of

biocidal products.

Number of opinions on Union authorisation [approval & renewal] of biocidal products

finalised and submitted to the Commission

10 20 15 estimate

ECHA Single Programming Document 2025-2027 52

Opinions on same biocidal products,

administrative changes, minor changes

and major changes of the Union authorisations.

Number of opinions on Union authorisation related processes: same biocidal

products, administrative, minor and major changes finalised and submitted to the

Commission

21 35 45 estimate

Opinions on classification of changes to

national or Union authorisations of products.

Number of opinions on classification of changes

finalised and submitted to the applicant

n/a n/a 9 estimate

Decisions on Technical equivalence applications.

Number of final decisions on technical equivalence applications concluded and

sent to the applicant

32 30 20 estimate

Assessments of applications for inclusion in the list of active substance suppliers (Article 95 BPR list).

Number of requests of

information and final decisions on Art 95 applications assessed and submitted to the applicant

n/a n/a 25 estimate

Opinions and decisions are timely and

fit-for-purpose.

Percentage of active substance and Union

authorisation opinions and decisions submitted within legal deadlines

n/a n/a 100 target

Number of requests from the

Commission for a BPC opinion [pursuant to Article 75(1)(g)]

to revise earlier adopted opinions

n/a n/a 0-4 estimate

Cooperation with EFSA further advanced to implement the basis and mechanisms for alignment of

evaluation of common substances (One Substance, One Assessment).

Number of meetings held with EFSA on alignment of evaluation of common

substances

n/a n/a 6 target

List of frequently used sentences in the SPCs updated and translated in all the EU official languages.

Number of updates of the list of frequently used sentences in the SPCs published

n/a n/a 1 target

Objective 2: Member States and Commission supported to facilitate biocides processes and

accelerate the Review Programme

Expected results

• Steady progress in the current ongoing Review Programme for existing active substances is ensured through fit for purpose support to Member State competent authorities, with a specific

focus on the evaluation of endocrine-disrupting properties.

• Overcoming roadblocks in the evaluation of active substances is sustained through direct support to Member State competent authorities, proposals for simplifications and guidance.

• Member State competent authorities are provided with technical support and advice in the early stages of disagreements in the mutual recognition process in order to reduce the number of

unsolved disagreements referred to the Commission. • ECHA’s output provides the basis for informed decisions of the Commission and the Standing

Committee. • Targeted support to Member State competent authorities concerning the evaluation of Union

authorisation applications reduces the delays in the submission of product assessment reports and

ECHA Single Programming Document 2025-2027 53

leads to improvements in their consistency and quality.

• Economic operators can rely on professional dossier management, guidance and helpdesk support for active substance approval or product authorisation at Union level.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Technical, procedural, regulatory and administrative support is provided to Member States in the evaluation and

BPC opinion forming for active substance approval and on Union authorisation of biocidal products and to the Commission.

Percentage of satisfaction of authority actors in relation to

biocides processes measured in annual survey

n/a n/a >85 target

Fit-for-purpose opinions following

requests by the Commission pursuant to Articles 38, 15(2) and 75(1)(g) of the BPR prepared.

Number of opinions on Article

15, Article 38 and Article 75(1)(g) finalised and submitted to the Commission

7 10 8 estimate

Support to Member State competent authorities’ (MSCAs) evaluations

provided by early (informal) working group discussions and written consultations.

Number of early (informal) written consultations and

early working group discussions to support the evaluation by Member States

n/a n/a 100 target

Accordance check performed for all evaluations on AS and UA submitted by MSCAs.

Percentage of Member State evaluations checked for accordance

n/a n/a 100 target

Organisation of information and

training sessions for MSCAs to clarify

and discuss emerging issues on the implementation of BPR.

Number of information and

training sessions for MSCAs

related to BPR organised

n/a n/a 2 target

Organisation of a stakeholder workshop to share information and discuss challenges concerning various actors for the implementation of BPR.

Number of stakeholder workshops related to BPR organised

n/a n/a 1 target

Guidance documents developed according to agreed priorities and

maintained aiming for alignment across regulations.

Number of guidance documents related to biocides

processes finalised and published

n/a n/a 3 target

Technical input and support the Commission’s evaluation of the BPR.

Number of technical reports provided to support the Commission in BPR evaluation

n/a n/a 1 target

Support and advice to Member States Competent Authorities to facilitate the

resolution of disagreements in the mutual recognition process.

Number of disagreement

points related to mutual recognition closed

n/a n/a 100 estimate

Objective 3: Biocides IT tools integrated with other ECHA regulatory IT systems

Expected results

• Authority and Industry users can rely on user friendly and up-to-date IT tools in a more efficient

way.

• Synergies and savings on the mid- and longer term are created for ECHA.

ECHA Single Programming Document 2025-2027 54

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Progress with the development of Biocides IT tools in the frame and according to the plans of the general

ECHA IT strategy.

Number of updates of R4BP 3

released n/a n/a 2 target

Number of BPR IT user group meetings

n/a n/a 1 target

First set of IUCLID validation rules for active substance applications agreed with Member State Competent

Authorities

n/a n/a Q4 target

Resources 2023 actual

2024 est.

2025 est.

Financial resources (costs, EUR) 10 213 821 11 477 824 12 363 134

Human resources (FTE) 56 55 55

ECHA Single Programming Document 2025-2027 55

3. Environmental Policy

Overview

ECHA implements a number of specific environmental legislations, by performing a wide range of

administrative, technical, and scientific tasks, as detailed below.

EU Prior Informed Consent (PIC) regulation implements, with additional obligations, the UN

Rotterdam Convention relating to the international trade of hazardous substances. ECHA supports the processing of information on the export and import of hazardous chemicals, provides support to

companies and designated national authorities (DNAs) from both the EU and third countries and supports

the Commission with the implementation of the Convention.

EU Persistent Organic Pollutants (POPs) regulation implements the UN Stockholm Convention,

aimed to protect human health and the environment from persistent organic pollutants. ECHA facilitates the reporting obligations on behalf of the Member State competent authorities and compiles the Union

overview of the implementation. ECHA also coordinates the enforcement activities via the Forum for Exchange of Information on Enforcement (Forum) and supports the Commission with the implementation

of the Convention.

Under the Waste Framework Directive, ECHA maintains a database (SCIP) on products containing

substances of very high concern (SVHCs) and placed on the EU market. The data is made available to waste operators, consumers and other interested parties. ECHA supports duty holders in meeting their

obligations.

The revised Drinking Water Directive aims to protect citizens and the environment from the harmful effects of contaminated drinking water and to improve access to drinking water. ECHA is setting up and

maintaining the European positive lists of substances that are authorised to be used for the

manufacturing of materials coming into contact with drinking water.

The 8th Environmental Action Programme (EAP) is the EU’s joint programme for implementing the European Green Deal on the ground until 2030. ECHA provides technical support to the Commission,

together with the European Environment Agency (EEA), in establishing a new framework of indicators, aiming to assess the effectiveness of the chemicals legislation by monitoring the drivers of pollution as

well as its outcomes.

Under the Batteries Regulation ECHA will continue to support the European Commission in identifying substances of concern found in batteries or used in their manufacturing. The Commission may request

ECHA to prepare proposals to restrict hazardous substances in batteries and waste batteries and to adopt an opinion (through RAC and SEAC) on restriction proposals submitted either by ECHA or by Member

States. The aim is to make batteries on the market more sustainable throughout their lifecycle.

Amendments to several Directives related to water protection, Water Framework, Groundwater and

Environmental Quality Standards (EQS) Directives, are being discussed in Ordinary Legislative Procedure and in the proposed changes ECHA has been assigned new tasks. The tasks include

development of watch lists for surface and ground water, and development of Priority Lists, EU-wide EQS

and indicative concentrations and ground water thresholds. ECHA must also establish and disseminate a

repository of national EQS values.

Under the Industrial Emissions Directive, ECHA is foreseen to input our knowledge on chemical uses, hazards and regulatory status into the revision and development of Best Available Technique Reference

(BREF) documents, according to the relevant workplans developed by the European Integrated Pollution Prevention and Control Bureau (EIPPCB). In addition, we have been tasked with the further development

of a Chemical Management System (CMS), to be updated and applied as agreed with IED stakeholders

in the context of the IED Forum.

ECHA Single Programming Document 2025-2027 56

Under the Packaging and Packaging Waste Regulation ECHA will support the European Commission in identifying substances of concern found in packaging and packaging waste. The Commission may

request ECHA to prepare proposals to restrict hazardous substances in packaging and packaging waste.

Following the publication of the relevant legislative proposals, the possible resourcing stemming from the adoption of the End-of-Life Vehicles (ELV) Directive, the Regulation establishing a common

data platform on chemicals and revision of the POP and Medical Devices Regulation, and RoHS

Directive has been included in the activity totals.

Objective 1: International trade of chemicals listed under the Rotterdam Convention and

the PIC regulation facilitated and managed

Expected results

• International trade of chemicals listed under the Rotterdam Convention takes place in compliance with the principles of shared responsibility and cooperation, as implemented in the PIC regulation.

• The Commission and other Authorities have access to the information and support needed to improve implementation and development of the UN Rotterdam Convention

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Export notifications processed.

Number of export notifications processed

10 857 11 000 11 000 estimate

Percentage of export notifications validated

96 90 90 target

Import notifications processed. Number of import notifications processed

n/a n/a 800 estimate

Explicit consent responses processed. Number of explicit consent responses processed

n/a n/a 2 000 estimate

Support provided to EU MS DNAs and the Commission, including the

management of explicit consent requests, to allow companies to export these chemicals in accordance with the EU’s international commitments.

Number of replies provided to DNAs and Commission

3 570 n/a 3 000 estimate

Support provided to companies (via the

helpdesk) and non-EU Authorities.

Number of Helpdesk replies related to PIC provided to

companies and non-EU Authorities

245 250 250 estimate

Annual report on PIC exports and

imports (Art. 10) published.

Timeline for publication of annual report on PIC exports

and imports (Art. 10)

n/a n/a Q4 target

Support provided to the Commission with the EU contribution to the Rotterdam Convention implementation, including the preparations of the draft

final regulatory actions (FRAs).

Timeline for providing support

to the Commission with the EU contribution to the Rotterdam Convention implementation, including the

preparations of the draft final regulatory actions (FRAs)

n/a n/a Q1-Q4 target

Support provided to the Commission in the continuous improvement of the

functioning and efficient implementation of the PIC Regulation.

Timeline for providing support to the Commission in the continuous improvement of

the functioning and efficient implementation of the PIC Regulation

n/a n/a Q1-Q4 target

ECHA Single Programming Document 2025-2027 57

Objective 2: European Commission supported in the implementation of the Stockholm Convention and the POP Regulation

Expected results

• The Commission and Member States have the scientific and technical support they need in their

work under the Convention and the POPs regulation within the limits of ECHA’s capacity.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Scientific dossiers drafted for a new EU

proposal to list a potential POP substance under the Stockholm Convention on Persistent Organic Pollutants.

Number of scientific dossiers

drafted for the identification of new substances under Stockholm Convention

1 1 1 estimate

Processes on POPs reviewed to take account of new mandate on POPs in

waste.

Timeline for implementing actions following review of

POPs processes

n/a n/a Q1-Q4 target

Technical and scientific support provided as required to the Commission for the listing process.

Number of requests for advice

and support related to the Stockholm Convention provided to various

stakeholders

55 50 50 estimate

The reporting system for the implementation of the POP regulation

maintained and the Union Overview report based on the Member States

reports updated. These outputs will be

delivered in line with resource constraints.

Indicator TBD when relevant

Objective 3: Substances of very high Concern In Products (SCIP) database maintained

Expected results

• SCIP database available and ensures that the information on articles containing Candidate List

substances is available throughout the whole lifecycle of products and materials, including at the waste stage to support the substitution of Candidate List substances in articles and contribute to a

circular economy by facilitating waste prevention and waste treatment operations.

• SCIP duty holders can meet their obligation to notify articles containing Candidate List substances that are placed on the EU market.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Notification portal and the public SCIP

database maintained.

Number of SCIP notifications received (incl. updates)

10.6 million

8-12 million

8-12 million

estimate

Percentage of SCIP

notifications published within 3 months

n/a n/a >80 target

Support provided to EU suppliers of

articles to submit the required information to ECHA.

Number of Helpdesk replies

provided to SCIP notifiers 1 020 1 000 1 000 estimate

ECHA Single Programming Document 2025-2027 58

Objective 4: Implementation of Drinking Water Directive (DWD)

Expected results

• Internal operational procedures and working instructions for handling the applications to be submitted from 2026 onwards established.

• Procedures for opinion forming by RAC and the Working Group developed and implemented. • IT tools for the reception, processing and dissemination of notifications available.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Procedures for opinion forming by RAC and the RAC Working Group developed and implemented.

Timeline for DWD procedures agreed by RAC

n/a n/a Q4 target

IT tools for the receipt, processing and dissemination of notifications available.

Number of IT tool releases related to DWD

n/a n/a 1 target

Guidance documents to support applicants and RAC published.

Number of DWD guidance documents published

n/a n/a 4 target

Workshop with stakeholders to inform

on the notification and the application procedures organised.

Number of workshops related

to DWD held with stakeholders

n/a n/a 1 target

Objective 5: An accessible and transparent evidence base to support the monitoring, measuring and reporting on chemicals

Expected results

• Implementation of the strategic priorities of the European Green Deal and the assessment of progress under the 8th EAP is supported.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Relevant indicators kept under review, monitored and reported as necessary.

Number of views of the chemicals indicators dashboard

n/a n/a 500 estimate

Objective 6: Implementation of the Batteries Regulation

Expected results

• Technical and scientific support given to the Commission in the implementation of the new Batteries

regulation. • Second part of the scoping study detailing the methodology to identity substances found in batteries

or used in their manufacturing, that have negative impacts on human health and the environment or recycling, commenced.

• Implementation plan in place for the restrictions work under the Batteries Regulation. • Setup of the internal operational procedures and working instructions according to the

implementation plan.

• Discussions/workshop with relevant stakeholders held.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Part of the scoping study completed and provided to the Commission.

Number of study reports provided to the Commission under the Batteries Regulation

n/a n/a 1 target

ECHA Single Programming Document 2025-2027 59

Preparation for the implementation of the Batteries Regulation completed.

Timeline for implementation plan for Batteries Regulation completed

n/a n/a Q4 target

Ongoing discussions held with relevant

stakeholders.

Number of meetings related to the implementation of the

Batteries Regulation held with stakeholders

n/a n/a 4 target

Objective 7: Preparation for the implementation of the Water Framework, Groundwater and Environmental Quality Standards (EQS) Directives (legislation pending)

Expected results

• Support is provided to the Commission regarding the ongoing Ordinary Legislative Procedure. • Implementation plan for ECHA’s tasks in the revised Directives developed.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Technical and scientific support provided to the EU Institutions during the adoption of the legal acts.

Timeline for direct inputs or

response to queries related to Water Framework, Groundwater and EQS

Directives from EU institutions during the legislative process

n/a n/a Q1-Q4 estimate

Preparation for the implementation of the tasks completed.

Timeline for implementation

plan of Water Framework, Groundwater and EQS

Directives agreed between

ECHA and the Commission

n/a n/a Q3 estimate

Objective 8: Development of Best Available Techniques Reference (BREF) documents under the Industrial Emissions Directive supported

Expected results

• Better utilisation of ECHAs databases and knowledge on industrial chemicals under the Industrial

Emissions Directive, by contributing to the BREF revision and development process.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Input to the review and update of Best

Available Technique (BAT) reference documents is provided, in particular with substance-related information from the ECHA databases.

Number of BAT reference documents supported

n/a n/a 2 estimate

ECHA Single Programming Document 2025-2027 60

Objective 9: Implementation of the Packaging and Packaging Waste Regulation (adopted

by the Council on 16 December 2024, entry into force pending publication in the Official Journal)

Expected results

• The scoping study on the presence of substances of concern in packaging and packaging

components commenced.

• Implementation plan for restrictions work under the Packaging and Packaging Waste Regulation developed and initiated.

• Technical and scientific support given to the Commission in the implementation of the new Packaging and Packaging Waste Regulation.

• Discussions/workshop with relevant stakeholders held.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Preparation of scoping study initiated. Timeline for initiation of preparation for packaging and

packaging waste regulation

n/a n/a Q2 estimate

Objective 10: Preparation for the implementation of the proposals under One Substance, One Assessment package (Data regulation, POPs, Medical devices, RoHS) (legislation

pending)

Expected results

• Support is provided to the legislator during the negotiations and adoption of the three legal acts under the One Substance, One Assessment package.

• Implementation plans for the new tasks developed.

• Commission is supported in setting up the governance under the Common Data Platform.

Main outputs Indicators

2023 actual

2024 est.

2025

target/ estimat

e

Technical and scientific support provided to the EU Institutions during

the adoption of the legal acts.

Number of direct inputs or response to queries from EU

institutions during the OSOA legislative process

n/a n/a 5 estimate

Preparation for the implementation of

the new legal acts initiated.

Timeline for implementation plans for OSOA developed

n/a n/a Q4 estimate

Number of OSOA Expert

Group meetings supported n/a n/a 2 estimate

Commission supported in setting up the

Governance of the Common Data Platform.

Number of meetings related

to CDPC with relevant agencies supported

n/a n/a 2 estimate

Resources 2023

actual

2024

est.

2025

est.

Financial resources (costs, EUR) 4 362 082 6 482 756 5 426 534

Human resources (FTE) 2011 34 25

11 in 2023, the Environmental policy activity was split in the following activities: Prior Informed Consent, Persistent Organic Pollutants, Waste

Framework Directive, Drinking Water Directive, 8th Environmental Action Programme

ECHA Single Programming Document 2025-2027 61

4. Other tasks, including tasks under grant, cooperation and

service-level agreement12

Overview

The EU Observatory for Nanomaterials (EUON) provides information on the safety of nanomaterials

on the EU market to support businesses and in particular SMEs, workers, consumers, and authorities.

With the EU Chemicals Legislation Finder (EUCLEF), ECHA provides a single point of entry for accessing information on various pieces of EU legislation applicable to a given chemical substance,

supporting compliance by the companies, and SMEs in particular.

The Chemical Agents Directive (CAD) and the Carcinogens, Mutagens or Reprotoxic substances

Directive (CMRD) provide a framework for setting occupational exposure limits, forming an integral

part of the EU’s mechanism for protecting the health of workers. Following the request from DG EMPL, ECHA prepares a scientific report for its Committee for Risk Assessment (RAC) based on the available

scientific data and any relevant information collected through a 90-day call for evidence.

The Instrument for Pre-accession Assistance (IPA) is an EU funding mechanism designated to

support (pre) candidate countries in building up their capacities throughout the accession process. ECHA

implements IPA projects to support their alignment with the EU chemicals acquis.

EFSA and ECHA are collaborating to enable the use of IUCLID for the purpose of the new transparency provisions under EFSA’s revised founding Regulation (EU) 2019/1381, including by the integration of

IUCLID into EFSA’s IT Infrastructure (IUCLID for EFSA).

Partnership for the Assessment of Risks from Chemicals (PARC) is a project under Horizon Europe seeking to develop next-generation chemical risk assessment. ECHA is an Associated Partner in PARC,

co-leading the subtask on priority setting (work package WP 2.1) and providing further input/advice to

other work packages.

The Regulation on Serious Cross-Border Threats to Health (SCBTH) has allocated tasks to several EU agencies including ECHA to play a role in the preparedness and reaction to such threats. DG SANTE

is financially supporting ECHA in setting up for the Regulation during the 2025-2027 transitional phase

preceding its inclusion in the Basic Regulation.

Objective 1: EUON database on nanomaterials on the EU market available and updated

Expected results

• Objective information on nanomaterials on the EU market allows both professional and general audiences to review and increase their understanding of how nanomaterials are used in the EU,

what safety information is available on them, and what safety research is ongoing.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Specific data gaps in the public knowledge about nanomaterials via

the commissioning of external studies continued to be addressed.

Number of EUON studies commissioned as per

Contribution agreement with Commission

n/a n/a 2 target

EUON promoted via different channels to increase its outreach to a wide

variety of audiences.

Number of views of EUON pages

186 084 130 000 300 000 target

Number of visitors to EUON pages

n/a n/a 150 000 target

12 See also Annex XI

ECHA Single Programming Document 2025-2027 62

Objective 2: EUCLEF database on EU chemicals legislation available and maintained

Expected results

• Companies, including SMEs, use EUCLEF to navigate through the EU chemicals legislative framework

and find relevant information on how chemical substances are regulated across the EU.

• EUCLEF helps companies and SMEs in particular to understand the obligations that apply to their substances of interest so they can ensure to comply with them and take informed market decisions.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

EUCLEF promoted wider to increase the utility of the service for the target audience, with a particular focus on

SMEs.

Number of views of EUCLEF pages

395 000 400 000 350 000 target

Number of visitors to EUCLEF pages

n/a n/a 130 000 target

Advice provided via the EUCLEF helpdesk.

Number of queries

answered by EUCLEF helpdesk service

n/a n/a 100 estimate

Objective 3: Opinions of the Risks Assessment Committee (RAC) on OELs delivered to the Commission

Expected results

• The Commission is able to use the RAC opinion in its procedure to propose and adopt occupational exposure limit (OEL) values.

• SLA agreement terms and timelines are met.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

SLA commitments completed. Number of OEL requests

received under SLA 5 5 5 estimate

RAC opinions completed and delivered to the Commission.

Number of RAC opinions on

OELs completed and provided to the Commission

5 5 5 target

Objective 4: IPA grant implemented fully in support of EU candidate and pre-candidate

countries on chemicals management

Expected results

• Candidate and pre-candidate countries build up capacity towards effective implementation of EU chemicals legislation ahead of EU accession.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Support actions as agreed in the IPA

grant agreement for 2023-June 2026 implemented.

Timeline for IPA support

actions delivered as per agreement with Commission

Q1-Q4 Q1-Q4 Q1-Q4 target

New IPA agreement prepared. Timeline for signing the new

IPA agreement n/a n/a Q4 target

ECHA Single Programming Document 2025-2027 63

Objective 5: IUCLID platform cooperation on Plant Protection Products (PPP) between

EFSA and ECHA continued

Expected results

• IUCLID is configured and modified where needed to handle plant protection products (PPP) dossiers and format development work is initiated for Food Contact Materials (FCM) and Synergists and

Safeners.

• Duty holders under EFSA PPP can prepare and submit information in the IUCLID format and EFSA can publish the public data.

• PPP dossiers are made available to EFSA with robust and simple level of integration with EFSA IT

landscape.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Submitted dossiers processed and made available to EFSA.

Percentage of dossiers submitted made available to

EFSA

n/a n/a 100 estimate

First version of the Food contact

Materials IUCLID format released.

Timeline for release of first

version of FCM format in IUCLID

n/a n/a Q2 target

Plan for the development of IUCLID

format to other relevant food regulated products prepared.

Timeline for plan for the

development of IUCLID supported

n/a n/a Q4 estimate

Objective 6: Input provided to research activities in support of current and future

regulatory challenges

Expected results

• Contributions to PARC with a view to providing direct support to EU chemical risk assessment/management authorities and processes, supporting the sustainable management of

chemicals.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Input provided to PARC projects. Timeline for providing input to PARC projects

Q1-Q4 Q1-Q4 Q1-Q4 estimate

Key Areas of Regulatory Challenge

report updated and promoted.

Timeline for publishing Key Areas of Regulatory Challenge

report

Q3 Q3 Q3 target

Objective 7: Implement the Regulation on Serious Cross-Border Threats to Health (SCBTH)

Expected results

• Agreements in place with DG SANTE and other agencies on deliverables and approach.

• Plan for addressing such incidents prepared and communicated.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Procedure in place, aligned with the

Agreements with DG SANTE and other

agencies on deliverables and approach, tested and reviewed.

Timeline for signing SCBTH

Contribution Agreement13 n/a n/a Q1 target

(Contributions to) requested (rapid) Percentage of requested n/a n/a 100 target

13 Indicator to be removed from the final version of the SPD if the service level agreement is signed during 2024

ECHA Single Programming Document 2025-2027 64

risk assessments promptly delivered. (rapid) risk assessments delivered within expected timelines

Contributions in the area of chemical events to the assessments of the MS

prevention, preparedness and response plans coordinated by ECDC made.

Number of meetings and

events related to SCBTH attended

n/a n/a 2-4 target

Resources 2023

actual

2024

est.

2025

est.

Financial resources (costs, EUR) 5 721 374 784 712 1 304 712

Human resources (FTE) 1814 19.5 20.5

14 In 2023, the ‘Other tasks’ activity was split in the following activities: EU Observatory for Nanomaterials, EU Chemicals Legislation Finder,

Support to Occupational health legislation, Instrument for Pre-Accession assistance (IPA), Support to other legislation, IUCLID for EFSA, Partnership for the Assessment of Risk from Chemicals

ECHA Single Programming Document 2025-2027 65

5. Governance and enablers

Overview

ECHA’s horizontal activities support the organisation and provide the necessary tools, infrastructure, and

capabilities for ECHA to carry out its mandate. The governance structure is aimed at facilitating effective

decision-making and enabling efficient execution of the operational activities.

ECHA coordinates the work of the Forum for Exchange of Information on Enforcement (Forum15) and the related Biocidal Products Regulation Subgroup (BPRS). The Forum serves to exchange and

identify best practice with respect to enforcement; proposes, coordinates and evaluates harmonised enforcement projects and joint inspections; trains and coordinates exchange of inspectors; develops

working methods and tools of use to local inspectors; liaises with stakeholders as necessary and

examines proposals for restrictions with a view to advising on enforceability.

The Board of Appeal16 ensures an independent review of decisions that ECHA adopts under REACH and

BPR, when they are challenged. These concern registration, data sharing, PPORDs (exemptions from the general obligation to register for product and process orientated research and development), testing

proposals, compliance check and substance evaluation under REACH; as well as certain decisions under

BPR related to, among others, technical equivalence of active substances and data sharing.

ECHA’s governance enables the management bodies to exercise their leadership functions, formulate strategic priorities, and put them into action. It furthermore supports the liaison of the Executive Director

and the leadership team with the EU Institutions, Member States and other EU agencies.

ECHA’s communications focus centres on proactive, clear and strategic external and internal activities, that promote its work and achievements, to build, maintain and enhance the Agency’s identity and keeps

stakeholder audiences well-informed and favourably inclined.

The Agency’s engagement efforts ensure that ECHA proactively identifies its stakeholders and their

needs, allowing it to implement a mutually beneficial engagement programme.

Through its helpdesk, IT tools and website, ECHA supports companies to access and remain on the

European Union (EU) single market. ECHA also coordinates and supports Member State helpdesks for

REACH, CLP and BPR to achieve high quality timely, up-to-date and harmonised advice across the EU.

Legal advice and support are provided on all issues that have legal implications for ECHA, aiming to

ensure that action taken, especially the decisions, opinions and agreements, conform with the regulations that govern the Agency and its work. Support and drafting are also provided on request for legislative

changes. In litigation, decisions are strongly defended, and the Commission is supported when court

cases relate to ECHA’s Committee opinions.

ECHA’s ICT provides services for the Agency and for external users, in industry, in national authorities, and general public. The services cover ICT governance, process analysis and design, procurement,

delivery, management of ICT tools and management of ICT assets.

ECHA’s financial resources are managed in accordance with the principles of economy, efficiency and

effectiveness. The total expenditure budget is financed through fee income and EU contribution.

ECHA develops and implements actions to enable the achievement of its people and organisational objectives and, thereby, facilitate the attraction, development and retention of competent, committed

people.

15 Art. 77 of Regulation (EC) No 1907/2006 16 Art. 90 of Regulation (EC) No 1907/2006 and Art. 77 of Regulation (EU) No 528/2012

ECHA Single Programming Document 2025-2027 66

ECHA’s corporate services support ECHA’s staff and stakeholders by providing a range of services related to ECHA’s premises, physical security infrastructure, staff travel, and physical, hybrid and virtual

meetings management services. ECHA’s corporate services team also coordinates ECHA’s environmental

management systems and ECHA’s European Commission’s Eco-Management and Audit Scheme (EMAS)

registration.

ECHA will keep on monitoring any other legislative developments which may lead to further tasks allocated to ECHA in the future and ensure its readiness for their timely and effective implementation,

as necessary and provided resources availability.

Objective 1: A level playing field for economic operators through increasingly harmonised enforcement across EU

Expected results

• Citizens benefit from a higher degree of human health and environment protection as a result of

increased compliance with EU chemicals legislation. • Duty holders benefit from a harmonised enforcement across EU.

• Authorities benefit from knowledge on the areas needing enforcement action.

• Enforcement related issues are shared among Member States to increase effectiveness of EU regulatory actions on chemicals.

Main outputs Indicators 2023

actual

2024

est.

2025

target/

estimate

Forum coordinated enforcement

projects (four REFs, one BEF and three pilot projects) implemented.

Number of Forum enforcement projects ongoing

n/a n/a 8 estimate

Subject matter of next EU-wide

REACH enforcement project (REF) agreed and steps taken to implement

actions.

Timeline for initiating

discussions on next EU-wide REACH enforcement project

(REF) and taking steps to implement actions

n/a n/a Q4 target

Training provided for national trainers

and inspectors developed and delivered.

Number of enforcement trainers trained by the Forum

840 200 500 target

Advice on enforceability on all submitted proposals for restrictions delivered and published.

Number of requests for advice on enforceability issued/ responded to

n/a n/a 0 estimate

Further streamlined process to support NEAs in enforcement of ECHA

dossier evaluation decisions, considering the findings of the JEAP.

Timeline for identification of proposals for streamlined

process to support NEAs

n/a n/a Q4 target

Objective 2: Board of Appeal decisions are adopted without undue delay and are of high quality

Expected results

• Any natural or legal person affected by decisions taken by ECHA can make use of their right of

appeal and expect an independent and impartial review.

• Within the scope of its competences, Board of Appeal helps ECHA to ensure that REACH and the BPR are implemented coherently and correctly, by providing clarifications of the legal requirements

where relevant. • The rights of registrants and interested parties are effectively safeguarded.

ECHA Single Programming Document 2025-2027 67

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Appeals brought against decisions of the Agency, according to procedural

requirements, processed and decided.

Number of appeals submitted

REACH 10 12 10 estimate

Number of appeals submitted BPR

2 2 2 estimate

Number of appeals concluded REACH

14 12 12 target

Number of appeals concluded

BPR 1 2 2 target

Communication to parties and the

general public about appeal decisions completed.

Number of press items issued n/a n/a 14 estimate

Support provided to the Secretariat in defence of Board of Appeal decisions when challenged before the EU Courts.

Number of EU legal cases for which BoA is engaged

n/a n/a 2 estimate

Objective 3: ECHA's Governance aligns with strategy and adapts to the changing

organisational and institutional landscape

Expected results

• The management bodies steer and execute the strategy statement and operational and organisational requirements as well as ensure compliance.

• ECHA aligns closely with institutional and Member State partners to deliver the shared legal

mandate and share competences and knowledge. • ECHA enhances its regulatory outputs and addresses environmental and health issues via

structured cooperation with EU institutions, agencies and global partners. • ECHA aligns its activities and organisational model with its strategy and mandate.

• ECHA supports the Commission to enhance engagement and synergies at international level.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Secretariat for the Management Board

(MB) provided, with required plenary meetings and required (pre) meetings of subgroups.

Percentage of statutory documents adopted by MB

within the required timeframe

n/a n/a 100 target

Percentage of MB members trained on roles and responsibilities

n/a n/a 100 target

Percentage of MB members attending plenary meetings

n/a n/a 80 target

Final and draft Programming Documents adopted by the MB.

Timeline for MB adoption of programming document

n/a n/a Q4 target

Quarterly and annual activity reports

with key performance indicators (KPI) delivered to / adopted by the MB.

Timeline for delivery of

quarterly reports and annual activity report

n/a n/a Q1-Q4 target

Quality, internal control, risk

management frameworks implemented, including through operating the network of quality

Timeline: Discharge granted

to the Executive Director for y-2 by the European Parliament

n/a n/a Q2 target

ECHA Single Programming Document 2025-2027 68

assurance officers, maintaining certifications, performing the annual internal control assessment and

providing quarterly updates of the risk register.

Timeline for ISO certification and EMAS registration of

ECHA’s Environmental Management System (EMS)

n/a n/a Q3-Q4 target

The ECHA audit and evaluations plan implemented with regular reports to

MB.

Number of reservations from the Court of Auditor

observations on the accounts y-1

n/a n/a 0 target

Number of major and critical deficiencies identified during internal and external audits and evaluations, including the

internal control assessment

n/a n/a 0 target

Review of the agency-wide reporting and monitoring data, to consolidate and streamline practices ahead of the

2026 five yearly report on ECHA’s operations (Art 117.2 REACH).

Timeline for review of data concluded and 5-yearly report

started

n/a n/a Q4 target

Input on resource forecasting for the

next multi-annual financing period prepared and communicated to the Commission and institutional partners.

Timeline for preparation and communication to the

Commission and institutional partners of the input on resource forecasting for the

next MFF

n/a n/a Q2-Q4 estimate

Support the efforts of relevant actors in

improving the workability of ECHA's scientific Committees.

Percentage of Scientific

Committee (RAC and SEAC) membership positions filled

n/a n/a 67% estimate

Agency wide policies, including data protection implemented; conflict of

interest prevention policy and anti- fraud strategy reviewed.

Number of breaches of trust or disciplinary procedure

initiated for conflict-of- interest management or fraud prevention

n/a n/a 0 target

Number of personal data breaches reported, as per legal requirements, to the European Data Protection

Supervisor

n/a n/a 5 estimate

Percentage of MB members and senior management

declarations of interest as well as senior management meetings with stakeholders

published

n/a n/a 100 target

Engagements with Member States

authorities conducted, including a meeting of heads of chemicals

authorities, Executive Director country visits, and management of the Member

State partner database.

Number of high-level meetings conducted with

Member States and European Union institutions

n/a n/a 15 target

ECHA Single Programming Document 2025-2027 69

Regular engagements and coordination activities with other EU agencies conducted, focusing on EFSA, EEA,

EMA, ECDC and EU-OSHA, complemented by bilateral arrangements and contributions to the

Network of EU Agencies.

Number of Memoranda of Understandings and other

bilateral arrangements

reviewed or newly established with institutional and international partners

n/a n/a 4 estimate

Routine international engagements

conducted, such as hosting courtesy or business visits from third countries and information provision on the

requirements of EU chemicals legislation.

Number of courtesy or business visits organised with

international organisations and third countries (excluding IPA and OECD)

n/a n/a 6 estimate

Number of OECD meetings attended and supported

n/a n/a 14 estimate

Objective 4: ECHA’s communication is effective, transparent, targeted and timely

Expected results

• Improved coverage of ECHA’s work in protecting citizens’ and workers’ health and the environment. • Stakeholder audiences better understand ECHA’s role, aims and activities.

• Increased trust in ECHA’s science-based decision-making on chemicals safety. • Broader staff engagement.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Communications Action Plan for 2025 implemented.

Percentage of neutral and positive media coverage of ECHA

96 >85 >85 target

Communications Action Plan for 2026 developed.

Timeline for the development of the 2026 Communications Action Plan

n/a n/a Q4 target

Growth in number of social media followers.

Number of social media followers

n/a n/a 140 000

target

ECHA website acts as a communications channel.

Number of visitors to all ECHA public domains

(*.echa.europa.eu) including also the subdomains: ECHACHEM, EUON, PCN,

IUCLID, Chesar, etc.

5.8 million

4.2 million

4.2 million

target

Cooperation on communications alignment and capacity building

initiatives undertaken with sister Agencies and Member States authorities through the MS Competent

Authorities Communicators Network.

Number of Communications Network Meetings held

n/a n/a 2 target

Assessment of ECHA's external

perception in view of new strategy and

mandate.

Timeline for launch of the

assessment of ECHA's external perception in view of

new strategy and mandate

n/a n/a Q2 target

ECHA Single Programming Document 2025-2027 70

Objective 5: Open and transparent engagement with all stakeholders

Expected results

• ECHA can identify its key stakeholders across relevant sectors.

• Stakeholders feel able to approach ECHA and contribute to its work where appropriate.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Stakeholder perception benchmarks established.

Timeline for launch of Stakeholder perception

benchmarking survey

n/a n/a Q2-Q3 target

Preparations for ECHA Conference 2026

commenced.

Timeline for kick-off of

preparations of 2026 ECHA Conference

n/a n/a Q2-Q3 target

Accredited Stakeholders (ASOs) review completed and proposals implemented.

Timeline for completion of ASO review and implementation of proposals

n/a n/a Q4 target

NGO and Accredited Stakeholder Organisations dialogues held.

Number of meetings held with NGOs and ASOs

n/a n/a 3 target

Engagements with stakeholders. Number of engagements with stakeholders

n/a n/a 200 estimate

Objective 6: Companies, and in particular SMEs, have the necessary advice to meet legal obligations

Expected results

• High quality and harmonised advice for companies is available in relevant EU languages across

Europe. • Companies successfully prepare and submit data required under the EU’s chemicals legislation.

• Companies have the necessary advice provided on their queries and questions.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Questions are timely and effectively answered.

Number of Helpdesk questions answered (across all our legal

basis)

n/a n/a 10 000 estimate

Percentage of queries answered within 15 working days

n/a n/a 75 target

Topics of broad interest/relevance discussed and agreed among all

national helpdesks for harmonised advice.

Number of meetings with

national helpdesks n/a n/a 15 target

Regular contacts with SMEs to understand and address better their specific needs established under the

different legislations in ECHA’s

portfolio.

Number of SME dedicated dialogues held

n/a n/a 1 target

ECHA Single Programming Document 2025-2027 71

Objective 7: Compliance with legal requirements related to finances, human resources,

procurement, intellectual property and access to documents

Expected results

• ECHA's actions related to its financial interests, human resources and procurement are legally sound and in line with the legal framework.

• ECHA’s intellectual property is professionally managed.

• Transparency is increased when citizens get swift responses when requesting access to documents.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

ECHA’s decisions comply with legal requirements, are consistent and proportionate.

Timeline for legal support Q1-Q4 Q1-Q4 Q1-Q4 target

ECHA’s contributions in legal proceedings follow ECHA’s policies and are timely delivered.

Number of new Court and Board of Appeal proceedings handled

28 n/a 26 estimate

Legal review, advice and training provided to ensure sound decisions on access to documents.

Number of access to documents requests received and concluded

139 100 150 estimate

Objective 8 (IT): IT operations are efficient, secure and of high quality

Expected results

• IT security on ECHA infrastructure, systems, and data, including hybrid work practice, is ensured, managed, maintained and improved to face the increasing and more sophisticated worldwide cyber

threats. • Staff are able to operate and use the IT tools with appropriate level of user satisfaction, highest

availability and efficiency. • External stakeholders can collaborate with ECHA in a fit-for-purpose, reliable and efficient manner.

• Coherence and coordination are maintained across the contractors to optimise overall delivery. • The IT operations and development investments are governed thoroughly and efficiently.

• Obsolete IT systems stood down.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

The modernisation of end-of-life administrative tooling continued.

Percentage of administrative tooling modernised

n/a n/a 80% target

New Cybersecurity and Information Security regulations implementation continued according to the given

guidelines.

Number of high impact security incidents

0 <2 <2 target

Number of data breaches n/a n/a 0 target

User satisfaction surveys completed and indicating a high level of

satisfaction.

Percentage of internal IT user

satisfaction n/a n/a >85 target

Timeline for baseline data collection for User satisfaction

score based on regular NPS data collection (Net Promoter

Score)

n/a n/a Q4 target

Key IT systems and solutions have high availability.

Percentage of availability of key systems

99 >98 >98 target

ECHA Single Programming Document 2025-2027 72

Objective 9 (IT): IT functions and business processes transformed, modernised and

enhanced

Expected results

• New solutions are designed and implemented in a generic way to allow the quick adaptation/configuration of new processes in the future (new tasks) and quick deployment of the

solutions.

• Modularity of IT solutions improves the ability to re-use IT resources and maximize the value of the investments.

• A data product focus practice is introduced and widely adopted in the organization leveraging the investments in data technologies, platforms and governance.

• Transitioning of ECHA’s infrastructure and solutions to public cloud will enable higher efficiency and unlock the benefits coming by leverage of new technologies (e.g., AI).

• Increased implementation of agility, improved governance, user centric development, data management capabilities and reduction of technical debt, will increase the quality of the solutions

and value of the IT investments.

• Further alignment and improved ways of working with the contractor ecosystem, increases the value of output and quality of the solutions and services.

• Efficient and timely implementation of the solutions required by the new tasks is enabled.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Plans to transition to public cloud

infrastructure and services completed.

Percentage of workloads migrated from data centre to

public cloud

n/a n/a 100 target

Timeline for completion of

Public Cloud migration project n/a n/a Q3 target

Year 2 of the long term (5 years) IT vision, plan and roadmap reviewed and

updated.

Timeline for review and update of long-term (5 years)

IT vision, plan and roadmap

n/a n/a Q3 target

IT governance has incrementally enhanced.

Number and share of teams working in regulatory context

which are part of the program increment (PI) practise (An agile practise to synchronise,

align and coordinate IT delivery across a portfolio of applications)

n/a n/a 9/15

teams target

The target enterprise architecture adopted, and implementation ongoing

to improve tooling for regulatory processes for internal and authority users.

The target architecture includes in total

40 capabilities, which can be used to implement all regulatory processes. 15 of these capabilities will be needed to

implement the first process (DWD solution) to new architecture.

Number of common

capabilities implemented n/a n/a

15/40 capabil

ities

target

ECHA Single Programming Document 2025-2027 73

Objective 10: ECHA’s budget is implemented in accordance with the objectives set in the

Programming Document and the Financial Regulation

Expected results

• ECHA has sufficient financial resources to deliver its mandate which are allocated and implemented effectively and efficiently according to the principles of sound financial management.

• ECHA’s Management Board receives relevant information on the evolution of fee income,

expenditure and risks to exercise its oversight function.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Annual budget prepared and implemented in accordance with the objectives set in the Programming

Document and the Financial Regulation.

Percentage of expenditure

committed 99.3% >95% >95% target

Percentage of cancelled

payment appropriations

(including carry-forward)

0.8% <5% <5% target

Percentage of payments

processed within legal

deadlines

99.4% >99% >99% target

Annual accounts prepared for and

presented to ECHA’s MB and the relevant EU institutions, in accordance with the requirements of the Financial

Regulation.

Number of audit observations on financial transaction

management leading to a qualified opinion by the Court of Auditors (as per the latest

available audit opinion)

0 0 0 target

Procurement and contracting activities implemented in accordance with the objectives set in the Programming Document and the Financial Regulation,

while meeting the requirements of legality and regularity.

Number of audit observations on procurement and contract management leading to a qualified opinion by the Court

of Auditors (as per the latest available audit opinion)

0 0 0 target

Objective 11: Attract, develop and retain competent and committed staff to implement

ECHA’s mandate, purpose and vision

Expected results

• Through the implementation of its People and Organisational Strategy 2024-2028, ECHA facilitates

the engagement of a competent and diverse staff base within a positive work environment that fosters high performance and flexible deployment of staff.

• ECHA and its partners benefit from the quality and diversity of experience and competence of ECHA

staff who are highly motivated to implement ECHA’s strategic goals and priorities.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

ECHA’s Wellbeing Action Plan 2025- 2026 developed and implemented, in

conjunction with ECHA’s Joint Committee for Health and Wellbeing.

Percentage of staff participating in annual

medical check-ups organised by the Agency

n/a n/a 80% target

Regular communication with ECHA’s Staff Committee to maintain a healthy working culture and positive relations and dialogue.

Number of meetings held between Staff Committee and senior management

n/a n/a 4 target

ECHA Single Programming Document 2025-2027 74

Actions related to ECHA’s People and Organisational Strategy 2024-2028,

and the organisational review completed.

Percentage turnover rate of Temporary Agents

1.1 <5% <5% target

Percentage turnover rate of Contract Agents

4.6 <10% <10% target

Percentage of staff participating in biannual staff satisfaction survey

n/a n/a 80% target

Percentage of Establishment Plan posts filled

96.8 95% 95% target

Objective 12: A safe, productive and healthy physical work environment for staff and

guests

Expected results

• ECHA staff, Committee members, experts from Member States and partner institutions benefit from appropriate infrastructure and services that facilitate and support ECHA’s scientific-technical work

and decision-making.

• ECHA’s environmental management systems prepare ECHA to meet its 2030 carbon neutrality

pledge.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Planning for ECHA’s future building requirements commenced.

Number of planning meetings for ECHA’s future building requirements

n/a n/a 4 target

ECHA’s Environmental Work Programmes 2023-2025 and 2026-

2028 implemented.

Annual CO2 emissions generated by ECHA (tonnes)

n/a n/a <1250 target

Objective 13: Support development and implementation of new legal requirements

Expected results

• ECHA’s information, knowledge and competences are increasingly used to support the

implementation of other EU legislation and policy areas related to chemical safety. • The Commission and other institutions are, upon request, provided with scientific-technical advice

and data for the development of chemicals legislation, including One Substance, One Assessment.

• New tasks are implemented in a fit-for-purpose manner within the resources available.

Main outputs Indicators 2023 actual

2024 est.

2025

target/ estimate

Contribution provided to the Commission in relation to REACH

Revision, Basic Regulation, and other tasks (’s guidelines 2024-2029, including work on Green Deal REACH

revision as well as reducing administrative burdens and simplifying implementation.).

Timeline for contribution related to REACH revision, basic Regulation, and other tasks provided to the

Commission

n/a n/a Q1-Q4 target

ECHA Single Programming Document 2025-2027 75

Resources 2023

actual

2024

est.

2025

est.

Financial resources (costs, EUR) 29 726 767 36 754 217 38 987 181

Human resources (FTE) 169 195 198

ECHA Single Programming Document 2025-2027 76

Annexes

Annex I: Organisation

A. Organisation chart of the Agency

B. Overview of regulatory tasks of the Agency

Annex II: Resource allocation per activity

Annex III: Financial Resources

Table 1: Revenue

Table 2: Expenditure

Table 3: Budget outturn and cancellation of appropriations

Annex IV: Human resources - quantitative

Table 1: Table 1: Overview of all categories of staff – REACH/CLP – BPR – Environmental policy – Other tasks

A: Statutory staff and SNE

B: Additional external staff expected to be financed from grant, contributions or service-level agreements

C: Other Human Resources

Table 2: Multiannual staff policy plan

Table 3: Recruitment forecasts for 2025 following retirement/mobility or new requested posts

Annex V: Human resources - qualitative

A. Recruitment policy

B. Appraisal of performance and reclassification/promotions

C. Gender representation

D. Geographical balance

E. Schooling

Annex VI: Environment management

Annex VII: Building policy

Annex VIII: Privileges and immunities

Annex IX: Evaluations and audits

Annex X:

A. ECHA Integrated Management System and Framework

B. Anti-Fraud Strategy

Annex XI: Plan for grant, contribution or service-level agreements

Annex XII: Strategy for cooperation with third countries and/or international organisations

ECHA Single Programming Document 2025-2027 77

Annex I: Organisation

A. Organisation chart of the Agency (Staff in place as at 31/12/2024)

ECHA Single Programming Document 2025-2027 78

B. Overview of regulatory tasks of the Agency

Legal act Date of legal act Mission/Tasks/Functions Remarks Regulation (EC) No 1907/2006 concerning

the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency,

amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC)

No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC

Regulation (EC) No 1272/2008 of 16 December 2008 on classification, labelling

and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending

Regulation (EC) No 1907/2006 (CLP)

18/12/2006

16/12/2008

Manage and carry out technical, scientific and

administrative aspects of REACH and CLP Regulations The REACH and CLP processes are designed to

ensure a high level of protection of human health and the environment, including the promotion of alternative methods for

assessment of hazards of substances, as well as the free circulation of substances on the internal market while enhancing competitiveness and innovation

Provide the Member States and the institutions of the Union with the best possible scientific and technical advice on questions relating to

chemicals which fall under REACH or CLP Manage IT based guidance documents, tools and data bases

Support the national helpdesks and run a helpdesk for registrants (through the ECHA

Helpdesk) Make information on chemicals publicly

accessible Develop a poison centre notification portal

The Agency, established on 1 June

2007, will manage the registration, evaluation, authorisation and restriction processes for chemical

substances as well the classification and labelling of substances and mixtures to ensure consistency

across the European Union. These REACH processes are designed to provide additional information on chemicals, to ensure their safe use,

and to ensure competitiveness of the European industry. In its decision-making, the Agency

will take the best available scientific and technical data and socio- economic information into account. It

will also provide information on chemicals and technical and scientific

advice.

Regulation (EU) No 528/2012 of the European Parliament and the Council of 22 May 2012 concerning the making available

on the market and use of biocidal products (BPR)

22/05/2012 Manage and carry out technical, scientific, and administrative aspects of the Biocidal Products Regulation

The purpose of the Biocides Regulation is to improve the functioning of the internal market through the harmonisation of the rules on the placing on the market and use of biocidal

products, whilst ensuring a high level of protection of both human and animal health and the environment. The provisions of the

Regulation are underpinned by the precautionary principle, the aim of which is to

Under the Biocidal Products Regulation, adopted in 2012, ECHA is responsible for specific tasks with

regard to applications for active substance approval and Union authorisation and other related tasks such as data sharing inquiries. The

Biocidal products Committee has been established within the Agency to provide opinions to the Commission

on scientific and technical matters relating to applications under the Regulation.

ECHA Single Programming Document 2025-2027 79

Legal act Date of legal act Mission/Tasks/Functions Remarks safeguard the health of humans, animals and

the environment. Establish and maintain the Register for Biocidal Products

Coordinate and manage the processing and evaluation of the applications covered by the Regulation (including active substance approval, Union authorisation, data sharing,

technical equivalence, alternative suppliers) Provide guidance, support to national helpdesks and assist and advise application

(through the ECHA Helpdesk) Make information on biocides publicly accessible.

Regulation (EU) No 649/2012 of the European Parliament and of the Council of 4

July 2012 concerning the export and import of hazardous chemicals (PIC)

04/07/2012 Manage and carry out technical, scientific, and administrative aspects related to export and

import of dangerous chemicals under the PIC Regulation The objectives of the PIC Regulation are to implement the Rotterdam Convention on the

Prior Informed Consent Procedure for Certain

Hazardous Chemicals and Pesticides in International Trade, and to promote shared

responsibility and cooperative efforts in the international movement of hazardous chemicals in order to protect human health

and the environment from potential harm. Through its provisions it contributes to the environmentally sound use of hazardous chemicals.

Manage the tasks related to and the cooperation with Member States on export notifications and explicit import consents

Manage guidance documents and IT tools Make information publicly available

The recast PIC Regulation, adopted in 2012, further adds to the remit of the

Agency, and complements it with scientific, technical, and administrative tasks related to export and import of dangerous chemicals.

Regulation (EU) 2019/1021 of the European Parliament and of the Council of 20 June 2019 on persistent organic pollutants

20/06/2019 Support the Commission and the Member States in fulfilling their obligations under the recast POPs – Regulation.

The recast of the POPs-Regulation also adds to the remit of the Agency, and complements it with scientific,

ECHA Single Programming Document 2025-2027 80

Legal act Date of legal act Mission/Tasks/Functions Remarks The objective of the POPs-Regulation is to

implement international obligations of the Union and the Member States for eliminating Persistent Organic Pollutants in order to

protect human health and the environment from these substances. Through its provisions the Regulation ensures the elimination of hazardous chemicals or, in exceptional cases,

their environmentally sound use. Carry out certain technical, scientific, and administrative tasks allocated in the proposal

to ECHA related to the identification of new POPs, enforcement and reporting on the implementation of the Regulation.

Make information on POPs publicly available.

technical, and administrative tasks

related to persistent organic pollutants.

Directive (EU) 2020/2184 of the European

Parliament and of the Council of 16 December 2020 on the quality of water intended for human consumption

16/12/2020 Preparing the first EU positive lists of

substances and preparing the necessary methods and tools as well as setting up the procedure for the operational phase starting in 2025.

The Agency shall review and deliver an opinion

on all the substances, compositions and constituents on the first European positive lists

by 15 years after its adoption. For the purposes of updating the European positive list the Agency shall deliver opinions

on the inclusion or removal of substances and compositions.

Directive 2008/98/EC of the European

Parliament and of the Council of 19 November 2008 on waste and repealing certain Directives

19/11/2008 Establish a database for information on the

presence of substances of very high concern on the candidate list in articles and make that available to waste operators and consumers.

The legal requirements for suppliers

of articles entered into force on 5 January 2021.

Decision (EU) 2022/591 of the European Parliament and of the Council of 6 April 2022

on a General Union Environment Action Programme to 2030

06/04/2022 Support to the Commission and to the European Environment Agency (EEA) in

monitoring, assessing and reporting on the progress of the Union and the Member States with regard to attaining the priority objectives

ECHA Single Programming Document 2025-2027 81

Legal act Date of legal act Mission/Tasks/Functions Remarks of the General Union Environment Action

Programme.

Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on serious cross-border threats to health and repealing Decision No

1082/2013/EU

23/11/2022 Carrying out a risk assessment for the following categories of serious cross-border threats to health:

• threats of chemical origin;

• threats of environmental origin, including those due to the climate

Regulation (EU) 2023/1542 of the European Parliament and of the Council of 12 July 2023 concerning batteries and waste

batteries, amending Directive 2008/98/EC and Regulation (EU) 2019/1020 and repealing Directive 2006/66/EC

12/07/2023 Support the European Commission by: • Assisting in preparing the report on

substances of concern contained in

batteries or used in their manufacturing;

• Preparing, if requested by the Commission, a restriction proposal on

substances used in the manufacturing of batteries or present in batteries when they are placed on the market;

• Providing an opinion on the effectiveness of the restriction proposal to control the risk (through the RAC)

and the socio-economic impact (through the SEAC).

ECHA Single Programming Document 2025-2027 82

Legal act Date of legal act Mission/Tasks/Functions Remarks Directive (EU) 2024/1785 of the European

Parliament and of the Council of 24 April 2024 amending Directive 2010/75/EU of the European Parliament and of the Council on

industrial emissions (integrated pollution prevention and control) and Council Directive 1999/31/EC on the landfill of waste (Text with EEA relevance)

24 April 2024 Support the Commission in the review of the

Best Available Techniques Reference documents (BREF).

ECHA's new tasks would include the following:

• Data mining of ECHA databases and generating a list of hazardous substances potentially used in BREF

sectors; extract substance-related information, characterise the uses of those substances by sectors covered

by BREFs.

• Develop guiding principles for the Chemicals Management System

focussing on data structure and methodologies for a site inventory of chemicals associated with further development of a site-level risk

assessment methodology and

contribute to the development of guiding principles on how to conduct a

comparative risk assessment

Proposal for a Regulation of the European

Parliament and of the Council on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU)

2019/904, and repealing Directive 94/62/EC (COM/2022/677 final)

Adopted by the

Council on 16 December 2024, entry

into force pending

publication in the Official Journal

The Agency shall carry out assessments

underpinning restrictions of substances in packaging. The Agency shall assist the Commission in

preparing the report on substances of concern contained in packaging or used in their manufacturing.

Entry into force expected in Q1 2025

ECHA Single Programming Document 2025-2027 83

Legal act Date of legal act Mission/Tasks/Functions Remarks

Proposals in legislative process

Proposal for a Directive of the European Parliament and of the Council amending Directive 2000/60/EC establishing a framework for Community action in the

field of water policy, Directive 2006/118/EC on the protection of groundwater against pollution and deterioration and Directive

2008/105/EC on environmental quality standards in the field of water policy

26/10/2022 Support the European Commission by: • Carrying out technical and scientific

work related to amendment of ‘watch list’ and coordination of ‘watch list’

activities; • Carrying out assessments

underpinning amendments of the

priority list of substances and derivation of Environmental Quality Standards;

• Carrying out assessments underpinning the review of Annexes I and II;

• Develop guidance on analytical

methods.

EP and Council positions adopted, but trilogues not yet started as of 19/09/2024

Proposal for a Regulation of the European

Parliament and of the Council on circularity requirements for vehicle design and on management of end-of-life vehicles,

amending Regulations (EU) 2018/858 and 2019/1020 and repealing Directives 2000/53/EC and 2005/64/EC (COM/2023/451 final)

13/07/2023 The Agency shall carry out:

• Assessments underpinning restrictions of hazardous substances in end-of-life vehicles.

• Assessments underpinning review of exemptions from the restrictions.

EP adopted its opinion, but Council

not yet. Trilogues not yet started as of 19/09/2024

Proposal for a Regulation of the European Parliament and of the Council on the safety

of toys and repealing Directive 2009/48/EC (COM(2023) 462 final)

28/07/2023 The Agency shall carry out: 1. Assessment underpinning establishing or

strengthening chemical limit values in toys for children under 36 months or toys for other children intended to be taken in the mouth.

2. Assessment underpinning amending the limit values for ‘heavy metals’ in toys. 3. Assessment underpinning amendments to

the lists of allergenic fragrances that are prohibited in toys or that have to be labelled if present in toys.

EP and Council adopted their opinions, but trilogues not yet started

as of 19/09/2024

ECHA Single Programming Document 2025-2027 84

Legal act Date of legal act Mission/Tasks/Functions Remarks 4. Assessment underpinning a derogation for

the use of CMR substances in toys.

Proposal for a Directive of the European Parliament and of the Council amending Directive 2011/65/EU of the European Parliament and of the Council as regards the

re-attribution of scientific and technical tasks to the European Chemicals Agency (COM(2023) 781 final)

07/12/2023 The Agency shall carry out: • Assessments underpinning restrictions

of hazardous substances in electrical and electronic equipment.

• Assessments underpinning review of applications for exemptions from the restrictions.

Part of the OSOA legislative package, Council adopted its position, but EP not yet. Trilogues not yet started as of 19/09/2024

Proposal for a Regulation of the European Parliament and of the Council amending

Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) 2019/1021 of the European Parliament and of the Council as regards the re-attribution

of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals

(COM(2023) 783 final) https://environment.ec.europa.eu/system/fil es/2023-

12/COM_2023_783_1_EN_ACT_part1_v6_0. pdf

07/12/2023 The Agency shall update existing guidelines on conducting the risk-benefit assessment of the

presence of phthalates in medical devices. The Agency will, if requested by the Commission, also develop guidelines for other substances, which are classified as either carcinogenic,

mutagenic or toxic to reproduction, of category 1A or 1B or have endocrine disrupting properties for human health of Category 1, in

accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008 (the CLP Regulation).

The Agency shall, at the request of the Commission, develop a report analysing the human health, environmental, social, and

economic impact of introducing or modifying concentration limit values specified in Annexes IV and V to Regulation (EU) No 2019/1021

(POPs Regulation).

Part of the OSOA legislative package, Council adopted its position, but EP

not yet. Trilogues not yet started as of 19/09/2024

Proposal for a Regulation of the European

Parliament and of the Council establishing a common data platform on chemicals, laying down rules to ensure that the data contained

in it are findable, accessible, interoperable and reusable and establishing a monitoring and outlook framework for chemicals (COM(2023) 779 final)

07/12/2023 The Agency shall assist the Commission with

the development of processes and tools to support the Regulation, including:

• Development and hosting of a

Common data platform • Hosting of the Information Platform for

Chemical Monitoring (IPCHEM)

Part of the OSOA legislative package,

Council adopted its position, but EP not yet. Trilogues not yet started as of 19/09/2024

ECHA Single Programming Document 2025-2027 85

Legal act Date of legal act Mission/Tasks/Functions Remarks https://environment.ec.europa.eu/system/fil

es/2023- 12/COM_2023_779_1_EN_ACT_part1_v2.pd f

• Hosting information on regulatory

processes on chemicals • Development and hosting of a

repository of reference values

• Hosting information on the obligations under Union acts on chemicals

• Hosting environmental sustainability related data on chemicals

• Develop and run a process for a data generation mechanism

• Develop a mechanism for notification

of studies and a database for study notifications

• Develop and run a process for early

warning and action system for emerging chemical risks and

framework of indicators

• Hosting an observatory for specific

chemicals with potential contribution to emerging chemical risks.

ECHA Single Programming Document 2025-2027 86

Annex II: Resource allocation per activity17

WP activity

2025 2026 2027 2028

TA CA/

Budget TA CA/

Budget TA CA/

Budget TA CA/

Budget SNE SNE SNE SNE

1. REACH/CLP 265 57 76 987 232 265 57 86 216 561 265 57 89 414 102 265 57 90 526 865

1.1 Dossier preparation 17 7 5 879 712 17 7 5 945 970 17 7 6 166 490 17 7 6 243 232

1.2 Dossier submission and processing 19 17 11 504 671 19 17 13 378 432 19 17 13 874 602 19 17 14 047 272

1.3 Identification and prioritisation of

(groups of) substances 36 4 10 046 669 36 4 11 891 939 36 4 12 332 980 36 4 12 486 464

1.4 Evaluation 82 10 18 515 992 82 10 19 324 402 82 10 20 041 092 82 10 20 290 504

1.5 Authorisation 26 4 6 240 745 26 4 7 432 462 26 4 7 708 112 26 4 7 804 040

1.6 Restrictions 26 5 6 427 136 26 5 7 432 462 26 5 7 708 112 26 5 7 804 040

1.7 Classification and labelling 27 5 6 077 028 27 5 7 432 462 27 5 7 708 112 27 5 7 804 040

1.8 Data management 18 3 7 425 402 18 3 8 918 955 18 3 9 249 735 18 3 9 364 848

1.9 Making data publicly available 7 2 2 985 136 7 2 2 972 985 7 2 3 083 245 7 2 3 121 616

1.10 Promotion of alternatives to animal

testing 7 0 1 884 740 7 0 1 486 492 7 0 1 541 622 7 0 1 560 808

2. Biocides 44 11 12 363 134 44 11 13 378 432 44 11 13 874 602 44 11 14 047 272

3. Environmental policy18 17 8 5 426 534 37 22 16 636 420 37 22 18 639 390 37 22 18 965 590

4. Other tasks, including tasks under

grant, cooperation and service-level

agreements

12 8.5 1 304 712 12 8.5 784 712 12 8.5 784 712 12 8.5 784 712

5. Governance and enablers 138 60 38 987 181 142 63 44 994 830 142 63 46 908 151 142 63 47 508 554

Overall TOTAL 476 144.5 135 068 793 500 161.5 149 433 955 500 161.5 154 946 957 500 161.5 156 865 513

17 For 2025, this table includes the planned resources as per the adopted legislations. As of 2026, the table outlines the resources linked to the new legislative proposals pending adoption. ECHA

expects stable resources in the work areas of EUON, EUCLEF, OEL, IPA, PARC, IUCLID for EFSA and SCBTH. Although the resources are dependent on the renewal of certain agreements, continuity is presumed for the purposes of this planning exercise. Any changes to the continuity of the work or resources estimates will be reported in the next SPD update. 18 The planned resources for 2025 do not include the following posts which are subject to adoption of the legislative proposals: Water Framework, Groundwater and Environmental Quality

Standards (EQS) Directives - 7 TAs and 4 CAs; One Substance, One Assessment package 12 TAs and 8 CAs, in total €4,195,881. To indicate the potential growth in Environmental policy tasks, the figures for the period 2026 and onwards include the additional resources for these tasks.

ECHA Single Programming Document 2025-2027 87

Annex III: Financial resources

Table 1: Revenue ECHA

Revenues

2025 2026

Budget As requested by

the agency

EU contribution 94 843 960 104 331 157

Other revenue 44 420 714 45 102 798

Total revenues 139 264 674 149 433 955

REVENUES

2024 2025 2026 VAR

2026 / 2025

2027 2028 Executed Budget

Budget As requested by the agency

1 REVENUE FROM FEES AND CHARGES 34 308 851 39 034 561 40 036 807 3% 40 841 937 40 505 686

2. EU CONTRIBUTION 88 028 813 94 843 960 104 331 157 10% 108 836 384 111 013 112

of which Administrative (Title 1 and Title 2) 71 857 843 74 524 974 74 715 270 0% 76 720 881 78 356 329

of which Operational (Title 3) 10 557 039 18 829 699 29 477 838 57% 32 115 503 32 656 782

of which assigned revenues deriving from

previous years' surpluses 5 613 931 1 489 287 1 109 450 -26% 0 0

3 THIRD COUNTRIES CONTRIBUTION (incl. EFTA and candidate countries)

3 263 660 2 961 441 3 240 079 9% 3 403 924 3 472 003

of which EFTA 3 263 660 2 961 441 3 240 079 9% 3 403 924 3 472 003

of which Candidate Countries - 0 0

4 OTHER CONTRIBUTIONS - 0 0

5 ADMINISTRATIVE OPERATIONS 1 440 219 1 120 000 1 041 200 -7% 1 080 000 1 090 000

6 REVENUES FROM SERVICES RENDERED

AGAINST PAYMENT 4 297 112 1 304 712 784 712 -40% 784 712 784 712

7 CORRECTION OF BUDGETARY IMBALANCES - 0 0

TOTAL REVENUES 131 338 655 139 264 674 149 433 955 7% 154 946 957 156 865 513

ECHA Single Programming Document 2025-2027 88

REACH / CLP

Revenues

2025 2026

Budget As requested by

the agency

EU contribution 76 316 097 77 238 000

Other revenue 36 973 875 37 109 291

Total revenues 113 289 972 114 347 291

REVENUES

2024 2025 2026 VAR

2026 / 2025

2027 2028 Executed Budget

Budget As requested by the agency

1 REVENUE FROM FEES AND CHARGES 28 622 051 32 708 824 33 445 541 2% 33 674 993 33 674 993

2. EU CONTRIBUTION 74 806 000 76 316 097 77 238 000 1% 79 434 000 81 022 680

of which Administrative (Title 1 and Title 2) 63 236 199 63 159 290 63 281 851 0% 65 026 336 66 332 914

of which Operational (Title 3) 7 404 391 11 763 284 13 956 149 19% 14 407 664 14 689 766

of which assigned revenues deriving from previous years' surpluses

4 165 410 1 393 523 928 410 -33% 0 0

3 THIRD COUNTRIES CONTRIBUTION (incl.

EFTA and candidate countries) 2 499 040 2 090 339 2 129 038 2% 2 216 209 2 260 533

of which EFTA 2 499 040 2 090 339 2 129 038 2% 2 216 209 2 260 533

of which Candidate Countries -

4 OTHER CONTRIBUTIONS -

5 ADMINISTRATIVE OPERATIONS 1 102 373 870 000 750 000 -14% 770 000 780 000

6 REVENUES FROM SERVICES RENDERED AGAINST PAYMENT

4 297 112 1 304 712 784 712 -40% 784 712 784 712

7 CORRECTION OF BUDGETARY IMBALANCES -

TOTAL REVENUES 111 326 576 113 289 972 114 347 291 1% 116 879 914 118 522 918

ECHA Single Programming Document 2025-2027 89

BIOCIDES

Revenues

2025 2026

Budget As requested by

the agency

EU contribution 8 014 498 8 058 000

Other revenue 7 055 314 7 312 426

Total revenues 15 069 812 15 370 426

REVENUES

2024 2025 2026 VAR

2026 / 2025

2027 2028 Executed

Budget

Revenues

estimated by

the agency

As requested by

the agency

1 REVENUE FROM FEES AND CHARGES 5 686 800 6 325 737 6 591 266 4% 7 166 944 6 830 693

2. EU CONTRIBUTION 7 831 585 8 014 498 8 058 000 1% 8 219 000 8 383 380

of which Administrative (Title 1 and Title 2) 5 083 293 6 501 349 6 485 194 0% 6 659 284 6 889 954

of which Operational (Title 3) 1 352 080 1 481 809 1 434 757 -3% 1 559 716 1 493 426

of which assigned revenues deriving from

previous years' surpluses 1 396 212 31 340 138 049 340%

3 THIRD COUNTRIES CONTRIBUTION (incl. EFTA and candidate countries)

573 487 579 577 581 160 0% 596 699 608 633

of which EFTA 19 573 487 579 577 581 160 0% 596 699 608 633

of which Candidate Countries 0 0 0 -

4 OTHER CONTRIBUTIONS 0 0 0 -

5 ADMINISTRATIVE OPERATIONS 181 939 150 000 140 000 -7% 140 000 140 000

19 The amount is comprised of EFTA and Switzerland contributions, where the amounts per year are as follows:

2025 2026 2027 2028

EFTA 222 730 220 967 229 310 233 896

Switzerland 356 847 360 193 367 389 374 737

ECHA Single Programming Document 2025-2027 90

6 REVENUES FROM SERVICES RENDERED

AGAINST PAYMENT 0 0 0 -

7 CORRECTION OF BUDGETARY IMBALANCES 0 0 0 -

TOTAL REVENUES 14 273 811 15 069 812 15 370 426 2% 16 122 643 15 962 706

Environmental Policy

Revenues

2025 2026 As requested

by the agency

As requested by

the agency

EU contribution 10 513 365 19 035 157

Other revenue 391 525 681 081

Total revenues 10 904 890 19 716 238

REVENUES

2024 2025 2026 VAR

2026 /

2025

2027 2028 Executed

Budget

Revenues

estimated by

the agency

As requested by

the agency

1 REVENUE FROM FEES AND CHARGES 0 0 0 - 0 0

2. EU CONTRIBUTION 5 391 228 10 513 365 19 035 157 81% 21 183 384 21 607 052

of which Administrative (Title 1 and Title 2) 3 538 351 4 864 336 4 948 225 2% 5 035 261 5 133 461

of which Operational (Title 5) 1 800 568 5 584 605 14 086 932 152% 16 148 123 16 473 590

of which assigned revenues deriving from

previous years' surpluses 52 308 64 424 42 991 -33% 0 0

3 THIRD COUNTRIES CONTRIBUTION (incl. EFTA

and candidate countries) 191 133 291 525 529 881 82% 591 016 602 837

of which EFTA 191 133 291 525 529 881 82% 591 016 602 837

of which Candidate Countries - 0 0

4 OTHER CONTRIBUTIONS - 0 0

5 ADMINISTRATIVE OPERATIONS 155 907 100 000 151 200 51% 170 000 170 000

6 REVENUES FROM SERVICES RENDERED AGAINST

PAYMENT - 0 0

7 CORRECTION OF BUDGETARY IMBALANCES - 0 0

TOTAL REVENUES 5 738 268 10 904 890 19 716 238 81% 21 944 400 22 379 889

ECHA Single Programming Document 2025-2027 91

Table 2: Expenditure ECHA

Expenditure

2025 2026 Commitment

appropriation s

Payment

appropriation s

Commitment

appropriation s

Payment appropriations

Title 1 90 830 233 90 830 233 91 584 320 91 584 320

Title 2 19 177 922 19 177 922 18 954 228 18 954 228

Titles 3-6 29 263 544 29 256 519 39 267 907 38 895 407

Total expenditure 139 271 699 139 264 674 149 806 455 149 433 955

EXPENDITURE / Commitment appropriations 2024 2025

2026 VAR

2026 / 2025

2027 2028 Agency request

Title 1 Staff Expenditure 83 077 124 90 830 233 91 584 320 1% 94 090 847 95 217 052

11 Salaries & allowances 78 378 628 85 639 740 86 391 981 1% 88 804 483 89 881 536

- of which establishment plan posts 65 745 244 71 554 519 72 025 054 1% 74 150 216 74 934 180

- of which external personnel 9 271 153 10 595 221 10 807 127 2% 11 023 271 11 243 739

12 Expenditure relating to Staff recruitment 496 257 600 000 600 000 0% 600 000 600 000

Employer's pension contributions 3 362 231 3 490 000 3 559 800 2% 3 630 996 3 703 617

13 Mission expenses 18 770 24 481 24 972 2% 25 472 25 983

14 Socio-medical infrastructure 1 834 328 1 974 511 1 938 632 -2% 1 994 325 2 004 522

15 Training 568 989 689 000 702 782 2% 716 839 731 178

16 External Services 1 780 153 1 902 501 1 925 953 1% 1 949 728 1 973 833

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating

expenditure 22 105 259 19 177 922 18 954 228 -1% 19 226 327 19 610 866

20 Rental of buildings and associated costs 8 531 901 8 790 202 8 966 008 2% 9 145 330 9 328 238

21 Information and communication

technology 12 883 109 9 769 266 9 137 389 -6% 9 320 141 9 506 547

ECHA Single Programming Document 2025-2027 92

22 Movable property and associated costs 159 178 68 003 69 364 2% 70 752 72 168

23 Current administrative expenditure 522 074 540 451 771 265 43% 679 696 693 296

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 8 996 10 000 10 202 2% 10 408 10 617

Title 3 Operational expenditure REACH 16 217 153 19 313 155 20 892 144 8% 21 241 238 21 276 451

30 REACH 15 099 323 18 168 155 19 571 144 8% 19 990 238 20 025 451

31 MULTIANNUAL ACTIVITIES 617 815 795 000 1 071 000 35% 1 001 000 1 001 000

38 INTERNATIONAL ACTIVITIES 500 015 350 000 250 000 -29% 250 000 250 000

Title 4 Operational expenditure BIOCIDES 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

40 BIOCIDES 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

Title 5 Operational expenditure ENV 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

50 ENV 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

Title 6 Other tasks 5 188 479 1 304 712 784 712 -40% 784 712 784 712

60 Other tasks 5 188 479 1 304 712 784 712 -40% 784 712 784 712

TOTAL EXPENDITURE 130 987 971 139 271 699 149 806 455 8% 155 130 957 156 795 513

EXPENDITURE / Payment appropriations 2024 2025

2026 VAR 2026 /

2025

2027 2028 Agency request

Title 1 Staff Expenditure 83 077 124 90 830 233 91 584 320 1% 94 090 847 95 217 052

11 Salaries & allowances 78 378 628 85 639 740 86 391 981 1% 88 804 483 89 881 536

- of which establishment plan posts 65 745 244 71 554 519 72 025 054 1% 74 150 216 74 934 180

- of which external personnel 9 271 153 10 595 221 10 807 127 2% 11 023 271 11 243 739

12 Expenditure relating to Staff recruitment 496 257 600 000 600 000 0% 600 000 600 000

Employer's pension contributions 3 362 231 3 490 000 3 559 800 2% 3 630 996 3 703 617

13 Mission expenses 18 770 24 481 24 972 2% 25 472 25 983

14 Socio-medical infrastructure 1 834 328 1 974 511 1 938 632 -2% 1 994 325 2 004 522

15 Training 568 989 689 000 702 782 2% 716 839 731 178

ECHA Single Programming Document 2025-2027 93

16 External Services 1 780 153 1 902 501 1 925 953 1% 1 949 728 1 973 833

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating expenditure

22 105 259 19 177 922 18 954 228 -1% 19 226 327 19 610 866

20 Rental of buildings and associated costs 8 531 901 8 790 202 8 966 008 2% 9 145 330 9 328 238

21 Information and communication technology

12 883 109 9 769 266 9 137 389 -6% 9 320 141 9 506 547

22 Movable property and associated costs 159 178 68 003 69 364 2% 70 752 72 168

23 Current administrative expenditure 522 074 540 451 771 265 43% 679 696 693 296

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 8 996 10 000 10 202 2% 10 408 10 617

Title 3 Operational expenditure REACH 16 419 187 19 306 130 20 519 644 6% 21 057 238 21 346 451

30 REACH 15 099 323 18 168 155 19 571 144 8% 19 990 238 20 025 451

31 MULTIANNUAL ACTIVITIES 814 001 687 975 698 500 2% 817 000 1 071 000

38 INTERNATIONAL ACTIVITIES 505 864 450 000 250 000 -44% 250 000 250 000

Title 4 Operational expenditure BIOCIDES 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

40 BIOCIDES 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

Title 5 Operational expenditure ENV 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

50 ENV 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

Title 6 Other tasks 5 188 479 1 304 712 784 712 -40% 784 712 784 712

60 Other tasks 5 188 479 1 304 712 784 712 -40% 784 712 784 712

TOTAL EXPENDITURE 131 190 005 139 264 674 149 433 955 7% 154 946 957 156 865 513

ECHA Single Programming Document 2025-2027 94

REACH/CLP

Expenditure

2025 2026 Commitment appropriation

s

Payment appropriation

s

Commitment appropriation

s

Payment appropriations

Title 1 76 838 171 76 838 171 77 386 753 77 386 753

Title 2 15 840 959 15 840 959 15 656 182 15 656 182

Title 3 19 313 155 19 306 130 20 892 144 20 519 644

Total expenditure 111 992 285 111 985 260 113 935 079 113 562 579

EXPENDITURE / Commitment appropriations 2024 2025

2026 VAR 2026 /

2025

2027 2028 Agency request

Title 1 Staff Expenditure 71 315 955 76 838 171 77 386 753 1% 79 157 036 80 193 204

11 Salaries & allowances 67 320 981 72 463 119 73 013 644 1% 74 700 102 75 694 306

- of which establishment plan posts 57 205 272 61 398 999 61 728 241 1% 63 188 990 63 952 970

- of which external personnel 7 243 851 8 114 120 8 276 403 2% 8 441 932 8 610 772

12 Expenditure relating to Staff recruitment 385 246 449 120 449 120 0% 449 120 449 120

Employer's pension contributions 2 871 858 2 950 000 3 009 000 2% 3 069 180 3 130 564

13 Mission expenses 15 617 20 368 20 776 2% 21 192 21 616

14 Socio-medical infrastructure 1 526 161 1 630 945 1 596 500 -2% 1 647 308 1 655 729

15 Training 473 399 569 114 580 497 2% 592 107 603 950

16 External Services 1 594 552 1 705 505 1 726 216 1% 1 747 207 1 768 483

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating expenditure

18 425 175 15 840 959 15 656 182 -1% 15 880 928 16 198 551

20 Rental of buildings and associated costs 7 098 542 7 260 706 7 405 921 2% 7 554 040 7 705 121

21 Information and communication technology

10 752 347 8 069 413 7 547 481 -6% 7 698 432 7 852 402

22 Movable property and associated costs 132 437 56 169 57 293 2% 58 439 59 608

ECHA Single Programming Document 2025-2027 95

23 Current administrative expenditure 434 366 446 411 637 061 43% 561 422 572 653

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 7 484 8 260 8 426 2% 8 595 8 767

Title 3 Operational expenditure 16 217 153 19 313 155 20 892 144 8% 21 241 238 21 276 451

30 REACH 15 099 323 18 168 155 19 571 144 8% 19 990 238 20 025 451

31 MULTIANNUAL ACTIVITIES 617 815 795 000 1 071 000 35% 1 001 000 1 001 000

38 INTERNATIONAL ACTIVITIES 500 015 350 000 250 000 -29% 250 000 250 000

TOTAL EXPENDITURE 105 958 283 111 992 285 113 935 079 2% 116 279 202 117 668 206

EXPENDITURE / Payment appropriations 2024 2025

2026 VAR 2026 /

2025

2027 2028 Agency request

Title 1 Staff Expenditure 71 315 955 76 838 171 77 386 753 1% 79 157 036 80 193 204

11 Salaries & allowances 67 320 981 72 463 119 73 013 644 1% 74 700 102 75 694 306

- of which establishment plan posts 57 205 272 61 398 999 61 728 241 1% 63 188 990 63 952 970

- of which external personnel 7 243 851 8 114 120 8 276 403 2% 8 441 932 8 610 772

12 Expenditure relating to Staff recruitment 385 246 449 120 449 120 0% 449 120 449 120

Employer's pension contributions 2 871 858 2 950 000 3 009 000 2% 3 069 180 3 130 564

13 Mission expenses 15 617 20 368 20 776 2% 21 192 21 616

14 Socio-medical infrastructure 1 526 161 1 630 945 1 596 500 -2% 1 647 308 1 655 729

15 Training 473 399 569 114 580 497 2% 592 107 603 950

16 External Services 1 594 552 1 705 505 1 726 216 1% 1 747 207 1 768 483

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating expenditure

18 425 175 15 840 959 15 656 182 -1% 15 880 928 16 198 551

20 Rental of buildings and associated costs 7 098 542 7 260 706 7 405 921 2% 7 554 040 7 705 121

21 Information and communication

technology 10 752 347 8 069 413 7 547 481 -6% 7 698 432 7 852 402

22 Movable property and associated costs 132 437 56 169 57 293 2% 58 439 59 608

ECHA Single Programming Document 2025-2027 96

23 Current administrative expenditure 434 366 446 411 637 061 43% 561 422 572 653

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 7 484 8 260 8 426 2% 8 595 8 767

Title 3 Operational expenditure 16 419 187 19 306 130 20 519 644 6% 21 057 238 21 346 451

30 REACH 15 099 323 18 168 155 19 571 144 8% 19 990 238 20 025 451

31 MULTIANNUAL ACTIVITIES 814 001 687 975 698 500 2% 817 000 1 071 000

38 INTERNATIONAL ACTIVITIES 505 864 450 000 250 000 -44% 250 000 250 000

TOTAL EXPENDITURE 106 160 318 111 985 260 113 562 579 1% 116 095 202 117 738 206

BIOCIDES

Expenditure

2025 2026 Commitment

appropriation s

Payment

appropriation s

Commitment

appropriation s

Payment

appropriations

Title 1 10 116 432 10 116 432 10 228 510 10 228 510

Title 2 2 167 106 2 167 106 2 141 830 2 141 830

Title 4 2 786 274 2 786 274 3 000 086 3 000 086

Total expenditure 15 069 812 15 069 812 15 370 426 15 370 426

EXPENDITURE / Commitment and Payment appropriations

2024 2025

2026 VAR 2026 / 2025

2027 2028

Agency request

Title 1 Staff Expenditure 9 204 749 10 116 432 10 228 510 1% 10 890 476 10 903 053

11 Salaries & allowances 8 726 883 9 639 101 9 746 855 1% 10 404 417 10 412 507

- of which establishment plan posts 7 112 715 7 700 000 7 768 971 1% 8 386 975 8 354 715

- of which external personnel 1 123 794 1 399 101 1 427 084 2% 1 455 626 1 484 739

12 Expenditure relating to Staff recruitment 97 025 63 560 63 560 0% 63 560 63 560

Employer's pension contributions 490 374 540 000 550 800 2% 561 816 573 053

ECHA Single Programming Document 2025-2027 97

13 Mission expenses 2 140 2 791 2 847 2% 2 904 2 963

14 Socio-medical infrastructure 209 113 223 120 224 229 0% 225 360 226 513

15 Training 64 865 77 857 79 415 2% 81 004 82 625

16 External Services 104 723 110 003 111 604 1% 113 231 114 885

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating expenditure

2 497 199 2 167 106 2 141 830 -1% 2 172 581 2 216 036

20 Rental of buildings and associated costs 972 637 993 293 1 013 159 2% 1 033 423 1 054 092

21 Information and communication technology

1 445 874 1 103 927 1 032 525 -6% 1 053 177 1 074 241

22 Movable property and associated costs 18 146 7 685 7 839 2% 7 996 8 156

23 Current administrative expenditure 59 516 61 071 87 154 43% 76 808 78 346

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 1 025 1 130 1 153 2% 1 177 1 201

Title 4 Operational expenditure 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

40 BIOCIDES 2 441 849 2 786 274 3 000 086 8% 3 059 586 2 843 617

TOTAL EXPENDITURE 14 143 797 15 069 812 15 370 426 2% 16 122 643 15 962 706

Environmental policy

Expenditure

2025 2026

Commitment appropriation

s

Payment appropriation

s

Commitment appropriation

s

Payment appropriations

Title 1 3 875 630 3 875 630 3 969 057 3 969 057

Title 2 1 169 857 1 169 857 1 156 216 1 156 216

Title 5 5 859 403 5 859 403 14 590 965 14 590 965

Total expenditure 10 904 890 10 904 890 19 716 238 19 716 238

ECHA Single Programming Document 2025-2027 98

EXPENDITURE / Commitment and Payment

appropriations 2024 2025

2026

VAR 2026 / 2025 2027 2028

Agency request

Title 1 Staff Expenditure 2 556 421 3 875 630 3 969 057 2% 4 043 335 4 120 795

11 Salaries & allowances 2 330 764 3 537 520 3 631 482 3% 3 699 964 3 774 723

- of which establishment plan posts 1 427 257 2 455 520 2 527 842 3% 2 574 251 2 626 495

- of which external personnel 903 507 1 082 000 1 103 640 6% 1 125 713 1 148 228

12 Expenditure relating to Staff recruitment 13 986 87 320 87 320 0% 87 320 87 320

Employer's pension contributions 0 0 0 - 0 0

13 Mission expenses 1 014 1 322 1 349 2% 1 376 1 404

14 Socio-medical infrastructure 99 054 120 446 117 903 -2% 121 657 122 280

15 Training 30 725 42 029 42 870 2% 43 728 44 603

16 External Services 80 878 86 993 88 133 1% 89 290 90 465

17 Receptions and events 0 0 0 - 0 0

Title 2 Infrastructure and operating expenditure 1 182 884 1 169 857 1 156 216 -1% 1 172 818 1 196 279

20 Rental of buildings and associated costs 460 723 536 203 546 928 2% 557 867 569 025

21 Information and communication technology 684 888 595 926 557 383 -6% 568 532 579 904

22 Movable property and associated costs 8 596 4 149 4 232 2% 4 317 4 404

23 Current administrative expenditure 28 192 32 969 47 050 43% 41 466 42 297

24 Postage / Telecommunications 0 0 0 - 0 0

25 Meeting expenses 486 610 623 2% 636 649

Title 5 Operational expenditure 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

50 ENV 1 958 107 5 859 403 14 590 965 149% 16 728 247 17 062 815

TOTAL EXPENDITURE 5 697 412 10 904

890 19 716 238 81% 21 944 400 22 379 889

ECHA Single Programming Document 2025-2027 99

Other tasks

EXPENDITURE / Commitment and Payment

appropriations 2024 2025

2026

VAR 2026 / 2025 2027 2028

Agency request

Title 6 Operational expenditure 5 188 479 1 304 712 784 712 -40% 784 712 784 712

6000 IPA programme 185 892 tbc tbc - tbc tbc

6010 EUON 844 452 tbc tbc - tbc tbc

6011 EUCLEF 1 607 166 tbc tbc - tbc tbc

6020 OELs 950 210 tbc tbc - tbc tbc

6021 Further development of IUCLID (as co-

investments from third parties) 1 600 758 784 712 784 712 0% 784 712 784 712

6022 Serious Cross-Border Threats to Health

(SCBTH) 520 000

TOTAL EXPENDITURE 5 188 479 1 304 712 784 712 -40% 784 712 784 712

ECHA Single Programming Document 2025-2027 100

Table 3: Budget outturn and cancellation of appropriations

REACH/CLP20

Budget outturn 2022 2023 2024

Revenue actually received (+) 103 843 022 105 374 686 111 375 356

Payments made (-) -87 607 470 -92 464 683 -97 730 392

Carry-over of appropriations (-) -17 082 211 -16 292 777 -17 778 364

Cancellation of appropriations carried over (+) 184 535 143 554 67 774

Adjustment for carry over of assigned revenue appropriations from previous year (+) 4 830 587 4 641 672 5 002 211

Exchange rate differences (+/-) -3 052 -8 929 -8 175

Adjustment for negative balance from previous year (-)

Total 4 165 410 1 393 523 928 410

BIOCIDES21

Budget outturn 2022 2023 2024

Revenue actually received (+) 14 373 921 13 104 870 14 273 813

Payments made (-) -10 807 744 -11 482 684 -12 200 480

Carry-over of appropriations (-) -2 151 735 -1 602 791 -1 943 550

Cancellation of appropriations carried over (+) 16 122 12 444 13 965

Adjustment for carry over of assigned revenue appropriations from previous year (+) 25 506 731 233

Exchange rate differences (+/-)

Adjustment for negative balance from previous year (-)

Total 1 456 071 32 570 143 980

20 The amount of EUR 479 223.80 in 2024 remained uncommitted and is cancelled. 21 The amount of EUR 54 600.51 in 2024 remained uncommitted and is cancelled.

The total 2024 outturn of EUR 143 979.65 consist of the Pre-financing remaining open to be reimbursed by agency to Commission in year 2025 totalling EUR 138 049.20 and Pre-financing remaining open to be offset in year 2025 from the contribution of the Swiss Confederation, totalling EUR 5 930.45.

ECHA Single Programming Document 2025-2027 101

Environmental Directives and International Conventions (PIC, POPs, Waste Framework Directive, Drinking Water Directive, 8th

Environmental Action Programme, Batteries Regulation and Industrial Emissions Directive)22

Budget outturn 2022 2023 2024

Revenue actually received (+) 4 844 983 5 139 326 5 738 269

Payments made (-) -3 203 975 -3 385 037 -4 029 943

Carry-over of appropriations (-) -1 597 685 -1 696 866 -1 667 493

Cancellation of appropriations carried over (+) 5 406 7 001 2 135

Adjustment for carry over of assigned revenue appropriations from previous year (+) 3 580 - 25

Exchange rate differences (+/-)

Adjustment for negative balance from previous year (-)

Total 52 308 64 424 42 991

22 The amount of EUR 48 378.39 in 2024 remained uncommitted and is cancelled

ECHA Single Programming Document 2025-2027 102

Annex IV: Human resources - quantitative23

Table 1: Overview of all categories of staff – REACH/CLP – BPR – Environmental policy – Other tasks

A: Statutory staff and SNE

S ta

ff p

o p

u la

ti o n

2024 2025 2026

Authorised staff24 Actually filled as of

31.12.202425 Occupancy/ Execution rate, % Envisaged staff26 Envisaged staff27

R E

A C

H /

C L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

R E

A C

H /

C L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

R E

A C

H /

C L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

R E

A C

H /

C L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

R E

A C

H /

C L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

TA

AD 310 43 17 370 303 41 10 354 98% 95% 59% 96% 310 43 33 386 310 43 38 391

AST 94 9 6 109 90 9 6 105 96% 100% 100% 96% 94 9 6 109 94 9 6 109

AST/SC

Total AD+AST 404 52 23 479 393 50 16 459 97% 96% 70% 96% 404 52 39 495 404 52 44 500

Total CA28

97 15 15 14.5 141.5 94 14 11 13 132 97% 93% 73% 90% 93% 97 15 24 15.5 151.5 97 15 29 15.5 156.5

SNE 3 2 0 5 1 1 2 33% 50% 40% 3 2 0 5 3 2 5

Total 504 69 38 14.5 625.5 488 65 27 13 593 97% 94% 71% 90% 95% 504 69 63 15.5 651.5 504 69 73 15.5 661.5

23 As per the Commission’s request, this table also outlines the expected resources to be allocated to the Agency as of 2025, in accordance with the new legislative statements pending adoption. 24 The posts related to the Water directives (7 TAs and 4 CAs) were expected to come to ECHA during 2024 and were foreseen in the Authorised budget. However, the posts were not received in

2024. This negatively affects the 'posts filled' ratio. 25 Under external recruitment: 2 TAs REACH and 1 CA BIOCIDES. 26 The indicated figures include the following posts, which are subject to adoption of the legislative proposals: Water Framework, Groundwater and Environmental Quality Standards (EQS) Directives

7 TAs and 4 CAs; One-Substance-One-Assessment package 12 TAs and 8 CAs. 27 Envisaged staff 2026- 2028: ECHA expects stable resources in the work areas of EUON, EUCLEF, OEL, IPA, PARC, IUCLID for EFSA and SCBTH. Although the resources are dependent on the

renewal of certain agreements, continuity is presumed for the clarity of this planning exercise. Any changes to the continuity of the work or resources estimates will be reported in the next SPD update. 28 CA Headcount.

ECHA Single Programming Document 2025-2027 103

S ta

ff p

o p

u la

ti o n

2027 2028

Envisaged staff Envisaged staff

R E A

C H

/ C

L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

R E A

C H

/ C

L P

B io

c id

e s

E n

v ir

o n

m e n

ta l

p o

li c y

O th

e r t

a s k s

T O

T A

L

TA

AD 310 43 39 392 310 43 39 392

AST 94 9 6 109 94 9 6 109

AST/SC

Total AD+AST 404 52 45 501 404 52 45 501

Total CA29

97 15 28 15.5 155.5 97 15 28 15.5 155.5

SNE 3 2 5 3 2 5

Total 504 69 73 15.5 661.5 504 69 73 15.5 661.5

29 CA Headcount.

ECHA Single Programming Document 2025-2027 104

Split of the posts for Environmental policy and Other tasks30

Posts for

2024

Posts for

2025

Posts for

2026

Posts for

2027

Posts for

2028

TA CA TA CA TA CA TA CA TA CA

PIC 7 1 7 1 7 1 7 1 7 1

POP 1 1 1 2 1 2 1 2 1

WFD31 5 5 5 5 5

DWD 3 2 6 3 7 3 8 3 8 3

8th Environmental Action Programme of the EU 1 1 1 1 1 1 1 1 1 1

Batteries Regulation 2 1 2 1 2 1 2 2

Industrial Emissions Directive (IED) 3 3 3 3 3

Water Directives 7 4 7 4 7 4 7 4 7 4

Packaging and packaging waste legislation 1 1 1 1

RoHs Directive 3 4 3 4 3 4 3

ELV Directive 1 1 1 1

Data regulation 7 8 9 10 9 10 9 10

TOTAL Environmental policy 23 15 39 24 44 29 45 28 45 28

EUON 3 3 3 3 3

OEL 4 4 4 4 4

EUCLEF - - - - - - - - - -

IUCLID for EFSA32 4 4 4 4 4

IPA 1.5 1.5 1.5 1.5 1.5

PARC33 2 2 2 2 2

SCBTH - 1 1 1 1

TOTAL Other tasks 0 14.5 0 15.5 0 15.5 0 15.5 0 15.5

30 ECHA expects stable resources in the work areas of EUON, EUCLEF, OEL, IPA, PARC, IUCLID for EFSA and SCBTH. Although the resources are dependent on the renewal of certain agreements,

continuity is presumed for the purposes of this planning exercise. Any changes to the continuity of the work or resources estimates will be reported in the next SPD update. 31 In 2021, 8 FTEs temporarily redeployed from REACH/CLP to the Environmental policy budget line to perform the work related to the Waste Framework Directive (WFD). As of 2023, 3 FTEs

redeployed back to REACH/CLP, while 5 FTEs temporarily remain on the Environmental policy budget line for the WFD. 32 Human resources for IUCLID for EFSA are on loan from EFSA. 33 As of June 2021, the activity is financed from the REACH/CLP budget.

ECHA Single Programming Document 2025-2027 105

B: Additional external staff expected to be financed from grant, contributions or service-level

agreements34

Human Resources Year 2025 Year 2026 Year 2027 Year 2028

Envisaged FTE Envisaged FTE Envisaged FTE Envisaged FTE

Contract Agents (CA)35 13.5 13.5 13.5 13.5

Seconded National Experts (SNE) 0 0 0 0

TOTAL 13.5 13.5 13.5 13.5

C. Other Human Resources

Structural service providers36 In place as at 31/12/2024

Interim workers Total FTEs as at

31/12/2024

Security 5 Number 29.58

34 ECHA expects stable resources in the work areas of EUON, EUCLEF, OEL, IPA, PARC, IUCLID for EFSA and SCBTH. Although the resources are dependent on the renewal of certain agreements,

continuity is presumed for the purposes of this planning exercise. Any changes to the continuity of the work or resources estimates will be reported in the next SPD update. 35 Planning covers 2025-2028 as follows EUON: 3 CAs, OEL: 4 CAs, IUCLID as service for EFSA: 4 CAs, IPA: 1.5 CAs, 1 SCBTH. 36 Service providers are contracted by a private company and carry out specialised outsourced tasks of a horizontal/support nature. Aligned with the Commission, the following general criteria are

fulfilled: 1) no individual contract with the Commission 2) on the Commission premises, usually with a PC and desk 3) administratively followed by the Commission (badge, etc.) and 4) contributing to the added value of the Commission.

ECHA Single Programming Document 2025-2027 106

Table 2: Multiannual staff policy plan

C a te

g o

r y a

n d

g r a d

e

Authorised

budget37 Posts actually filled

as of

31/12/202438

Envisaged establishment plan

2024 2025 2026 2027 2028

TA TA TA TA TA TA

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

AD 16 0

0 0

0

0

0

AD 15 0

0 0

0

0 1

1

AD 14 6

6 3

3 6

6 6

6 6

6 5

5

AD 13 13 1

14 4

4 11 1

12 11 1

12 11 1

12 11 1

12

AD 12 12 2

14 11 1

12 15 2

17 15 2

17 15 2

17 15 2

17

AD 11 30 1

31 17 1

18 31 1

32 31 1

32 31 1

32 31 1

32

AD 10 41 5

46 46 6

52 51 12

63 51 12

63 51 12

63 51 12

63

AD 9 60 10 1 71 41 7 1 49 60 8 1 69 60 8 1 69 60 8 1 69 60 8 1 69

AD 8 52 9

61 60 7

67 67 12 2 81 67 12 2 81 67 12 2 81 67 12 2 81

AD 7 53 9 6 68 48 4 1 53 58 6 19 83 58 6 24 88 58 6 25 89 58 6 25 89

AD 6 27 5 10 42 41 9 4 54 10 1 11 22 10 1 11 22 10 1 11 22 10 1 11 22

AD 5 16 1

17 32 6 4 42 1

1 1

1 1

1 1

1

Total AD 310 43 17 370 303 41 10 354 310 43 33 386 310 43 38 391 310 43 39 392 310 43 39 392

37 To note that the posts related to the Water directives (3 TAs and 4 CAs) were expected to come to ECHA during the year 2024 and were foreseen in the Authorised budget. However, the posts

were not received in 2024. 38 Under external recruitment: REACH: 2 TAs and BIOCIDES: 1 CA.

ECHA Single Programming Document 2025-2027 107

C a te

g o

r y a

n d

g r a d

e

Authorised

budget37 Posts actually filled

as of

31/12/202438

Envisaged establishment plan

2024 2025 2026 2027 2028

TA TA TA TA TA TA

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

R E A C H

/C L P

B io

c id

e s

E n v ir o n m

e n ta

l p o li c y

T O

T A

L

AST 11 0 0 0 0 0 0

AST 10 0 0 0 0 0 0

AST 9 3

3 0 3

3 3

3 3

3 3

3

AST 8 8

8 6

6 12

12 12

12 12

12 12

12

AST 7 10 1 2 13 12

12 23 2

25 23 2

25 23 2

25 23 2

25

AST 6 18 1

19 18 1 1 20 23 2 1 26 23 2 1 26 23 2 1 26 23 2 1 26

AST 5 26 3 2 31 17 2

19 24 2 3 29 24 2 3 29 24 2 3 29 24 2 3 29

AST 4 16 3 2 21 10 4 3 17 6 2 1 9 6 2 1 9 6 2 1 9 6 2 1 9

AST 3 10 1

11 13 2

15 2 1 1 4 2 1 1 4 2 1 1 4 2 1 1 4

AST 2 3

3 14

2 16 1

1 1

1 1

1 1

1

AST 1

0 0

0

0

0

0

Total AST 94 9 6 109 90 9 6 105 94 9 6 109 94 9 6 109 94 9 6 109 94 9 6 109

AST/SC 6 0 0 0 0 0 0

AST/SC 5 0 0 0 0 0 0

AST/SC 4 0 0 0 0 0 0

AST/SC 3 0 0 0 0 0 0

AST/SC 2 0 0 0 0 0 0

AST/SC 1 0 0 0 0 0 0

TOTAL

AD+AST 404 52 23 479 393 50 16 459 404 52 39 495 404 52 44 500 404 52 45 501 404 52 45 501

ECHA Single Programming Document 2025-2027 108

• External personnel

Contract Agents39

Contract agents

FTE corresponding

to the

authorised budget 2024

Executed FTE as at

31/12/2024

Headcount as at

31/12/202440

FTE corresponding

to the

authorised budget 2025

FTE corresponding

to the

authorised budget 2026

FTE corresponding

to the

authorised budget 202741

FTE corresponding

to the

authorised budget 2028

Function Group IV 59 38.55 38 68 73 73 73

Function Group III 63 72.70 73 74 83 82 82

Function Group II 19.5 19.21 20 9.5 0.5 0.5 0.5

Function Group I 0 0 0 0 0 0 0

TOTAL 141.5 130.46 131 151.5 156.5 155.5 155.5

Seconded National Experts

Seconded National Experts

FTE

corresponding to the

authorised budget 2024

Executed FTE as at

31/12/2024

Headcount as

at 31/12/2024

FTE

corresponding to the

authorised budget 2025

FTE

corresponding to the

authorised budget 2026

FTE

corresponding to the

authorised budget 2027

FTE

corresponding to the

authorised budget 2028

TOTAL 5 1.26 2 5 5 5 5

39 Data in the table includes CAs engaged under REACH/CLP, Biocides, Environmental policy, and Other Tasks. 40 Data in the table includes statutory staff in place on the indicated date. Posts under recruitment are not included. 41 ECHA expects stable resources in the work areas of EUON, EUCLEF, OEL, IPA, PARC, IUCLID for EFSA and SCBTH. Although the resources are dependent on the renewal of certain agreements,

continuity is presumed for the clarity of this planning exercise. Any changes to the continuity of the work or resources estimates will be reported in the next SPD update.

ECHA Single Programming Document 2025-2027 109

Table 3: Recruitment forecasts for 2025 following retirement/mobility or new requested posts (Information on the entry level

for each type of posts: indicative table42)

Job title in the Agency

Type of contract TA/Official CA

(Official, TA or CA)

Function group/grade of recruitment

internal (Brackets) and external

(single grade) foreseen for

publication43

Recruitment

Function Group

(I, II, III and IV) Due to foreseen

retirement/

mobility

New post

requested due to

additional tasks

Internal

(brackets)

External

(brackets)

Toxicologist Due to turnover CA IV

Ecotoxicologist Due to turnover CA IV

Scientific Officer - Toxicologist Due to turnover AD 5-7 AD 6

Scientific Officer - Environmental

fate Due to turnover AD 5-7 AD 6

Regulatory Officer (EU environment,

e.g. RoHs, Water, etc) Due to turnover X AD 5-7 AD 6

Communications Officer Due to turnover AD 5 -7 AD 5

Scientific Officer - Exposure

assessment Due to turnover AD 5-7 AD 6

IT officer (product manager, IT

solutions Architect, project

manager, application management,

service manager)

Due to turnover AD 5-7 AD 6

Governance Officer Due to turnover AD 5-7 AD 5

IT Assistant Due to turnover CA III

Data management and analysis Due to turnover AD 5 - 7 AD 5

Regulatory Assistant Due to turnover CA III

Risk assessment Due to turnover AD 5- 7 AD 5

42 To be updated in 2025. 43 Indication of both is required.

ECHA Single Programming Document 2025-2027 110

Annex V: Human resources - qualitative

A. Recruitment policy

Implementing rules in place:

Yes No

If no, which other implementing

rules are in place

Engagement of CA Model Decision

C(2019)3016 X

Engagement of TA Model Decision

C(2015)1509 X

Middle management Model decision

C(2018)2542 X

Type of posts Model Decision C(2018)8800

X

B. Appraisal of performance and reclassification/promotions

Table 1: Reclassification of temporary staff/promotion of officials

Implementing rules in place:

Yes No

If no, which

other

implementing rules are in place

Reclassification of TA MB/12/2023 X

Reclassification of CA Model Decision C(2015)9561 X

Average seniority in the grade among reclassified staff

Grades 2020 2021 2022 2023 2024 Actual weighted average over 5

years

Average over 5 years

(According to

decision C(2015)9563)

AD05 N/A N/A 2.75 N/A 10.92 4.18 2.8

AD06 3.34 3.57 4.34 4.07 5.06 4.10 2.8

AD07 3.31 4.17 4.44 4.41 4.56 4.20 2.8

AD08 4.84 5.28 5.04 3.92 5.73 5.07 3

AD09 6.00 6.13 5.28 5.58 7.12 6.02 4

AD10 4.50 4.32 5.00 5.00 8.58 5.94 4

AD11 4.00 N/A 10.00 6.34 7.34 6.88 4

AD12 N/A N/A N/A N/A 4.38 4.38 6.7

AD13 5.63 N/A N/A N/A 11.00 8.32 6.7

ECHA Single Programming Document 2025-2027 111

Average seniority in the grade among reclassified staff

Grades 2020 2021 2022 2023 2024 Actual weighted average over 5

years

Average over 5

years (According to

decision

C(2015)9563)

AST1 N/A N/A N/A N/A N/A N/A 3

AST2 3.35 2.68 5.48 2.96 3.85 3.43 3

AST3 3.67 4.00 4.00 2.84 3.32 4.09 3

AST4 4.02 4.10 4.96 4.60 5.00 4.31 3

AST5 3.75 6.44 4.20 4.34 4.84 4.72 4

AST6 5.00 3.17 4.34 3.50 5.00 4.05 4

AST7 4.50 4.00 N/A 5.00 5.50 4.83 4

AST8 N/A N/A N/A N/A N/A N/A 4

AST9 N/A N/A N/A N/A N/A N/A N/A

AST10 N/A N/A N/A N/A N/A N/A 5

AST/SC1 N/A N/A N/A N/A N/A N/A 4

AST/SC2 N/A N/A N/A N/A N/A N/A 5

AST/SC3 N/A N/A N/A N/A N/A N/A 5.9

AST/SC4 N/A N/A N/A N/A N/A N/A 6.7

AST/SC5 N/A N/A N/A N/A N/A N/A 8.3

ECHA Single Programming Document 2025-2027 112

Table 2: Reclassification of contract staff

Function Group

Grade Staff in activity

at

01.01.2023

How many staff members

were

reclassified in 2024

Average number of

years in grade

of reclassified staff members

Average number of

years in grade of reclassified staff

members according

to Decision

C(2015)9561

CA IV

17 3 0 N/A Between 6 and 10 y

16 9 0 N/A Between 5 and 7 y

15 12 1 4.00 Between 4 and 6 y

14 16 5 3.35 Between 3 and 5 y

13 1 0 N/A Between 3 and 5 y

CA III

11 14 1 6.00 Between 6 and 10 y years 10 29 6 5.17 Between 5 and 7 y

9 13 2 4.69 Between 4 and 6 y

8 1 0 N/A Between 3 and 5 y

CA II

6 11 0 N/A Between 6 and 10 y

5 13 3 5.24 Between 5 and 7 y

4 2 1 5.96 Between 3 and 5 y

CA I 2 0 0 N/A Between 6 and 10 y

1 0 0 N/A Between 3 and 5 y

The Agency's policy on performance appraisal and promotion/reclassification – short

description

Following the extensive work of the Inter-Agency Standing Working Group, ECHA’s has adopted by analogy in 2015 a new policy with respect to performance appraisal articulated in the ECHA

Decision (MB/27/2015) on performance appraisal of temporary agents and contracts agents

dated 18 June 2015, (implementing Article 15(2) of the Conditions of Employment of Other Servants of the European Union (CEOS) and first paragraph of Article 44 of the Staff Regulations

(for temporary agents) and Article 87(1) of the CEOS and first paragraph of Article 44 of the

Staff Regulations (for contract agents).

ECHA’s policy with respect to promotion/reclassification is articulated in the ECHA Decision (MB/12/2023) on the policy and procedure for the reclassification of temporary agents dated 21

August 2023 (implementing Article 54 of the CEOS) and in the ECHA Decision (MB/06/2016) on the policy and procedure for the reclassification of Contract Agents dated 17 March 2016

(implementing Article 87(3) of the CEOS).

As a guiding principle, ECHA’s establishment plan evolution and the annual reclassification exercise is carried out in line with the multiplication rate for guiding the average career

equivalence as provided for in Article 6 and Annex IB of the Staff Regulations, and on the basis

of comparative merit and budgetary availability. This is applicable for temporary agents.

ECHA Single Programming Document 2025-2027 113

C. Gender representation

Table 1 - Data as at 31/12/2024 statutory staff (only officials, TA and CA)44

Official Temporary

Agents

Contract

Agents Grand Total

Staff % Staff

% of

Grand Total

Staff

% of

Grand Total

Staff